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Abstract 
DNA Nanotechnology allows the synthesis of nanometer sized objects that can be site 
specifically functionalized with a large variety of materials. However, many DNA struc-
tures need a higher ionic strength than that in common cell culture buffers or in bodily 
fluids to maintain their integrity and can be degraded quickly by nucleases. The aim of 
this dissertation was to overcome this deficiency with the help of cationic PEG-poly-lysine 
block copolymers that can electrostatically cover the DNA nanostructures to form “DNA 
origami polyplex micelles” (DOPMs). This straightforward, cost-effective and robust route 
to protect DNA-based structures could therefore enable applications in biology and na-
nomedicine, where un-protected DNA origami would be degraded. 
Moreover, owing to high polarity, the DNA-based structures are restricted to the aqueous 
solution based buffers only. Any attempt to change the favorable conditions, leads to the 
distortion of the structures. In this work it was demonstrated that, by using the polyplex 
micellization strategy, the organic solubility of DNA origami structures can be improved. 
The strategy was also extended to functional ligands that are otherwise not soluble in 
organic solvents. With this strategy, it is now also possible to perform organic solution 
reactions on the DNA-based structures, opening up the possibility to use hydrophobic 
organic reagents to synthesize novel materials. The polyplex micellization strategy there-
fore presents a cheap, robust, modular, reversible and versatile method to not only sol-
ubilize DNA structures in organic solvents but also improve their stability in biological 
environments. 
A third project was based on the possibility to synthesize complementary sequences to 
single-stranded gap regions in the DNA origami scaffold cost-effectively by a DNA poly-
merase rather than by a DNA synthesizer. For this purpose, four different wireframe DNA 
origami structures were designed to have single-stranded gap regions. The introduction 
of flexible gap regions resulted in fully collapsed or partially bent structures due to en-
tropic spring effects. These structures were also used to demonstrate structural transfor-
mations with the help of DNA polymerases, expanding the collapsed bent structures to 
straightened tubes. This approach presents a powerful tool to build DNA wireframe struc-
tures more material-efficiently, and to quickly prototype and test new wireframe designs 
that can be expanded, rigidified or mechanically switched. 
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Chapter 1 Introduction 
1.1 Nanotechnology 
“Why cannot we write the entire 24 volumes of the Encyclopedia Britan-
nica on the head of a pin?”  
A challenge put forward by Feynman in 1959, 30 years before it was 
even possible to manipulate individual atoms.1 
Nanotechnology is the understanding and manipulation of science, technology, and en-
gineering at the nanoscale, which is from 1 to 100 nanometers. In this regime, matter 
exhibits an unusual behavior that enables novel applications. For instance, certain na-
noparticles display different material properties (magnetic, conduction, chemical reactiv-
ity or color) when analyzed at different conformations or sizes. Over the past couple of 
decades, basic research at the nanoscale has enabled scientists to work with nano-
materials that occur naturally and exhibit unique physical, chemical, mechanical and op-
tical properties, which are not normally found at the macro- or micro-meter regime. Figure 
1-1 gives an overview of the size comparison between various substances at nano-, 
micro- and macroscale. 
1.1.1 History of nanotechnology 
The idea behind direct manipulation and control of individual atoms and molecules was 
conceived in 1959 by the physicists Richard P. Feynman was conceived in 1959 by the 
physicists Richard P. Feynman.1 In his talk entitled, “There’s plenty of room at the bot-
tom”, Feynman suggested that it should be possible to make nanoscale machines that 
“arrange the atoms the way we want”. He presented the possibility of “swallowing the 
doctor”, an idea where he conceptualized the generation of a minuscule, swallowable 
surgical robot that could perform predefined tasks in the human body. However, the term 
“Nano-technology” was only used for the first time in 1974 by Norio Taniguchi to describe 
the fabrication process for semiconductors that involved manipulation of single atom or 
molecule.2 Later in 1986, Eric Drexler again used the term “nanotechnology” in his book 
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entitled “Engines of Creation: The Coming Era Of Nanotechnology”,3 where he put for-
ward the idea of a nanodevice, termed ‘assembler’, that would build copies of itself and 
other complex items with atomic control. Drexler was also responsible for spreading the 
knowledge and implications of nanotechnology. 
 
Figure 1-1. Size comparison of various biological assemblies and technological devices 
on a logarithmic scale from 0.1 nm to 1 mm. The nanometer regime falls in the 1-100 nm 
range. The diameter of a carbon nanotube or a single double-stranded DNA molecule is 
a 100,000 times smaller compared with the diameter of human hair. Adapted from File: 
Biological and technological scales compared-en.svg, Guillaume Paumier (CC-BY-SA-
2.5). 
In 1982, with the invention of the scanning tunneling microscope (STM), it was possible 
to visualize atoms and bonds,4 and by 1989, STM was successfully used to manipulate 
individual atoms. The same year saw the development of the atomic force microscopy 
(AFM), which is the foremost tool for imaging, measuring and manipulating matter with 
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nanoscale precision. Another breakthrough that sparked the growth of nanotechnology 
in the modern era occurred in 1985, when fullerenes were discovered.5 This discovery 
revolutionized the field of nanoscale electronics and devices, as it provided a great po-
tential to synthesize carbon nanotubes with remarkable properties (extraordinary thermal 
and electrical conductivity), including exceptional strength and stiffness.6,7 
Although the field of nanoscience and nanotechnology is relative new, nanoscale mate-
rials have been around for centuries.8 Alternate-sized gold and silver particles have been 
used by craftsmen to create vibrant colors in glass windows of medieval cathedrals (Fig-
ure 1-2-A). Colloidal gold and silver particles were also used in the fourth century roman 
Lycurgus Cup that allowed it to appear green when lit from outside while appearing as 
translucent red when lit from the inside (Figure 1-2-B). Despite their historical presence, 
it was only after the recent leaps in the area of microscopy that allowed scientists to 
understand and take advantage of the various phenomena occur at the nanoscale re-
gime. 
 
Figure 1-2. Ancient craftsmen used nanomaterials to exploit the exceptional optical ef-
fects. A) One such example is of a glass window from a medieval cathedral that was 
stained with colloidal gold and silver nanoparticle to produce vibrant colors when illumi-
nated with sunlight from the outside. B) Another example is of the fourth century Lycur-
gus cup made by artisans in Rome. They used colloidal gold and silver nanoparticles to 
create a dichroic glass that appears green when illuminated from outside (left), and red 
when illuminated from the inside (right). Reprinting with permission from The British Mu-
seum (CC BY-NC-SA 4.0). 
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1.1.2 Phenomena that occur at nanoscale 
In essence, the properties exhibited by nanomaterials are a result of the surface area to 
volume ratio. This ratio for nanoparticles is higher when compared with bulk materials of 
similar masses. Higher surface area increases the interaction with the surrounding mol-
ecules, which in turn, improves the reactivity of nanomaterials. For instance, this phe-
nomenon is employed to generate better catalysts.9,10  
Besides higher surface area to volume ratio, nanomaterials also display “quantum ef-
fect”.11,12 The quantum effects are significant only at the nanometer regime and are di-
rectly dependent on the particle size. Properties such as fluorescence, electrical conduc-
tivity, magnetic permeability, melting point, and chemical reactivity, change as a function 
of the size of the particle (Figure 1-3). For instance, in the example of the Lycurgus cup 
mentioned above, the motion of gold’s electrons is confined, which changes the way the 
particle interacts with the light, making the material appear as red or purple compared 
with yellow color of the bulk state. These quantum effect can be “tuned” by controlling 
the particle size and shape, allowing to control matter-light interactions. The ability to 
construct new processes and particles has enhanced the fields of medicine, imaging, 
computing, chemical catalysis, and materials synthesis.13 From nanoengineered batter-
ies to fuel cells and water treatment, from desalination to drug delivery and clothing in-
sulation, nanomaterials enable cleaner, safer and more affordable modes to improve 
technology in all fields of science.14–16 
1.1.3 Nature’s perspective of nanotechnology 
In nature, there are abundant biological processes take place at the nanoscale, including 
all the reactions occurring within a cell. Nature has efficiently and effectively mastered 
the way of handling nanomaterials and has built inspiring complex machines that can 
function autonomously. A very basic example is that of a double-stranded deoxyribonu-
cleic acid (DNA) molecule, which is only 2 nm in diameter and is the material responsible 
for carrying the entire genetic information of a living being. 
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Figure 1-3. An example of the quantum effect exhibited by gold nanoparticle solution 
(Gold nanorods (A); silica-gold core-shell nanoparticles (B); gold nanocages (C)), that 
enables a wide variety of colors. The color of the colloidal solutions arises from the col-
lective excitation of the conducting electrons, or ‘plasmons’, that results from the absorp-
tion of photons at different wavelengths. The absorption varies with (A) aspect ratio 
(length to width ratio), (B) shell thickness, or (C) the concentration of the gold precursor.17 
Adapted from ref. [17] with permission from The Royal Society of Chemistry. 
Understanding and drawing inspirations from nature has led to the development and 
advancements in fields beyond medicine, molecular biology and synthetic biology. The 
area of research called biomimicry, involves examining the properties and potential uses 
of natural nanostructures.18 For instance, the self-cleaning property of lotus-leaves has 
inspired the production of several objects with super-hydrophobic surfaces which are 
currently in use by the coating industry.19–22 The lotus-leaf has projections that are 
100 nm in height and can trap air, leading to the formation of super-hydrophobic sur-
faces. The water droplets just sit and slide on the surface of the leaf, keeping it dirt-
free.23,24 Another classic example of biomimicry is inspired from gecko feet and their abil-
ity to stick to surfaces reversibly.25,26 The foot of a gecko is covered with projections 
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called ‘setae’ that are further covered with thousands of 200 nm long projections. These 
projections adhere to most surfaces via van der Waals forces. This entire understanding 
has led to advancements in adhesives that can be applied and reused. 
1.1.4 Manufacturing nanomaterials 
The process of fabricating materials with at least one dimension in the nanoscale regime 
is termed nanomanufacturing. This involves both the production of nanoscale materials 
and manufacturing of parts from nanoscale materials. Nanomanufacturing uses two 
basic approaches, either top-down or bottom-up. A lot of the current research and devel-
opment is devoted to the integration of the two approaches.27–29 
Top-down approach 
The top-down approach is widely adapted in large-scale industrial manufacturing of ma-
terials and it involves fabricating the material by reducing large pieces all the way down 
to the nanoscale. This style of fabrication utilizes a lot of energy and chemicals, which 
are sometimes very toxic, and wastes excess material that is eventually discarded. A 
very common example of this approach is photolithography, which is the gold-standard 
in modern semiconducting industry for large-scale production of nanoscale devices.30,31 
Other processes like nanoimprint lithography (NIL) and electron beam lithography (EBL) 
are examples of upcoming manufacturing methods that can generate sub-10 nm fea-
tures.32–35  
Bottom-up approach 
In contrast, the bottom-up approach utilizes intermolecular forces between atomic- and 
molecular-scale components to build new products.36–38 The method is cost-effective and 
involves inexpensive tools. This approach can be time-consuming unless the concept of 
“self-assembly” is used, which is the term referring to the process where molecular com-
ponents come together spontaneously to form ordered structures guided by inter-molec-
ular interactions, including hydrogen bond, π-π stacking of the aromatic rings, Van der 
Waals and electrostatic interactions.39–42  
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Self-assembly 
The concepts of molecular self-assembly and/or supramolecular chemistry can be ap-
plied to create ensembles of nanostructures.43,44 Living cells offer countless examples of 
functional self-assemblies that control the organization of non-living systems. For in-
stance, the Watson-Crick base pairing in DNA or the enzyme-substrate interactions, are 
direct examples of self-assembly based on molecular recognition in biology. Here, mo-
lecular recognition plays an important role, which is governed by non-covalent intermo-
lecular forces. By fine-tuning the primary components on the basis of the shape, surface, 
charge, magnetic dipole, mass, etc. it is possible to improve the extent and strength of 
molecular interactions. 
So far, the conventional top-down methods are still far from achieving Feynman’s vision 
of creating miniature factories using nanomachines to build complex products. However, 
the bottom-up approach to nanofabrication involving molecular self-assembly has paved 
the way for manufacturing assemblies which can be potentially utilized to create na-
nomachines that function autonomously to further create other nanomaterials. Unfortu-
nately, despite the ongoing research, it is still very challenging to assemble molecules in 
a controlled way into complex asymmetric patterns. In this aspect, DNA can provide a 
very useful bottom-up self-assembling solution, as explored in the field of DNA nano-
technology.45,46 The work presented in this dissertation relies solely on the self-assembly 
of DNA into useful structures. The following sections briefly overview the implications of 
DNA nanotechnology. 
In essence, DNA nanotechnology employs DNA out of its biological context, and utilizes 
the basic information carrying nucleobases to assemble unnatural structural motifs in 
such a way that is controllable, programmable and uniquely addressable with functional 
elements. To understand and unfold the approaches utilized to create DNA assemblies 
(1.3), it is essential to establish a basic understanding of the DNA molecule. In the fol-
lowing section (1.2), the DNA molecule is explained from a genetics point of view (1.2.1). 
Thereafter, the focus shifts on the structural aspects of DNA (1.2.2), followed by the 
commonly used methods to synthesize DNA (1.2.3). Additionally, the stability of the DNA 
molecule is also introduced to understand the limitations that inherently come along with 
using DNA to build complex assemblies (1.2.4).  
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1.2 Deoxyribonucleic acid (DNA) 
1.2.1 DNA, the genetic material, “The secret of life”  
“With genetic engineering, we will be able to increase the complexity of 
our DNA, and improve the human race. But it will be a slow process, be-
cause one will have to wait about 18 years to see the effect of changes to 
the genetic code.” 
-Stephen Hawking 
 
Figure 1-4. The biosphere comprises of numerous living creatures, all of which comprise 
of a common source of genetic information whose chemical basis is deoxyribonucleic 
acid (DNA). The image is called ‘Entry into Noah’s Ark’ and was painted by Jan van 
Kessel in 1650. Reprinted with permission from the Museum of Fine Arts of Rennes 
(courtesy of Wikimedia Commons).  
All living organisms, be it prokaryotes or eukaryotes, reproduce themselves by passing 
down “heredity information” from one generation to another. This information consists of 
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the instructions which are necessary to generate the macromolecules that are responsi-
ble for all the functioning and properties of cells. Such structural and functional infor-
mation is stored inside cells within chromosomes that reside in the nucleus of a eukary-
otic cell or in the nucleoid of a prokaryote. Chromosomes are packed with deoxyribonu-
cleic acid (DNA), thanks to proteins (histones) that are responsible for packaging of DNA 
into chromatin fibers, so that during cell division, the chromosomes can be replicated 
and distributed in the right proportion between daughter cells. DNA is therefore the raw 
material that stores genetic information, and understanding its structure is crucial (Figure 
1-4). 
In a simplistic view, the transfer of genetic information takes place from DNA to proteins 
via RNA (ribonucleic acid). This fundamental principle in molecular biology is termed the 
“central dogma” (Figure 1-5). Whenever there is a requirement of a particular protein, the 
specific nucleotide sequence in the region of interest, or “gene”, is first copied into RNA 
with the help of RNA polymerases (via a process called transcription). Following RNA 
synthesis, proteins are produced (via a process called translation). In this essential pro-
cess, the four DNA nucleotides are the basic source of information for all living organ-
isms. 
 
Figure 1-5. The central dogma of molecular biology. 
1.2.2 Structure of DNA 
Race for the double helix 
Before James Watson and Francis Crick proposed the structure for DNA, Friedrich 
Miescher, a Swiss chemist in 1869, isolated DNA from the nuclei of human white blood 
cells and called the isolated material ‘Nuclein’.47 For many decades thereafter, DNA re-
mained understudied, as proteins were thought to hold the key for heredity. In the 1900s, 
Phoebus Levene started investigating the chemical structure of nucleic acids. He isolated 
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individual nucleotides and sugar components from both DNA and RNA, and proposed 
that nucleic acids are composed of a series of nucleotides, and that each nucleotide is, 
in turn, composed of one nitrogenous bases, a sugar molecule, and a phosphate group 
(Figure 1-6). Although his proposal of a tetra-nucleotide structure for DNA was disap-
proved, his work played a major role in decoding DNA structure.48 Nevertheless, despite 
his investigations and numerous publications, Levene dismissed DNA as the material 
responsible for heredity.  
 
Figure 1-6. Chemical composition of a nucleotide. A nucleotide is composed of three 
distinctive chemical subunits: one phosphate group (highlighted in green), a five-carbon 
sugar molecule (highlighted in grey) and a nitrogenous base (highlighted in blue) – which 
in turn can be either a pyrimidine or a purine molecule (right panel). 
It was only in 1944, that Oswald Avery and coworkers showed that a nucleic acid, deox-
yribonucleic acid (DNA), was at the core of heredity, by demonstrating that the exchange 
of DNA molecule between bacteria could modify one strain into another.49 This work had 
a major impact on Erwin Chargaff, who proposed rules that further clarified the chemistry 
of nucleic acids. He stated that in any DNA molecule the amount of adenine (A) is com-
parable to the amount of thymine (T), and similarly, that the amount of guanine (G) cor-
responds to the amount of cytosine (C), in other words the total amount of purines and 
pyrimidines is nearly equal (Figure 1-7). He also concluded that the nucleotide composi-
tion of DNA differs from species to species.50  
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Figure 1-7. Chargaff’s rules for the chemical composition of DNA that stated that the total 
amount of purines and pyrimidines is nearly equal. 
In 1953, Rosalind Franklin produced two sets of high-resolution X-ray diagrams of DNA 
fibers that paved the way for Watson and Crick to determine the three-dimensional, dou-
ble-helical model for the structure of DNA (Figure 1-8 B and C). From the X-ray diagrams, 
Maurice Wilkins and Rosalind Franklin suggested that the structure of DNA could be 
helical, with a maximum diameter of about 20 Å and the phosphate groups sticking out 
of the outside of the structural unit. Wilkins reported that the helical pitch was about 
34 Å.51,52 
 
Figure 1-8. A) The structure of a DNA molecule as described by Watson and Crick. B) 
and C) The two sets of high-resolution X-ray diagrams of DNA fibers produced by 
Rosalind Franklin that helped to determine the double-helical model for the structure of 
DNA. All the images are adapted from ref. 52 and 53. 
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The structure of DNA as described by Watson and Crick (Figure 1-8 A), comprises two 
helical chains coiled around a common axis, following a right-handed confirmation. Each 
chain is composed of phosphodiester groups that connect ß-D-deoxyribofuranose resi-
dues with linkages at 3’ and 5’ positions. Nucleobases and sugars are roughly perpen-
dicular to each other, while the nucleobases are perpendicular to the central axis. In each 
chain, the bases are located on the inside while the phosphates are facing outside at a 
distance of 10 Å from the axis. The nucleotide sequences of opposite strands run in 
reversed directions, making the two chains anti-parallel. Within the same chain, adjacent 
residues are placed at a distance of 3.4 Å, separated by an angle of 36 °, such that there 
are 10 residues in a single helical turn. Confirming the rules proposed by Chargaff, the 
two chains are held together by hydrogen bonds between purines and pyrimidines.53,54 
Figure 1-9 is a schematic representation of the above described double-helical structure 
of the DNA. 
Nucleotides in a single strand of DNA are complementary to the nucleotides of the other. 
This basic principle was termed as “Watson-crick base pairing”, which allows the rela-
tively hydrophobic bases to be packed in the interior of the double helix in an energeti-
cally favorable manner. The hydrogen-bond based base-pairing, in which adenine pairs 
with thymine via two bonds while guanine pairs with cytosine via there bonds, allows only 
the correct pairs stably interact. In addition to hydrogen bonding and hydrophobic inter-
actions, it is widely believed that DNA double-helix is significantly stabilized mainly due 
to the π – π stacking interactions between consecutive aromatic nucleobases on the 
same strand.55 
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Figure 1-9. The structure of the DNA double helix. The double helix of DNA consists of 
minor and major grooves and it 2 nm in width. The hydrogen bond interaction between 
the nucleobases are shown in the yellow box, the adenine-thymine pair is on top while 
the guanine-cytosine pair is in the bottom. The phosphodiester bonds between the suc-
cess sugar resides is highlighted in green. 
Conformations of DNA 
Depending on the level of hydration, nucleotides sequences, chromosomal packing, en-
vironmental ion content and several other factors, the structural form of the DNA double-
helix can exhibit differential handedness, length of helical pitch, total number of base 
pairs per turn and lengths of the major and the minor grooves.56,57 Currently, DNA con-
formations that are found in nature include, A-DNA, B-DNA and Z-DNA forms. B-form of 
DNA (B-DNA), as described by Watson-Crick, is the most common form, which occurs 
at high hydration levels and physiological conditions. It is right-handed and has a wide 
major groove, which makes it easily accessible to proteins. On the other hand, the A-
form of DNA (A-DNA) is found at dehydrated conditions or during hybrid pairings be-
tween DNA-RNA or enzyme-DNA. This conformation is structurally wider compared with 
B-DNA and has a narrow major groove, which reduces protein access. Both of these 
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forms are right-handed. In contrast, the Z-form of DNA (Z-DNA) is a rare left-handed 
conformation that occurs under high salt-concentrations. For regulatory purposes, bases 
undergo chemical modifications such as methylation during which DNA adopts the Z-
form.58,59 There have also been reports of protein-DNA complexes with Z-DNA.60,61 There 
have been several synthetically created conformations of DNA that so far includes: C-
DNA, E-DNA, L-DNA, P-DNA and S-DNA. However, these forms of DNA do not occur 
naturally. 
A-tracts 
Some naturally occurring structural polymorphs of B-DNA have been observed to exhibit 
inherent curvatures due to the presence of tilt-dominated base-stacking between homo-
polymeric sequences of adenine-thymine (CAnT), where n is between 4 and 8, with a 
phase repetition of 10-11 base pairs.62–64 These consecutive A-T sequences, termed ‘A-
tracts’, produce a small bend (~11-28°) towards the direction of the base pair tilt which 
is larger at the 3’ than the 5’ end. Collectively these A-tracts produce a large overall 
curvature.65,66 The potential structural conformation can be correctly explained by the 
delocalized bent model that correctly predicts the curvature on the basis of the ‘wedge’ 
model. This considers the ‘twist’, ‘tilt’ and ‘roll’ angles formed due to base-stacking be-
tween the adjacent base pairs.67,68 A-tracts have been used to manipulate the DNA to-
pography extensively to produce circular closed DNA rings.69–71 
DNA triple helix 
Other forms of DNA involve multiple strands. For instance, the triple-stranded DNA (H-
DNA) is a DNA structure with three oligonucleotides that wrap around each other to form 
a triple helix. The third strand binds to the major groove of B-DNA double-helix via 
Hoogsteen base pairs, which are non-Watson-Crick base pairs that utilizes alternative 
hydrogen-bonding patterns. 
DNA quadruplexes 
Beside duplexes and triplexes, DNA can also form quadruple helices. Guanine-rich se-
quences, form a quadruple-stranded DNA structure called G-quadruplexes.72–74 These 
helical structures can be formed by one, two or four unique strands, depending on the 
length of the nucleotide sequences. In cells, the unimolecular form occurs naturally at 
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the chromosomal end, or telomere. Guanine nucleobases form hydrogen bonds via 
Hoogsteen base pairing leading to square-planar structures that are stabilized by the 
presence of a cation. A single layer is called “G-tetrad”, and several of G-tetrads can 
stack up to form a G-quadruplex. These are biologically relevant and are present in abun-
dance in vivo. 
Similar to G-quadruplexes, cytosine-rich DNA sequences can also form four-stranded 
quadruplex structures called “i-motifs”. They too involve hoogsteen base-pairings 
between C-C, with one of the cytosines containing hemi-protonated nitrogens which is 
only possible at low pH conditions (pH 5-6). This makes i-motifs sensitive to changes in 
pH, which can convert them to a linear structure in basic conditions. The pH sensitivity 
has made it possible to use DNA as a molecular switch, by using i-motifs to tighten and 
loosen DNA rings.75,76 Quite recently, i-motifs were discovered in human cell nuclei.77  
1.2.3 DNA synthesis 
DNA nanotechnology heavily relies on the usage of chemically synthesized artificial oli-
gonucleotides. This section briefly introduces the methods of synthesizing DNA that are 
relevant to the work presented in the dissertation. DNA synthesis, in general, refers to 
the natural in vivo DNA replication mechanism or to the in vitro enzymatic polymerase 
chain reaction (PCR) that is wide used by molecular biologist. Alternatively, artificial gene 
synthesis method can also be used to produce synthetic DNA. 
DNA replication mechanism – Nature’s way of synthesizing DNA 
During the life of a multicellular organism, the vast amount of genetic information carried 
in the DNA is duplicated and transmitted in an essentially unchanged form. The high 
fidelity of this process is maintained not only by an accurate replication mechanism, but 
also thanks to the presence of DNA repair mechanisms aimed at minimizing mismatches 
and damages caused by external insults (Discussed in details in section 0). 
DNA replication is an essential process that must occur prior to cell division. For DNA 
replication to occur, the first step involves the unwinding and unzipping of the double 
helix that typically starts at AT-rich sites. This is carried out by an enzyme called helicase, 
which breaks the hydrogen bonds between complementary DNA strands. Replication is 
performed by a family of enzymes called DNA polymerases, which synthesize the new 
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strand following a 5’ to 3’ direction. The DNA polymerase binds to a short piece of RNA 
“primer” that is added on the template by a primase. Deoxyribonucleoside triphosphates 
(dNTP) act as the raw material for the synthesis of the new strand. Interestingly, DNA is 
replicated at rates as high as 1000 nucleotides per second. 
Polymerase chain reaction (PCR) – Artificial way of synthesizing DNA 
The polymerase chain reaction is the most widely used method in molecular biology to 
enzymatically synthesize specific segments of a DNA or a gene in vitro. This method can 
also be efficiently used to amplify DNA to produce thousands to millions of copies of the 
region of interest from a very small amount of DNA. Since its conception in 1985, this 
method has been used in major biological and medical research areas such as biomarker 
discovery, gene regulation, and cancer research. 
The process uses pairs of primers, forward and reverse primers that consist of short 
stretches of DNA complementary to each template strand, spanning over a region of 
interest. These primers act as initiation sites for the DNA polymerases. The method uti-
lizes thermostable DNA polymerases to synthesize counter strands in a multi-step pro-
cess involving repeated heating and cooling steps operated by an appropriately pro-
grammed machine. Each thermal cycle involves three steps, denaturation (the double-
stranded DNA is separated into two separate strands), annealing (primers bind to their 
respective positions on the two strands) and extension (DNA polymerases synthesize a 
new DNA strand, 72 °C). This cycle is repeated to produce a large number of copies of 
the original DNA molecule. 
Oligonucleotide Synthesis – Solid-phase synthesis 
Oligonucleotide synthesis is a rapid and inexpensive, chemical process to produce cus-
tom-made short fragments of nuclei acids (oligonucleotides) of the desired sequence. 
This method is used for a variety of applications in molecular biology and medicine, 
where short oligonucleotides are used as anti-sensing oligonucleotides, small interfer-
ence RNA, primers for DNA sequencing and amplification, probes for detecting comple-
mentary DNA or RNA via molecular hybridization and for artificial gene synthesis. 
The most widely used method to date is fully automated and involves phosphospho-
ramidite chemistry, in which the building blocks are derived from either 2’-deoxynucleo-
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sides, ribonucleosides or chemically modified nucleosides. Naturally occurring nucleo-
sides have active functional groups (amines, hydroxyl groups and phosphate groups) 
that cause undesired product formation, leading to inefficient oligonucleotide synthesis. 
To avoid this, all the groups are rendered inactive by the addition of protection groups. 
Protected phosphoramidite building blocks are added in a step-wise manner to the 5’-
terminus of the growing oligonucleotide chain, which is bound to a solid-support. The 
phosphoramidites are added in the desired order. Addition of each nucleoside involves 
four chemical reactions: de-blocking (removal of the protection group to obtain free 5’-
terminal hydroxyl group), coupling (addition of the appropriate nucleoside phospho-
ramidite), capping (blocking of the 5’-terminal hydroxyl group to avoid further chain elon-
gation) and oxidation (further stabilization of the phosphodiester linkage). Upon comple-
tion of the oligonucleotide assembly, the product is cleaved off from the solid phase and 
deprotected. The typical post-processing step involves high-performance liquid chroma-
tography (HPLC) purification to isolate the oligonucleotide with high purity. The major 
limitation of the process is that it is only limited to short nucleic acid sequences, as longer 
sequences tend to carry more defects. In particular, the current practical length limit is 
about 100-200 base pairs. Thousands of oligonucleotides can be synthesized in parallel 
using a DNA microarray.  
The work presented in the Chapter 5 explores several DNA polymerases in combination 
with chemically produced oligonucleotides as primers to fill single-stranded DNA ‘gap 
regions’. This combination of the techniques is achieved with the help of DNA nanotech-
nology. 
Artificial gene synthesis – DNA printing 
Artificial genes can also be produced in the laboratory by using silicon chip based gene 
synthesize techniques, known as the DNA printing technique. This method does not re-
quire pre-existing DNA sequences, and the final product is not limited by either the se-
quence or the size. DNA printing has so far been used to synthesis entire bacterial ge-
nome and yeast chromosomes consisting of nearly million base pairs.78–80 Gene synthe-
sis is an important tool in many fields of recombinant DNA technology including heterol-
ogous gene expression, vaccine development, gene therapy and molecular engineering. 
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1.2.4 Stability of DNA 
The forces that keep the two strands of a double-stranded (ds) DNA molecule together 
are susceptible to several external and internal stressors that can destabilize and dam-
age the dsDNA. Naturally occurring metabolic and hydrolytic processes can damage the 
DNA in the form of cleavage of bonds or changes in the DNA conformation, etc.81 in vivo, 
these damages are usually immediately repaired by various mechanisms. If not, DNA 
damage can lead to stalling of the replication fork or double strand breaks.82 Some of 
these damages are actively repaired by cellular mechanism, while some lead to muta-
tions that can be either harmful or beneficial. The most common stability factors and DNA 
damages are discussed below. 
Thermal stability 
DNA denaturation is the breaking of the hydrogen bonds and the base pair stacking that 
hold the two strands together. The most common method to denature a dsDNA is by 
increasing temperature. At high temperatures, the cohesive forces between consecutive 
aromatic rings destabilize, and the hydrogen bonds between the nucleobases on the 
opposing strands break. The thermodynamic stability of a dsDNA can be measured by 
identifying the “melting temperature (Tm)”, which is the temperature at which 50% of the 
nucleotides are unpaired. The Tm of a dsDNA molecule usually depends on the guanine 
and cytosine content (higher GC%, higher Tm). Other factors include the length of the 
sequence (longer sequence, higher Tm), the ionic strength of the solution (higher con-
centration of cations, higher Tm), and the DNA concentration, which can significantly 
change the Tm of a dsDNA. Determining the Tm is a crucial step for several techniques 
in molecular biology. For instance, in PCR it is important to know the Tm for the primers 
to adjust the correct temperatures for the annealing step of the process. Currently, sev-
eral computational methods can accurately predict the thermodynamic stability of the 
DNA by considering a number of factors that can affect the Tm. The most widely used 
options are NUPACK and mfold.83,84  
pH stability 
DNA is susceptible to acidic conditions, as low pH can catalyze the hydrolytic cleavage 
of the β-N-glycosidic bond, releasing the nucleobase.85–87 Purines (adenine and guanine) 
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are good leaving groups via the 9N-nitrogen, making depurination faster than depyrim-
idination. It is estimated that as many as 5,000 purines per cell are lost each day in 
humans, as compared with only 500 pyrimidines.88 Reportedly, depurination by carcino-
gens play a major role in cancer initiation.89 However, such damages to the DNA at a 
cellular level are typically repaired by base excision repair (BER).90 
The mechanism of depurination involves protonation at N-7, followed by the disruption 
of the N-glycosidic bond.91 The resulting structure can further undergo β-elimination un-
der basic conditions or in the presence of heat and salt.92 Depurination leads to the for-
mation of apurinic sites, which introduces mutations. Depurination is also one of the ma-
jor limiting factors for the production of synthetic oligonucleotides. Studies show that 
depurination was also fatal for the DNA recovered from ancient samples as it led to the 
loss of information. 
Instability due to ultraviolet radiation 
DNA is susceptible to a small fraction of the photons that it absorbs (<0.1%) as it trans-
forms the remaining into heat. When DNA directly absorbs a photon in the ultraviolet 
radiation B (UVB, 280-315 nm) range,93 this can causes the dimerization of adjacent 
thymine or cytosine bases in the sequence. This direct DNA damage can result into sun-
burn and melanoma (form of skin cancer) in humans.94,95 The photochemical dimeriza-
tion often leads to the formation of a cyclobutane pyrimidine dimers (CPD) consisting of 
a four-membered ring that can interfere with DNA replication, leading to mutations.96 The 
lesion leads to conformational changes of the DNA structure, which are sometimes re-
paired by photolyase enzymes in a process called photoreactivation.97 These lesions are 
more actively repaired by nucleotide excision repair (NER). 
Indirect DNA damage can occur when the UVB-photon is absorbed by a chromophore 
that cannot convert the absorbed energy immediately, leading to an long-lived excited 
state.98 This excited chromophore can either participate directly in a biomolecular reac-
tion with the DNA or can transfer the energy to other species, leading to the formation of 
a free radical and highly-reactive oxygen species. This chemically reactive species can 
then diffuse and cause DNA damage through the oxidation of the purine bases.  
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1.3 DNA nanotechnology 
1.3.1 Historical development 
The concept of DNA nanotechnology was laid down by a crystallographer, Nadrian 
Seeman, in the early 1980s. Seeman envisioned that a branched six-arm DNA molecule 
could form a three-dimensional crystalline material for the organization of biological mac-
romolecules such as proteins (Figure 1-10 B).99 He brought together naturally occurring 
branched DNA molecules and the four-arm Holliday junctions, as well as borrowing the 
concepts of sticky-end cohesion, ligation and reciprocal exchange of strands from ge-
netic engineers.100 With this, he was able to build an immobile Holliday junction (Figure 
1-10 A).101 To achieve that, he used unique sequences to break the two-fold symmetry 
that led to branch migration.102 Using single-stranded overhangs as ‘sticky-ends’, he 
demonstrated that it was possible to deliberately connect these junctions together to cre-
ate assemblies that can further be utilized as scaffolds to organize macromolecules in 
3D (Figure 1-10 B).103,104 These sticky-end interconnections made it possible to rigidify 
the mechanically relatively unstable and flexible Holliday junctions. 
 
Figure 1-10. The beginning of DNA nanotechnology. (A) A DNA four-way junction with 
self-complementary, single-stranded ‘sticky ends’ that self-assembles into a quadrilateral 
shape. (B) A mock-up schematic of three-dimensional DNA crystal (green) that hosts 
proteins (purple). The artistic representations in this figure were inspired from the ref. 99. 
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1.3.2 DNA tile motifs 
Introducing two reciprocal exchanges between two duplexes instead of a single one, it 
is possible to generate a double-crossover (DX) motif with five potential isomers depend-
ing on the polarity of the duplexes and the half or full helical turn separation during the 
reciprocal exchange.105,106 Compared with Holliday junctions, DX motifs are more stable 
and rigid, enough to create two-dimensional and three-dimensional geometries with pe-
riodic or aperiodic connectivity.107 Several efforts have been spent in exploring the pos-
sibilities to construct n-arm junctions,108,109 DNA cubes and truncated octahedrons,104,110 
periodic 1D and 2D DNA arrays,111,112 DNA catenanes and knots.113,114 DNA was also 
used as a dynamic component in molecular dynamics and to building the first ever pro-
totype of a nanomechanical device.115 The DX motif provides a stable immobile junction 
that inspired numerous other motifs subsequently called DNA-tile motifs where multiple 
combinations of reciprocal exchanges led to motifs such as triple crossovers (TX),116 
paranemic crossovers (PX) and its topoisomer (JX2),117,118,106,119 cross tiles (4X4 tile), 
and other morphologies including three- and six-point stars,120–122 tensegrity triangles 
and T-junctions.123–129 Figure 1-11 overviews the various DNA tile motifs. 
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Figure 1-11. DNA tile motifs. A) An example of a single reciprocal exchange between 
two DNA hairpins. Reciprocal exchange generating a four-arm junction from two double 
helices, B) shows exchange between strands of the same polarity, C) shows exchanges 
between strands of opposite polarity. D) DNA double crossover (DX) molecules pro-
duced by two reciprocal exchanges between two double-stranded molecules of opposite 
polarity. E) Paranemic crossover (PX) as a result of reciprocal exchange between two 
double-stranded molecules of same polarity. F) Three-pointed star motif, G) 4X4 cross 
tile motif, and H) six-pointed star motif. The bottom panels are the corresponding atomic 
force micrographs for two-dimensional crystal assembly using these tile motifs. From left 
to right, a double-crossover motif (DX, scale = 300 nm), paranemic crossover motif (PX, 
scale 100 nm), three-pointed star motif (scale = 75 nm), 4X4 cross tile motif (scale = 
75 nm) and six-pointed star motif (scale =75 nm). The artistic representations in this fig-
ure were inspired from the ref. 99. 
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1.3.3 Directed nucleation assembly and algorithmic assembly 
In 2003, Reif and colleagues showed that a single DNA strand can be used as template 
to direct the assembly of DX tiles into well-defined discrete structures rather than uncon-
trollable 2D crystals (Figure 1-12 A).130 This set the standard to produce complex pat-
terned aperiodic molecular structures, which typically presents a major challenge in nan-
otechnology. In this design, the template DNA strand stores and carries information that 
is pre-encoded in the form of a 5-bit code. The resulting pattern and bit value can be 
modified by reprogramming the template strand. Similarly, an octahedron was con-
structed using a continuous 1700 nucleotide long template DNA strand with the help of 
five synthetic 40-mer oligonucleotide strand (Figure 1-12 B).128 The complex structure 
constituted 12-uniquely addressable struts (five DX and seven PX) that assembled in to 
an octahedron without many misfoldings and purification steps. These assembly strate-
gies inspired the scaffold DNA origami technique and is discussed in detail in the follow-
ing section. 
Aperiodic DNA crystals can be assembled using principles that are borrowed from com-
puter science. This algorithmic self-assembly method has been used for DNA computing. 
The working principle was shown using ‘Wang tiles’, where four independent sides of a 
square tile were defined by unique sequences, and the assembly only proceeded when 
a neighboring tile with a complementary sequence was available.131 There are several 
limitations to this process, as growth was hindered due to mismatches that made the 
assembly error-prone. Despite these limitations, the recent advances in DNA nanotech-
nology enabled error-free algorithmic DNA assembly. It recently was demonstrated by 
Woods et al. that a diverse set of molecular algorithms can be executed with error-rates 
as low as 1 in 3,000.132 The group constructed 21-distinct circuits that executed algo-
rithms including copying, sorting, counting, etc. By using pre-programmed molecular in-
teractions, DNA tiles that can further be reprogrammed to implement any one of the wide 
range of algorithms using a 6-bit code. 
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Figure 1-12. Examples of directed nucleated assembly and algorithmic self-assembly of 
DNA. A) Self-assembly of a barcode lattice design around a pre-programmed scaffold 
DNA strand. The design uses antiparallel DNA DX tile with two hairpin loops that serve 
as topographic markers in AFM imaging. The ‘red’ input scaffold strand is required for 
the assembly of tiles and consists of stem loops. The barcode information (01101 in this 
example) is represented by either the presence (designated as 1) or the absence (des-
ignated as 0) of a stem loop. AFM visualization of the barcode confirms the assembly. 
Adapted with permission from ref. [130]. Copyright (2003) National Academy of Sci-
ences. B) DNA octahedron assembled from a 1,669-nucleotide long single-stranded 
DNA and five 40-mer oligonucleotides. The design consists of five DX struts and seven 
PX struts. The outcome was visualized by cryo-electron microscopy. Adapted with per-
mission from Springer Nature: Nature [128], copyright (2004). 
  
1.3 DNA nanotechnology 
 
25 
 
1.3.4 Scaffolded DNA origami and single-stranded DNA tiles 
The advent of stable immobile branched junction motifs made DNA a good candidate for 
building frameworks for functional molecules. Despite this success, DNA tile-based 
nanostructures pose certain limitations as they are based on the interactions between a 
large number of short nucleotides, which restrict complexity. The requirement of multiple 
reaction steps and several rounds of purification leads to a reduced yield of the end 
product. Additionally, the yield of correctly assembled structures is highly sensitive to the 
stoichiometry of the oligonucleotides. Therefore, to produce structures without many as-
sembly defects and avoid the above mentioned limitations, in 2006 Paul Rothemund 
developed the “scaffolded DNA origami” technique (Figure 1-13 A). This used 7-kilobase 
long ‘scaffold’ single-stranded DNA derived from bacteriophages, was capable of folding 
into a desired pattern via a ‘one-pot’ assembly with the help of several short ‘staple 
strands’.133 The DNA origami technique revolutionized the field of DNA nanotechnology 
– arguably unlike any single advances before. With this method, any arbitrary design can 
now be obtained by using the open source software package, caDNAno.134 For detailed 
understanding of the technique and to get all the insights on the folding pathway kinetics 
please refer to the extensive work by the Dietz group.135,136 
A similarly simple, robust and modular, ‘one-pot’ assembly approach was demonstrated 
in 2012 by Yin and coworkers (Figure 1-13 B). The team made use of computer-aided 
design for the conception of complex arbitrary structures, assembled using several hun-
dred oligonucleotides but without the need for a long scaffold strand.137 This method was 
termed as the ‘single-stranded tile’ or ‘brick’ assembly, and short oligonucleotides con-
taining four modular domains as building blocks to construct a canvas with 310-uniquely 
addressable pixels. Over 100 distinct two-dimensional shapes were demonstrated.  
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Figure 1-13. Scaffolded DNA origami and single-stranded tile assembly. A) The scaf-
folded DNA origami technique utilizes a long ‘scaffold’ single-stranded DNA in combina-
tion with short ‘staple’ strands to self-assemble a desired shape. The staple strands hold 
the scaffold in place. Right panel shows various DNA origami shapes with the respective 
folding path and AFM images. Scale bars = 100 nm. Adapted with permission from 
Springer Nature: Nature [133], copyright (2006). B) The single-stranded tile assembly 
technique uses a 42-nucleotide long motif that consists of four domains and by designing 
distinct binding interactions is it possible to assemble a DNA lattice composed of parallel 
helices connected by single-stranded linkages forming a ‘brick-wall’ pattern that can also 
be viewed as ‘molecular canvas’. Right panel shows a collection AFM images of complex 
shapes assembled using the molecular canvas. Each image is 150 nm X 150 nm in size. 
Adapted with permission from Springer Nature: Nature [137], copyright (2012). 
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1.3.5 Expanding the design space offered by DNA 
Scaffolded DNA origami and the single-stranded tile methods laid the foundation for 
higher-order and large-scale construction of DNA nanostructures. Combining basic DNA 
interactions (sticky-end cohesion, hybridization and base-pair stacking) with the creative 
design strategies mentioned in the previous paragraph, a large variety of DNA nanostruc-
tures have been designed over the past decade. 
Sticky-end cohesion  
The principle of sticky-end cohesion is based on extended single-stranded DNA se-
quence that can hybridize to neighboring motifs. This concept was used by Seeman and 
coworkers to interconnect n-arm junctions and double crossover tiles to construct 1D and 
2D arrays that could reach the millimeter scale. Mao et al. built large 2D arrays that 
reached 40 µm in size, which were composed of three- or six- pointed stars with the help 
of multiple sticky ends. He also demonstrated the possibility to switch from a 1D to a 2D 
array by just modifying the number of sticky ends.121,122 Qian et al. designed planar 
square DNA origami tiles with protruding sticky end that hybridized into larger 2D struc-
tures spanning up to nearly 1 µm2 (Figure 1-14).138,139 The group further used the DNA 
surface as a canvas to display patterns with nanometer resolution. Similarly, 3D 
nanostructures could be formed in a densely ordered fashion by sticky-end hybridiza-
tions. Yin et al. constructed 3D structures with dimensions of 100 nm X 100 nm X 100 nm 
that were assembled using ~30,000 DNA bricks.140 
Base-pair stacking and blunt-end interactions 
Together with Watson-Crick base-pairing interactions, the π-π stacking interaction be-
tween adjacent aromatic rings of the nucleobases play a major role in stabilizing DNA 
duplexes. DNA binding kinetics following base-pair stacking are well-studied and it is 
established that a CG/GC pair exhibits a stronger base-pair stacking than a AT/TA pair. 
In 2011, Woo and Rothemund demonstrated that blunt-end stacking can serve a basis 
for molecular recognition in DNA (Figure 1-15 A).141 They used 2D DNA origami struc-
tures to generate controlled geometric arrangements on the basis of 16-bit binary codes 
and shape complementarity. Recently, Sacca et al. used a combination of shape com-
plementarity dependent base-pair stacking interactions and base-pairing to construct 
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long polymeric DNA filaments with tunable bending stiffness and persistence length (Fig-
ure 1-15 B). They demonstrated the possibility to generate stiff DNA filaments with per-
sistence length 1000-fold higher than double-stranded DNA (50 nm) and more than two 
times the value of natural actin filaments (~15 µm).142 
 
Figure 1-14. Example of large-scale ‘fractal assembly’ of DNA origami assembly based 
on sticky-end cohesion.138 A) Planar square DNA origami tiles with protruding sticky ends 
hybridized into larger 2D structures spanning up to nearly 1 µm2. B) The DNA surface 
can be used as a canvas to display patterns with nanometer resolution. Adapted with 
permission from Springer Nature: Nature [138], copyright (2017). 
Simmel et al. produced large-scale and ordered assemblies on the surface of mica. DNA 
origami structures interacted through blunt-end stacking and surface mobility was elec-
trostatically controlled (Figure 1-15 C).143 The interaction of individual species to the sur-
face is typically directly dependent on the concentration of magnesium ions, which serve 
as salt bridges between the charged mica surface and the phosphate backbone of the 
DNA molecule. These interactions were weakened in the presence of monovalent cati-
ons such as sodium ions. A similar approach was used by Sugiyama et al. to prepare 
micrometer-sized 2D lattices on lipid-bilayers (Figure 1-15 D).144 Dietz et al. used base-
pair stacking and shape complementary to generate 3D assemblies with molecular 
weights ranging in the gigadalton (GDa) scale (Figure 1-15 F).145 The resulting tubes 
consisted of wedge-shaped building blocks and were 350 nm in diameter and over 1 µm 
in length. Inspired by Seeman’s idea of organizing functional elements on 3D lattices, 
Liedl et al. demonstrated 3D DNA origami crystals by blunt-end stacking interactions 
(Figure 1-15 E).146 The group used the tensegrity triangle motif of DNA origami as the 
monomeric unit to construct micrometer-scale 3D rhombohedral polycrystalline with cav-
ities to host a wide variety of components, including for instance gold nanoparticles. 
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Figure 1-15. Examples of large-scale DNA origami assemblies using base pair stacking 
and blunt-end interaction based. A) Blunt-end stacking of 2D DNA origami structures for 
controlled geometric arrangements on the basis of 16-bit binary codes and shape com-
plementarity (Scale = 60 nm).141 Adapted with permission from Springer Nature: Nature 
Chemistry [141], copyright (2011). B) Long polymeric DNA filaments assembled using 
the combination of shape complementarity and base-pairing (Scale = 100 nm).142 
Adapted with permission from ref. [142]. Copyright (2018) American Chemical Society. 
C) Large-scale assemblies of DNA origami structures with blunt-end on the surface of 
mica by electrostatically controlled adhesion and mobility.143 Adapted with permission 
from John Wiley and Sons: Angewandte Chemie International Edition [143], copyright 
(2014). D) Micrometer-sized 2D lattices on lipid-bilayer (Scale = 100 nm).144 Adapted 
from ref. 144 (CC BY 4.0). E) 3D DNA origami crystals by blunt-end stacking interactions 
with host molecules (Scale = 500 nm).146 Adapted with permission from John Wiley and 
Sons: Advanced Materials [146], copyright (2018). F) 3D assemblies with molecular 
weights ranging in the gigadalton (GDa) scale using base-pair stacking (Scale = 
50 nm).145 Adapted with permission from Springer Nature: Nature [145], copyright (2017). 
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1.3.6 Assembling heterogeneous materials with DNA 
As discussed in the previous sections (1.1.2), nanomaterials exhibit intriguing properties 
that are not observed in bulk materials. One of the central challenges in nanotechnology 
is the precise organization of these nanomaterials. DNA nanotechnology provides unique 
addressable templates that have been used to organize inorganic or organic nanomateri-
als into complex superstructures through programmable hybridization. With the added 
benefit of the DNA origami technique, complicated architectures can be utilized.147,148 
The following subsections summaries some of the prominent examples in the field where 
inorganic nanomaterials or biological molecules were organized using DNA origami 
structures. 
Inorganic nanomaterials 
A key requirement to use DNA as a template for organization, is the modification of inor-
ganic nanomaterials with DNA. Alivisatos et al. and Mirkin et al. were the first ones to 
report the usage of DNA to organize gold nanoparticles (AuNPs).149,150 Both used thiol-
modified DNA strands to functionalize the surface of AuNPs to create DNA-nanoparticle 
conjugates that further self-assembled into distinct ‘aggregates’. These reports led to 
numerous DNA architectures based on the controlled organization of AuNPs using sim-
ple DNA tiles assemblies.126,151–155 Yan and coworkers positioned AuNPs linearly on a 
triangular 2D DNA origami.156 This report paved the path for several DNA origami-nano-
particle architectures that were extensively used to exploit the novel properties of nano-
particles.157–160 Gang and coworkers demonstrated 3D arrangement of nanoparticles by 
using tetrahedron-shaped origami with AuNPs attached to the four vertices (Figure 1-16 
A). The tetrahedrons served as the building block for the construction of highly-ordered 
face-centered cubic lattice. Together with varying the basic unit structure and the posi-
tioning and size of the particles, the group demonstrated a wide-range of crystallographic 
lattice arrangements.161 Similar to AuNPs, silver nanoparticles (AgNPs) were also orga-
nized into different arrangements, including the bow-tie antenna configuration on a rec-
tangular DNA origami (Figure 1-16 B).162–164 
Besides metal nanoparticles, quantum dots can also be organized using DNA origami 
structures.165–168 Quantum dots (QDs) are semiconducting zero-dimensional nanocrys-
tals that exhibit unique optical and electronic properties that can be used for a wide range 
of application, replacing the larger light-emitting diode (LED) particles. Several studies 
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have explored the QD-DNA origami architectures with programmable assembly either by 
directly functionalizing the QDs or by using the commercially available streptavidin func-
tionalized QDs (Figure 1-16 C).169,170 Liddle and coworker used the latter to test variety 
of factors that affect the yield of QDs and monitored it in real-time using single particle-
tracking system.171,172 They also reported that by tuning the relative position of the QDs 
and placing them in close proximity to gold nanoparticles, it is possible to tune the fluo-
rescence lifetimes.173 
 
Figure 1-16. Assembly of inorganic nanomaterials using DNA origami. A) Tetrahedron-
shaped origami with AuNPs attached in the center formed the basic unit structure that 
can further be assembled with other units into a highly-ordered face-centered cubic lat-
tice.161 Adapted with permission from The American Association for the Advancement of 
Science: Science [161], copyright (2016). B) Silver nanoparticles in a bow-tie antenna 
configuration on a rectangular DNA origami.163 Adapted with permission from John Wiley 
and Sons: Small [163], copyright (2013). C) Streptavidin coated quantum dots in a 1D 
linear array arrangement on a DNA origami nanotube.170 Adapted with permission from 
ref. 170, copyright (2010), American Chemical Society. D) Alignment of SWNTs pairs 
into linear parallel orientation with programmable spacing using multiple DNA origami 
constructs.174 Adapted with permission from American Chemical Society: Journal of the 
American Chemical Society [174], copyright (2013). 
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DNA origami structures have also been used to arrange one-dimensional single-wall car-
bon nanotubes (SWNTs) in to precise linear assemblies. SWNTs exhibit exceptional 
electronic properties and have been extensively studied for superior synthesis, disper-
sion, sorting on the basis of length or electronic property, and modifications.175–177 How-
ever, arrangement of SWNTs into complex geometry for large-scale production remains 
challenging. Maune et al. demonstrated a general method to immobilize SWNTs in two 
dimensions using rectangular DNA origami.178 They used single-stranded DNA ‘hooks’ 
with thymine repeats (poly-T) that are known to bind to SWNTs sidewalls by π-π inter-
actions, which prove to be sufficient to solubilize and stabilize individual SWNT against 
aggregation in aqueous solutions.179,180 A similar strategy was also used by Zhao et al. 
to place SWNTs of discrete lengths around triangular- and rectangular-shaped 2D DNA 
origami.181 Mangalum et al. aligned SWNTs pairs with programmable spacing by using 
multiple DNA origami constructs into linear parallel orientations exceeding 500 nm in 
length (Figure 1-16 D).174 Alternatively, SWNTs were assembled on DNA origami with 
directional and spatial control with the help of biotin-streptavidin interactions.163 It is im-
portant to note that the biotins were placed on the SWNTs with the help of single-
stranded DNA, similar to previously mentioned approaches. 
Biomolecules  
The solid-phase DNA synthesis method enables the possibility of addition of various 
chemical groups (amine, carboxyl, thiol, azide, etc.) at terminal positions, internally, on 
the nucleobases, or the phosphate backbone of oligonucleotides. This enables the bio-
conjugation of DNA structures with other biomolecules. Using these modified oligonucle-
otides, peptides and proteins can be organized with spatial control on DNA origami tem-
plates.182,183 By controlling the intermolecular distances with the help of DNA, it is also 
possible to study the distance-dependent molecular interactions between biomolecules. 
However, it is important for protein-DNA conjugation processes to maintain the function-
ality and activity of proteins. Yang et al. reported an extensive review summarizing the 
advantages and disadvantages of all the possible protein-DNA conjugation methods, in-
cluding non-covalent binding and covalent binding with or without site-specific meth-
ods.184 Depending on the protein and the application a particular method can be ex-
plored. 
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There have been several reports on the organization of proteins into patterned arrays 
using DNA structures.185,186 Yan and coworkers reported several 2D nanoarray templates 
functionalized with aptamers, that recognize a variety of proteins (Figure 1-17 A).187 As 
a proof-of-principle, they patterned periodic arrays with alternative human α-thrombin 
binding and platelet derived growth factor (PDGF) binding aptamers. Building on the 
similar idea, Dietz and coworkers developed a method that used DNA origami to create 
a molecular support for structural determination by cryo-electron microscopy of transcrip-
tion cofactor p53 (Figure 1-17 B).188 The spatial control over the relative orientation of 
the protein-DNA complexes further facilitate the structure determination. 
Hariadi and coworkers engineered a biomimetic DNA origami system to precisely pattern 
the molecular interaction between groups of myosin V and myosin VI motors, and model 
2D cellular actin networks, to study their inter-motor interactions and to understand their 
role towards the collective movement of myosin on cellular actin networks.189 They also 
engineered a myosin-patterned circular gliding path for actin filaments with the help of 
DNA origami to monitor robustness of the motors and study the long-term behavior.190 
Similarly, kinesin and dynein motor proteins were organized on 12-helix bundle DNA 
origami to study the opposite-polarity behavior in form of a “tug-of-war” as a function of 
stoichiometry.191 Fu et al. also exploited spatially addressable DNA origami structures to 
systematically study an enzyme cascade (Figure 1-17 C).192 They reported sharp transi-
tions in the cascade activity as a function of inter-enzyme distances with the help of 
glucose oxidase/horseradish peroxidase enzyme pairs. They further demonstrated a 
substantial enhancement in the activity of the enzyme pair by the insertion of a non-
catalytic protein bridge in between. In a recent study, Högberg and coworkers used sur-
face plasmon resonance to study the spatial tolerance of antibodies to bind to antigens. 
For that, they patterned antigens on immobilized DNA origami and used antibodies with 
identical antigen-binding domains (Figure 1-17 D). They found that the bivalent-binding 
of antibodies takes place preferentially to two antigens that are separated at distances 
that range from 3 to 17 nm.193 
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Figure 1-17. Assembly of biological molecules using DNA origami. A) Periodic 2D multi-
protein DNA origami nanoarray templates functionalized with human α-thrombin binding 
and platelet derived growth factor (PDGF) binding aptamers.187 The array on the left has 
alternatively patterned thrombin (grey) and PDGF (yellow). The array on the right repre-
sents ‘S’-shaped array of thrombin. The corresponding AFM images are represented 
underneath the schematic representation. Adapted with permission from ref. [187]. Cop-
yright (2007) American Chemical Society. B) Design of the support structure built from 
DNA origami for structural determination by cryo-electron microscopy of transcription co-
factor p53 (red and the zoomed in representation).188 Adapted with permission from ref. 
[188]. Copyright (2016) National Academy of Sciences. C) Schematic representation of 
the spatially addressable DNA origami structures to systematically study an enzyme cas-
cade.192 The cascade activity was tested with the help of glucose oxidase/horseradish 
peroxidase enzyme pairs, along with the insertion of a non-catalytic protein bridge in 
between. Adapted with permission from ref. [192]. Copyright (2016) American Chemical 
Society. D) Schematic representation of immobilized DNA origami patterned with anti-
gens (left) and using antibodies with identical antigen-binding domains to study the spa-
tial tolerance of antibodies to bind to antigens (right).193 Adapted with permission from 
Springer Nature: Nature Nanotechnology [193], copyright (2019). 
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1.3.7 Functional devices built using DNA nanostructures 
Together with the modularity, unique structural motifs and self-recognition properties, 
DNA nanostructures can be used to produce reconfigurable and autonomous devices. 
So far, the research in this field has produced several controllable devices that have a 
useful non-equilibrium behavior. By tailoring the DNA sequences of structures, it is pos-
sible to store a defined set of instructions to perform tasks in the form of translational or 
rotational motion in response to specific molecular interactions or to some external stim-
uli or molecules. The following subsections summarize the various functional devices 
that have been built using DNA nanostructures. 
Strand displacement mediated devices 
The most common controllable DNA systems are based on strand displacement. In mo-
lecular biology, strand displacement is mediated by enzymes such as DNA polymerases. 
In contrast, the strand displacement in DNA nanotechnology is an enzyme-free process 
controlled by DNA hybridization. For this, one or more pre-hybridized DNA strands are 
displaced by a partially or fully complimentary strand. The displacement mechanism is 
initiated at single-stranded domains (referred to as toeholds). The rate of strand displace-
ment reactions can be quantitatively controlled by varying the length and sequence com-
position of the toehold, allowing to engineer the kinetics of the synthetic DNA devices.  
The strand displacement technique, in DNA nanotechnology, was pioneered by Yurke et 
al. where they demonstrated a set of DNA tweezers cycling between a closed and an 
open state by successive additions of complementary single-stranded DNA.194 Anderson 
et al. used a similar mechanism on a hollow 3D box constructed out of six 2D origami 
sheets with a controllable lid that was functionalized with a dual “lock-key system” out of 
DNA duplexes with sticky-end extensions that provided a toehold for the displacement 
by the ‘key’ (Figure 1-18 A).195 Grossi et al. took the method a step forward by placing 
an enzyme inside a ‘nanovault’ (Figure 1-18 B).196 The activity of the enzyme was dras-
tically reduced when encapsulated inside a closed vault. Tomaru et al. used strand dis-
placement to perform rotational motion with the help of a dynamic DNA origami ‘rotor’ 
that was supported on a ‘base’ (Figure 1-18 C). The rotor exhibited stepping operation 
when sequentially fed with four different signal DNA strands.197 Castro and coworkers 
presented studies towards understanding the basic aspects of the dynamics of DNA de-
vices by studying and predicting geometries and mechanical properties exhibited by 
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structural changes.198,199 Zhou et al. built a device that underwent deformation based on 
the entropic elasticity of single-stranded DNA.200 The structures could be bent into ge-
ometries with tunable curvature that can be controlled by the length of the ssDNA 
strands. Similar to this design they built another structure with two stable states and 
studied the free energy landscape as the structure underwent transformations between 
the two states (Figure 1-18 D).201 The actuation was demonstrated by strand-displace-
ment. 
 
Figure 1-18. Strand-displacement mechanism based dynamic DNA origami structures. 
A) Hollow 3D box with a controllable lid that was functionalized with a dual “lock-key 
system” out of DNA duplexes with sticky-end extensions that provided a toehold for the 
displacement by the ‘key’.195 The opening the lid was observed by a FRET pair repre-
sented by star and circle. Adapted with permission from Springer Nature: Nature [195], 
copyright (2009). B) ‘Nanovault’ design with the placement of a single enzyme inside 
(pink).196 The opening and closing of the vault is bases on sequence specific strand-
displacement mechanism. Adapted from ref. 196 (CC BY 4.0). C) Dynamic DNA origami 
‘rotor’ (red) supported on a ‘base’. The rotor exhibits stepping operation when sequen-
tially fed with four different signal DNA strands.197 Adapted from ref. 197 with permission 
from The Royal Society of Chemistry. D) Studying the free energy landscape as the 
structure underwent transformations between the two stable states.201 The actuation was 
demonstrated by strand-displacement. Adapted with permission from ref. 201, copyright 
(2015), American Chemical Society. 
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Molecular detection devices 
In the past years, numerous DNA devices were demonstrated that underwent structural 
transformations in the presence of specific molecules. Such a molecular detection device 
was presented by Kuzuya et al., that used DNA origami ‘pliers’ constituted out of two 
arms that would close into a locked state in response to the binding of either a protein, 
metal ion or miRNA (Figure 1-19 A). The single-molecule binding event led to a change 
in the confirmation into an immobile orientation that was detected by AFM.202 Similarly, 
Hudoba et al. designed a device that fluctuated between an uncompressed and com-
pressed state in response to the depletion forces caused by molecular crowding agents 
(like poly(ethylene-glycol) (PEG)) (Figure 1-19 B).203  
Certain specific molecular interactions were also explored with the help of aptamers, 
which are oligonucleotides with high binding affinity to specific target biomolecules. 
Douglas et al. built a logic-gated DNA ‘nanorobot’ that was designed to delivery molec-
ular payloads to target cells (Figure 1-19 D). The enclosed ‘cargo’ was exposed only 
when two different triggers were detected by the different combinations of aptamers.204 
A similar aptamers based drug delivery nanorobot was also presented by Li et al., where 
they used a rectangular DNA origami sheet to enclose a coagulation protease that was 
only exposed when nucleolin binding aptamers were triggered (Figure 1-19 C).205 Both 
these DNA nanorobots present a promising strategy for targeted drug-delivery and in 
vivo therapeutics. 
External physical stimuli triggered devices 
Several DNA devices also have the potential to be triggered by external stimuli such as 
light, temperature, pH etc. Yang et al. proposed such a device that used photo-induced 
isomerization of azobenzene moieties (Figure 1-20 A). They built hexagonal DNA ori-
gami rings functionalized with azobenzene-oligonucleotides on either one, two or side 
sides that assembled into distinct predesigned patterns and disassembled when irradi-
ated by UV light.206 Kohman and Han used a similar photo-cleavable linker in the form of 
othro-nitrobenzyl-group that enabled the transformation of a sphere shaped DNA struc-
ture into two tethered hemispheres (Figure 1-20 B).207 
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Figure 1-19. Dynamic DNA devices that respond to molecules present in the surrounding 
environment. A) Molecular detection device that used DNA origami ‘pliers’ constructed 
out of two arms that would close into a locked state as a response to the binding of a 
protein, metal ion or miRNA.202 Adapted with permission from Springer Nature: Nature 
Communications [202], copyright (2011). B) DNA origami device that fluctuated between 
an uncompressed and compressed state in response to the depletion forces caused by 
molecular crowding agents (like PEG).203 Adapted with permission from ref. 203, copy-
right (2017), American Chemical Society. C) A rectangular DNA origami sheet enclosing 
a coagulation protease that is only exposed when nucleolin binding aptamers were trig-
gered.205 Adapted with permission from Springer Nature: Nature Biotechnology [205], 
copyright (2018). D) A logic-gated DNA ‘nanorobot’ that was designed to deliver molec-
ular payloads only to targeted cells.204 Adapted with permission from The American As-
sociation for the Advancement of Science: Science [204], copyright (2012). 
Turek et al. proposed thermo-responsive actuation of a DNA ‘Flexor’ device with the help 
of poly(N-iso-propylacrylamide) (PNIPAM) (Figure 1-20 C). PNIPAM is a temperature 
sensitive polymer that exhibits a phase transition by the breaking of the hydrogen bonds 
at temperatures above 32 °C that results in increased hydrophobicity and change in the 
confirmation from a coiled-to-globule state.208 Kopperger et al. (Figure 1-20 D) and Lau-
back et al., in separate studies, demonstrated a dynamic device that controlled the move-
ment of a ‘robotic arm’ exclusively by external electric or magnetic fields respec-
tively.209,210 Both these studies display an extraordinary example of DNA devices that 
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were not only enabled control the motion of DNA structures but also exhibited the ability 
to move inorganic nanoparticles with precise control over the direction and speed. The 
robotic arms could serve a wide variety of purpose ranging from transport of molecular 
cargo, force-induced studies, molecular manipulation and ultimately helping in the reali-
zation of the nanomachine-based assembly line as envisioned by Feynman and Drexler.  
 
Figure 1-20. Dynamic DNA devices triggered by external stimuli. A) Hexagonal DNA 
origami rings that uses photo-induced isomerization of azobenzene moieties to assem-
ble into distinct predesigned patterns and disassembled when irradiated by UV light.206 
Adapted with permission from ref. 206, copyright (2012), American Chemical Society. B) 
Sphere shaped DNA structure functionalized with photo-cleavable linkage in the form of 
othro-nitrobenzyl group that allows for the transformation of the sphere into two tethered 
hemispheres.207 Adapted from ref. 207 with permission from The Royal Society of Chem-
istry. C) Thermo-responsive actuation of DNA ‘Flexor’ functionalized with poly(N-iso-
propylacrylamide) (PNIPAM). The hydrogen bonds in PNIPAM break at temperatures 
above 32 °C that results in increased hydrophobicity and change in the confirmation from 
a coiled-to-globule state.208 Adapted with permission from John Wiley and Sons: Ad-
vanced Functional Materials [208], copyright (2018). D) Dynamic systems that controlled 
the movement of a ‘robotic arm’ exclusively by external electric fields.209 Adapted with 
permission from The American Association for the Advancement of Science: Science 
[209], copyright (2018).
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Chapter 2 Motivation and objectives 
DNA nanotechnology enables bottom-up self-assembly of a comprehensive set of dis-
crete objects with dimensions ranging from the nanometer to the micrometer scale. How-
ever, the use of DNA based structures faces certain limitations when aiming for real-
world applications such as in next-generation optoelectronic circuits or cellular delivery 
for therapeutics or diagnostics applications.  
Increase stability (Chapter 3). DNA structures can disassemble when removed from 
their assembly medium, which usually is an aqueous saline solution. Moreover, they 
cannot sustain high temperatures or extreme pH conditions and can be degraded by 
various exonucleases present in many body fluids such as saliva or blood. One possible 
way to improve the mechanical and chemical sustainability of DNA origami is by shielding 
the structures inside a protective shell.  
The initial goals of this dissertation were to shield the DNA-based structures by using 
either of the two methods: Silica encapsulation of DNA origami structures and PEG block 
copolymer micellization of DNA origami structures.  
The silica encapsulation approach was however, discontinued due to lack of reproduci-
bility and is not discussed in this dissertation. Recently, several reports were published 
that have used that envisioned route to achieve controlled and reproducible silica encap-
sulation of DNA nanostructures.211,212 
The PEG block copolymer micellization approach was chosen to build a protective poly-
meric shell around the DNA origami structures that could help improve the stability in 
harsh organic environments by increase its ability to endure against digestion enzymes 
and extreme buffer conditions. Surface modification by poly(ethylene glycol) (PEG) is 
acknowledged as a powerful strategy to fabricate biocompatible materials. This approach 
is discussed in Chapter 3. 
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Solubility in organic solvents (Chapter 4). In addition to improving the stability of DNA-
based structures in harsh environments, the PEG block copolymer micellization ap-
proach was also explored to improve organic solubility. DNA is a highly polar biomolecule 
due to the presence of negatively charged phosphate groups in its backbone that makes 
it inherently stable in high-dielectric environments like water and makes it impossible to 
be soluble in pure organic solvents. To address this, the use of block copolymers could 
render DNA-based structures soluble in organic solvents and help expand the possibili-
ties of using low-polar buffers. This approach is discussed in Chapter 4 where the 
method was also tested for compatibility with bulky functionalities as well such as inor-
ganic nanoparticles (gold), biomolecular functionalities (streptavidin) and fluorescent 
molecules (Cy5 and Cy3). Additionally, the goal was to also confirm if the strategy al-
lowed the functionality of DNA origami in organic solvent with hydrophobic organic rea-
gents. We aim to establish this method with the hope that it could potentially lead to new 
organic reaction and products that utilizes the subnanometer-precise placement feature 
of DNA origami structures. 
Cost-effective production (Chapter 5). Another direction that was explored in this is 
dissertation was to find a way to make DNA origami cost-effective. Currently, DNA nan-
otechnology relies heavily on the use of costly modified or unmodified DNA oligonucleo-
tides. Towards that, we aim to use DNA polymerases to fill designed single-stranded gap 
regions in DNA origami triangulated truss structures. With this approach the aim was to 
transform the chemical energy obtained by the DNA polymerases into forces capable of 
mechanically transforming the structures. This approach is discussed in Chapter 5. Fur-
thermore, the final goal of the DNA polymerase assisted gap filling approach was to 
provide a cheap in-house, versatile and a competitive approach to insert functional ele-
ments (like, fluorophores) at any desired location in the DNA origami structures. This 
approach is however not discussed as it was not established in the duration of the dis-
sertation. 
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Chapter 3 Block copolymer micellization as 
a protection strategy for DNA ori-
gami 
The work presented in this chapter is published and sections 3.2, 3.3 and 3.5 were 
adapted with permission from John Wiley and Sons: Angewandte Chemie International 
Edition ref. [A], Copyright (2017). The artistic representations in all the figures in this 
chapter were produced in collaboration with Michael Matthies. The DLS analysis for pol-
yplexed ssDNA-AuNPs was performed by Saranya Muthusamy. The FRET studies were 
performed by Katarina Iric. All the contributors are former members of the group of 
Dr. Thorsten-Lars Schmidt at the Center of Advancing Electronics Dresden, TU Dresden. 
3.1 Introduction 
3.1.1 Cellular delivery of DNA nanostructures 
DNA nanotechnology allows the self-assembly of objects with programmable shapes and 
topologies using synthetic oligonucleotides (see section 1.3 for more details). Within the 
field, the DNA origami method has become one of the most powerful techniques, provid-
ing a route to construct megadalton-sized nanostructures (1.3.5). These can be deco-
rated with many functional elements including biological molecules or inorganic nano-
particles for potential applications in electronics, photonics or biology and nanomedicine 
(1.3.6). Within these set of applications, a growing area of interest is the cellular delivery 
of DNA nanostructures.213–216 
There are several mechanisms that need to be addressed before designing a potential 
DNA origami-based therapeutic delivery vehicle. Certain cell types (macrophages, mon-
ocytes, dendritic cells, etc.) do not require special targeting or cell penetration methods 
as long as the dimensions are with the preferred size range (50-200 nm).217,218 In con-
trast, many other cell types are selective and require specific targeting and internalization 
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techniques.213 In addition, post-internalization, the vehicle should also be designed to 
escape the endosome, localize at the target site and eventually carry out the required 
function. In the entire duration of this process, the structural integrity of the DNA 
nanostructures need to be maintained. Even a partial damage could hinder the capabil-
ities and could cause the release of attached molecules.219 
However, prior to recognition, binding and penetration to the cell, the first requirement 
for cellular delivery of the potential DNA origami vehicle, is surviving the journey to the 
targeted cell. For a typical in vivo delivery via intravenous administration, this would 
mean that the DNA origami-based therapeutic vehicle should be able to maintain the 
structural integrity in the blood, long enough to be distributed to the target cell.  
3.1.2 The need for stability of DNA nanostructures 
Typically, new diagnostic devices are tested with in vitro model systems, which help es-
tablishing appropriate conditions for the cells of interest. For mammalian cells, these 
conditions involve cell culture media such as RPMI or DMEM, temperatures of 37 °C, 
physiological pH and ions concentrations. The maintenance of the cell growth often re-
quires such medium to be supplemented with 2-20% of mammalian serum (e.g., fetal 
bovine serum, FBS).219  
Hahn et al. tested the compatibility of the in vitro tissue culture environment with DNA 
origami nanostructures.219 They reported that due to the unavailability of sufficient diva-
lent cation concentration in the biological environments, the nanostructures showed 
higher denaturation that damaged the structural integrity to an extent.220,221 Additionally, 
blood and other bodily fluids are known to contain a variety of nucleases that can rapidly 
degrade DNA based structures,222–226 which can directly impact the performance of the 
delivery vehicle. Even a partial digestion could affect the geometry and could lead to the 
release of attached molecular features.  
Exceptions to the above mentioned limitations include very small DNA structures,227 fully 
ligated,228,229 thin tubular structures,219 and hollow wireframe structures230–232 which show 
an increased stability compared with common multi-layer origami structures. Alterna-
tively, a lipid bilayer can protect DNA origami, mimicking the structure of enveloped vi-
ruses.233 At the time of publication of the work presented in this dissertation, spermidine 
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had been used to fold DNA origami or cationic block copolymers were used to encapsu-
late DNA origami, but stabilization against nucleases or low salt buffers was not studied 
there.234,235 However, since then several other studies have been reported and a detailed 
discussion of the same can be found in the section 3.4. 
The instability of DNA in biological environments is not only a crucial problem in DNA 
nanotechnology but also in more established fields such as non-viral gene therapy.236–
238 The next section briefly introduces gene therapy and the non-viral vector based 
method that uses block copolymers to improve the stability and circulation times of plas-
mid DNA.239–242,237 This inspiration led to the polyplex micelle protection method using 
(PEG)-b-poly(L-Lysine) block copolymers (PEG-PLys) to encapsulate various DNA ori-
gami structures. The strategy, optimizations and various stability tests are discussed in 
detail in further sections (3.2). 
3.1.3 Non-viral gene therapy 
Gene therapy is a procedure that uses exogenous genes to treat or improve the health 
conditions of the patient by modifying or correcting the defective genes that are respon-
sible for disease development.243,244 The foreign DNA can be introduced into patients by 
multiple methods, which are broadly classified into either viral vector based methods, 
that utilizes recombinant viruses, or non-viral vector based methods, that utilizes naked 
DNA or DNA complexes.245,237  
Viral vector mediated gene therapy relies on the ability of viruses to transport the thera-
peutic DNA inside the host cell. The gene of interest is packaged into a replication-defi-
cient viral particle. This method was considered as an attractive delivery system,246 how-
ever, there are several drawbacks to using viruses to deliver genes into cells. There are 
only a limited number of viral vectors available, out of which any of these can trigger the 
immune response leading to the elimination of the viral particle.247 After this, the viral 
vector can no longer be used again as it will be recognized by the immune system.248 In 
addition to that, the method has several other drawbacks including the size limitation of 
the gene or the difficulty of large-scale production, and not to mention the multigene 
disorders that can lead to heart diseases, Alzheimer’s disease, etc.249,250  
In contrast, the non-viral methods present certain advantages over the viral methods, 
including large-scale production and low host immunogenicity.237 The delivery methods 
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include physical methods such as electroporation, microinjection, gene gun, impalefec-
tion, hydrostatic pressure, continuous infusion etc.251–255,240 The methods also include the 
use of polymeric gene carries. However, these materials also face certain problems 
when injected into the bloodstream.256 The primary problem is the inadequate retention 
in blood circulation.257 A number of inherent biological barriers undermined the retention 
in the bloodstream, including nuclease digestion, harsh physiological environments and 
capture by microphages of the mononuclear phagocytic system (MPS).242 
In 1996, Katayose et al. proposed a way to fabricate potent gene carriers by forming 
“polymeric micelles” (PM).258 They synthesized the PM via an electrostatic interaction 
mediated self-assembly process between the block copolymers of poly(ethylene glycol) 
(PEG)-polycations and the plasmid DNA (pDNA).239 These micelles have a core-shell 
structure, wherein the pDNA forms the core compartment after complexation with the 
PEG-polycations, which form the shell compartment. It is important to note that the PEG 
shell provides a protective enclosure that inhibits adverse bio-interfacial interaction and 
gives the pDNA a stealth property in vivo.259–264 
Using this strategy, researchers were able to improve the blood circulation time, how-
ever, applications directed towards a more severe biological environment were still re-
stricted despite the advantageous structure of PMs.265 Improved survival in the circula-
tory system was achieved by enhancing the structural stability and the stealth property 
of PMs by modifying the polymer composition. 
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3.2 Results and discussions 
3.2.1 Strategy to form DNA origami polyplex micelles (DOPMs) 
Using the block copolymer, PEG-PLys, we hypothesized that similar to the non-viral gene 
therapy approach (3.1.3), the positive lysine residues would electrostatically attach to the 
negative phosphate residues of DNA and form DNA origami polyplex micelles (DOPMs), 
and that the shape of the structures would be maintained with the polymer shell protect-
ing the DNA origami structures. An overview of the strategy can be observed in Figure 
3-1. 
 
Figure 3-1. Overview of the polyplex micellization strategy. A-B) DNA origami structures 
can easily be degraded by nucleases or low salt conditions. C) By adding PEG-PLys 
block copolymers (molecular formula on bottom), DOPMs are formed through electro-
static interactions. D) These DOPMs are protected against nuclease digestion and low 
salt conditions. E) The polymer shell can be removed by the polyanionic dextran sulfate. 
3.2.2 Optimizations 
To optimize the stoichiometry, increasing amounts of PEG-PLys were mixed with a con-
stant amount of different origami designs including a thin long tube (6-HB);160 a compact 
24-helix bundle (24-HB);266 a flat rectangle (RO);133 a hollow triangulated wireframe do-
decahedral truss structure (D-truss);231 gold nanoparticles (AuNPs) densely covered with 
thiolated oligonucleotides, and finally 6-HB tubes decorated with AuNPs160 or quantum 
dots. In most experiments PEG-PLys with 12 kDa long PEG units and 18 lysines (“long 
PEG-PLys”) was used except for the AuNP or quantum dot (QDs) decorated 6-HBs, for 
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which PEG-PLys with 5 kDa long PEG units and 10 lysines (“short PEG-PLys”) were 
used (details in section 3.2.5). The relative concentration of PEG-PLys to DNA in the 
final complexation solution is described by the N/P ratio, which is the molar ratio between 
all amines (N) of the PLys segments and all phosphates (P) of the DNA backbones in a 
reaction. In the initial experiments, this ratio was varied from 1/64 to 8/1 at a constant 
DNA concentration and the resulting complexes were characterized by agarose gel elec-
trophoresis (AGE, Figure 3-2 for 6-HB and 24-HB; and Figure A 2 for RO and D-Truss), 
as well as by the transmission mode in scanning electron microscopy (tSEM, Figure 3-2 
and Figure 3-9), or atomic force microscopy (AFM, Figure 3-9). 
Compact multilayered DOPMs 
From the AGE results for 6-HB and 24-HBs DOPMs, it was observed that the increase 
in the N/P ratio led to a decrease in the electrophoretic mobility of the product bands up 
to N/P = 1/2 for 6-HBs and N/P = 1/4 for 24-HBs, from whereon the DOPMs migrated 
towards the cathode (Figure 3-2 A and G). This behavior is a result of the positive 
charges of the block copolymers that overcompensate the negative charges of the phos-
phates. A similar behavior was also observed previously for long double-stranded 
DNA.267  
Whereas, the tSEM images reveal intact structures where the shape of the DOPMs is 
strictly dictated by the underlying DNA origami core (Figure 3-2 B-D and H-I). The tSEM 
images for polyplexed 6-HB at N/P = 4 revealed locally concentrated DOPMs that were 
stacked in a periodic alignment. It was observed that such stacking was only produced 
because of a drying effect that takes place on the surface of the tSEM grid in the pres-
ence of uranyl acetate (Figure A 1 A-B). On grids stained with uranyl formate, no such 
stacking was observed and the DOPMs were found to be monodispersed (Figure A 1 C-
D). However, poly-L-ornithine modified TEM grids aided the lateral stacking of the 
DOPMs (Figure A 1 E-F). We hypothesize that this behavior could be a result of the 
charge repulsion between the positively charged DOPMs and poly-L-ornithine surface.  
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Figure 3-2. Formation of DOPMs with 6-HB or 24-HB and increasing amounts of PEG-
PLys. A and G) Fluorescence image of a native agarose gel. Constant amounts of DNA 
origami were incubated with increasing concentrations of PEG-PLys. The polymer shell 
can be removed or “decomplexed” (D) by incubation with dextran sulfate (see Figure 3-1 
E). B-D and H-I): tSEM images of unpurified reaction mixtures (at the given N/P ratios). 
E) Histogram of the shell thickness determined from tSEM images of laterally stacked 6-
HBs. F and J) Artistic representation of 6HB and 24-HB respectively. Scale 
bars = 200 nm for B-D and 100 nm for H-I. 
The laterally stacked polyplexed 6-HBs were further used to measure the PEG shell 
thickness by measuring the gap between the stacked 6-HBs DOPMs in a periodic align-
ment (Figure 3-2 D). To facilitate software-based determination of the inter-origami dis-
tance, the DNA origami structures were manually traced. Several profiles perpendicular 
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to the DNA origami axis were analyzed and plotted (Figure 3-2 E). Tockary et al. reported 
that the PEG chains were found to adapt a mushroom conformation and the theoretical 
calculation of the height of the tethered PEG mushroom was reported to be 9.4 nm for 
PEG with Mn 12 kDa.268 After the gap measurement using tSEM images of dried samples, 
the PEG shell thickness was found to be 8.7 ± 1 nm which is in good agreement with the 
theoretical value (Figure 3-2 E). Only those tSEM images were used for the gap meas-
urements where locally concentrated DOPMs were observed. The stacking of 6-HBs in 
a periodic alignment provided direct information on the height of the PEG mushroom for 
comparison to the theoretical value. 
 
Figure 3-3. Observation of folding of the RO in the middle. A) Artistic representation of 
the hypothesized mechanism for folding and unfolding along the helical axis of the flat 
RO. B-1) polyplexed; B-2) decomplexed; B-3,4) polyplexed, treated with FBS, gel ex-
tracted. B-5,6) polyplexed, DNase I treated, crude reaction; B-7,8) polyplexed, buffer 
exchange to 30 mM NaCl. After decomplexing, this occasional folding was reversed. 
Scale bars = 100 nm 
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Single-layer and wireframe DOPMs 
The AGE for flat RO and D-truss DOPMs showed a similar retardation in the product 
band migration with the increase in the N/P ratio (Figure A 2). The only exception was in 
the tSEM images. For flat RO, more than 50% of the cases folded along the helical axis 
in half when polyplexed at N/P = 4 (Figure 3-3). This folding in half could be reversed by 
decomplexing (Figure 3-3). A similar discrete folding in PMs had also been observed in 
double-stranded DNA due to DNA condensation led by the electrostatic complexation 
between the polyanionic DNA and cationic polymer.269 Similarly, in case for the D-Truss 
DOPMs, the underlying structure no longer exhibits wireframe texture when compared 
with the control structures (Figure 3-9 column 1 and 2). Both these observations suggest 
that for applications where a high rigidity and strict shape control is needed, reinforced 
multi-layer structures should be used. 
Gold nanoparticle polyplex micelles 
The effect of increasing amounts of PEG-PLys on oligonucleotide-functionalized AuNPs 
was similar to the previous observations with DNA origami (Figure 3-4 A). For that a 
constant amount of AuNPs (diameter = 17 nm, Figure 3-4 B) densely functionalized as 
in Gür et al.160 was incubated with increasing amounts of PEG PLys. The N/P ratio was 
calculated according to the phosphates in the oligonucleotide shell. A density of 1 oligo-
nucleotide/7 nm2 Au surface was assumed according to Hurst et al.270 Without PEG-
PLys, the AuNPs are only separated by the oligonucleotide shell around them (Figure 
3-4 C and D). An increasing amount of block copolymers separates the AuNPs better. 
Most likely, the regular packing observed in the tSEM images is formed during drying of 
the samples on the TEM grid and not already in solution. The histogram reveals two 
populations (Figure 3-4 E). One with a shell thickness (added radius) of 6.7 nm, the other 
with a thickness of 20 nm. The 20 nm thickness roughly corresponds to the expected 
value of ~7 nm for the oligonucleotide shell (20-mers) + 9.4 nm for the PEG.271 The 7 nm 
population may be separated only by the 19 nucleotide long thiolated oligonucleotide 
(Figure 3-4 D). These clusters may have been trapped by a common shell of AuNPs 
whereas all AuNPs of the 20 nm population are monodispersed and covered by an ad-
ditional complete shell of PEG-PLys. 
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Figure 3-4. Effect of increasing amounts of PEG-PLys on oligonucleotide-functionalized 
AuNPs. A) Fluorescence image of a native agarose gel. Constant amounts of AuNPs 
were incubated with increasing concentrations of PEG-PLys. B) tSEM image of control 
AuNPs. C-D) tSEM images for polyplexed AuNP functionalized with oligonucleotides at 
N/P = 1/2 and 4/1 respectively. Scale bars = 200 nm. E) Histogram of the shell thickness 
observed between particles at N/P = 4. F) Artistic representation of polyplexing experi-
ment (not to scale). G) Dynamic light scattering (DLS) measurements of the hydrody-
namic diameter (Zavg) of oligonucleotide-functionalized AuNPs polyplexed with increas-
ing amounts of either long (orange), or short (blue) PEG-PLys block copolymers. H-I) 
Prediction of the conformation of the PEG chains at different N/P ratios. J) Calculation 
of the PEG shell thickness (long = orange; short = blue) using the Zavg values from DLS 
measurement. 
Further, we also used dynamic light scattering (DLS) to measure the changes in the 
hydrodynamic diameter of the oligonucleotide-functionalized AuNPs polyplexed with in-
creasing amounts of either long (Figure 3-4 G orange), or short (Figure 3-4 G blue, refer 
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3.2.5 for more details) PEG-PLys block copolymers. From the shell thickness measure-
ments (Figure 3-4 J) we confirm a maximum added thickness of ~10.4 nm for long (N/P 
> 3/1) and ~4.2 nm for short (N/P ≥ 3/1) PEG-PLys block copolymer. From these studies 
we can also predict the changes in the conformation of the individual PEG units on the 
surface of AuNPs with the increase in the N/P ratio (Figure 3-4 H-I). The individual PEG 
units exhibit a more breathing-short conformation at lower N/P ratios, when there is a 
lower incorporation density of PEG-PLys block copolymers(Figure 3-4 H). In contrast, 
the PEG units take a compact-elongated form at higher N/P ratios, when the incorpora-
tion density reaches a maximum (Figure 3-4 I). Similar observations were also made for 
the conformation of the PEG chains on nanoparticles, where depending on the grafting 
density the PEG chains acquired either a ‘mushroom’ (low density) or a ‘brush’ (high 
density) conformation.272 These changes in the PEG unit conformation affects the overall 
PEG shell thickness. We recommend that the overhanging oligonucleotides on DNA ori-
gami should be designed to be longer than the above mentioned PEG shell thickness to 
facilitate the accessibility by functional ligands. However, the calculations are only valid 
for aqueous buffers, as the PEG shell thickness may vary with solvents.  
Direct imaging of a PEG shell is extremely difficult as shown before235,268 and also in our 
case, only the DNA core (and not the polymer shell) was visible in uranyl formate, uranyl 
acetate or osmium tetroxide stained tSEM images (Figure A 1 and Figure A 3). There is 
however strong indirect evidence for the presence of that polymer shell: (i) AFM imaging 
of DOPM was not possible, presumably due to the decreased adhesion of the PEG shell 
to the mica surface compared with untreated DNA origami; (ii) the folding of the RO in 
half is not common without additional interactions;273 (iii) the 6-HBs appear straightened 
and the unused scaffold becomes compacted and well visible (Figure 3-2 C, arrows), 
which is probably caused by the steric repulsion of the PEG chains surrounding the 6 
HB; (iv) at N/P ratios higher than 1, a lateral stacking of DOPMs on the TEM grid was 
observed (Figure 3-2 and Figure A 1). The border-to-border distance between the struc-
tures was 8.7 ± 1 nm and therefore in good agreement with the expected value (9.4 nm 
for the long PEG-PLys).268 No such stacking was observed for bare reference DNA ori-
gami structures or for DOPMs deposited to a TEM grid stained with uranyl formate in-
stead of acetate (Figure A 1); (v) finally, gold nanoparticles functionalized with DNA and 
PEG-PLys showed a separation corresponding to the length of the PEG chains (Figure 
3-4). Therefore, it can be concluded that DOPMs form, that they are monodispersed in 
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solution, and that their stacking on the surface of the TEM grids occurs during staining 
or drying. 
 
Figure 3-5. A) Temperature dependence of the polyplexing (polyplex micelle formation) 
and decomplexation reaction. The results indicate that both reactions work well at any of 
the tested temperatures (4 °C, 25 °C; or 37 °C). B) Time-dependence of the decomplex-
ation reaction at 25 °C. The results indicate that the decomplexation reaction occurs 
instantaneously at the time scale needed to load the gel (~1 minute). Complexation is 
equally fast as confirmed by various experiments. 
3.2.3 Decomplexation 
By mixing the DOPMs with an excess of polyanionic polymers such as dextran sulfate, 
the PEG-PLys could be removed as shown previously.274 We found that both the poly-
plexing (PM formation) and the decomplexation steps were completed within a minute at 
temperatures from 4-37 °C (Figure 3-5). The electrophoretic mobility and the shape and 
dimensions of decomplexed DOPMs were the same as for unmodified reference struc-
tures (Figure 3-2 A lane D or Figure 3-6). The decomplexed 24-HB DOPM retains a lower 
electrophoretic mobility compared with the reference structure (Figure 3-6 D). Poten-
tially, some PLys blocks of the block copolymer remain inside of compact multi-layer 
structures as they are not accessible to the dextran sulfate during the decomplexation 
step. 
Purification 
Additional purifications steps were necessary post-decomplexation, to remove all the 
block copolymers and dextran sulfate. This was analyzed using AGE as Gel green stains 
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the dextran sulfate (Figure 3-6 A, DS, lane 3), which is visible as a continuous smear 
migrating to the anode. When 6-HB DOPMs are decomplexed without additional filtering 
the excess DS is still present (Figure 3-6 A, lane 4). The DS can be removed by 100 kDa 
cutoff ultrafiltration filters (Figure 3-6 A, lane 5), but not by 10 kDa cutoff filters (lane 6). 
However, some of the DOPMs seem not effectively decomplexed or reform polyplexes 
during filtering off the excess DS (arrow, lane 5). To remove all PEG-PLys, a second 
washing step with DS is necessary (Figure 3-6 B, lane 7). However, additional washing 
steps incur a loss of material (Figure 3-6 B, lanes 8-9). The optimized purification protocol 
with 3 washing steps was chosen for all the DOPMs in this study with expected material 
loss Figure 3-6 C-G. 
 
Figure 3-6. Decomplexation and removal of block copolymers and dextran sulfate. A) A 
gel pre-stained with Gel green (instead of Sybr safe as in all other gels where staining is 
not explicitly stated). The arrow points the re-formation of polyplexed structures. B) To 
remove all PEG-PLys, a second washing step with DS is necessary (B, lanes 7-9). C-
G) Control of the respective structure (C); DOPM (P), decomplexed (D); crude decom-
plexing reaction without washing and filtration step) and sample washed 3 times with DS 
(W). 
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3.2.4 Stability tests 
Nuclease digestion assays 
After DOPM formation, the stability of DNA origami and DOPM was tested against nu-
clease digestion. For this, the samples were incubated for 16 hours at 37 °C in a buffer 
containing DNase I or RPMI media supplemented with 10% fetal bovine serum (FBS). 
FBS is a common cell culture media supplement that can contain nucleases, and has 
been previously shown to degrade DNA structures.219 
After the incubation, DNase I was removed by phenol-chloroform extraction while the 
samples incubated in FBS were gel extracted. The samples were then analyzed by AGE 
(Figure 3-7), and tSEM/AFM (Figure 3-9 columns 4-7). The results reveal that control 
DNA origami structures were completely degraded whereas polyplexed structures were 
protected against DNase I or FBS. As discussed earlier, the 24-HB structures show a 
reduced electrophoretic mobility, probably due to residual PLys residues trapped inside 
the structure. The electrophoretic mobility of the other structures is indistinguishable from 
the respective control DNA origami after polyplexing, DNase I treatment, removal of 
DNase I by phenol-chloroform extraction and final decomplexation. Corresponding tSEM 
and AFM images are found in Figure 3-9.  
In case of stability tests with FBS, tSEM and AFM images of crude reactions showed an 
extremely high degree of background contamination by proteins and other components 
from the FBS. Therefore, the images in Figure 3-9 were produced from samples cut out 
of the gels as indicated by the red boxes in the AGE images in Figure 3-7 B. 
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Figure 3-7. Gel images for the A) DNase I, and B) FBS stability tests for 24-HB, 6-HB, 
RO and D-Truss DOPMs. The AGE were pre-stained with Sybr Safe. The various con-
ditions mentioned to the left of the gel images are either marked with (+) or (-) signifying 
the presence or absence of the respective condition during the treatment. The red boxes 
denote the product bands that were excessed for tSEM or AFM analysis (Figure 3-9).  
Stability at low salt conditions 
Next, the stability of DOPMs at low salt conditions was tested. Most DNA origami struc-
tures need 200 mM to 2 M NaCl,275 or 4 to 20 mM MgCl2 to overcome the electrostatic 
repulsion of the negatively charged DNA backbones and to stay intact.219 High salinities, 
however, are often not desirable or not present (e.g. in cell culture media, serum or 
cells).275 We hypothesized that the polycationic segment of PEG-PLys may stabilize the 
DNA origami even better than divalent Mg2+ similar to spermidine.234 To test this, we 
incubated the DOPM and reference DNA origami for 16 hours in a buffer containing 
30 mM NaCl and 0 mM MgCl2 at 37 °C. 
Initially, the structures were also tested for stability in the RPMI medium, that is com-
posed of 132.9 mM Na+, 5.3 mM K+, 0.4 mM Mg2+ and 0.4 mM Ca2+. The AGE results for 
control 6-HB and RO structures incubated at these ionic concentrations did not show any 
apparent structural degradation (Figure 3-8 A). However, the compact 24-HB, seemed 
to be degraded without protection (Figure 3-8 A). In this lane, some staple strands ap-
peared indicating they detached from the structure. It can be concluded that the compact 
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24-HB structure requires a higher salinity than that in RPMI medium, which was also 
observed by Hahn et al.219  
In a buffer containing only 30 mM NaCl and no divalent cations, a staple strand band 
appeared even in the 6-HB structure (Figure 3-8 B, arrow). It should be pointed out that 
gel bands are always only a first indicator to structural integrity and even when no ap-
parent changes of the electrophoretic mobility can be observed as in the wireframe truss, 
further imaging is necessary. The AFM and tSEM images clearly indicated that all struc-
tures were degraded by a buffer exchange to 30 mM NaCl but remained intact when 
protected inside a PM (Figure 3-9). 
 
Figure 3-8. AGE for stability tests of structures in A) RPMI medium (no FBS added), and 
(B) 30 mM NaCl buffer at 37 °C for all the test DOPMs. The various conditions mentioned 
to the left of the gel images are either marked with (+) or (-) signifying the presence or 
absence of the respective condition during the treatment. S = scaffold controls, p8064 
for 6-HBs, ROs and D-Truss, and p7560 for 24-HBs. The grey arrow points to the staple 
strand band that appears at low salt conditions for non-protected 6-HBs. 
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Figure 3-9. AFM or tSEM images of DNA origami structures subjected to different treat-
ments (DNase I, cell culture buffer supplemented with 10% FBS; or buffer exchange to 
30 mM NaCl). A) 24-HB; B) 6-HB; C) RO; D) D-truss. Structures were protected (+) or 
un-protected (-) during the treatment. Before imaging, the protected structures (columns 
5; 7; 9) were decomplexed. The noisy background in columns 6-7 stems from residual 
FBS proteins that co-migrate with the DNA origami during AGE workup (Figure 3-7) and 
which did not adhere to the flat origami in imaging conditions (C-7). Scale bars = 100 nm. 
3.2.5 Short PEG-PLys block copolymer 
As mentioned earlier, the DOPMs were also prepared using a shorter PEG-PLys 
(PEG5kLys10 = 5 kDa PEG units and 10 lysines, purchased from Alamanda Polymers). 
To test the short PEG-PLys, 6-HBs and oligonucleotide functionalized AuNPs were pol-
yplexed with increasing amount of the block copolymer. From the AGE results, a similar 
behavior to the longer PEG12kLys18 block copolymer was observed (Figure 3-10 A and 
B). Similarly, it was also observed that that the PEG5kLys10 and PEG12kLys18 protect the 
DNA origami structures equally well from low salt, DNase I or FBS degradation (Figure 
3-10 C-E). 
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Figure 3-10. Gel for shorter PEG5kLys10 block copolymers (Alamanda polymers) used for 
the complexation of 6-HBs and AuNPs (A). The results are virtually indistinguishable 
from the longer PEG12kLys18 (Figure 3-2 and Figure 3-4), which was used everywhere 
else when not specified. (B) The Stability tests of 6-HB DOPMs using (short) PEG5kLys10 
block copolymers. 
3.2.6 Compatibility with bulky ligands 
For many potential applications, functional molecules or materials are introduced to DNA 
origami structures by coupling them to oligonucleotides and hybridizing these to comple-
mentary strands displayed on the DNA origami. To test if the DOPM strategy is compat-
ible with functionalizations, we introduced sterically demanding AuNPs (17 nm diameter 
plus oligonucleotide shell) as described previously or streptavidin-coated quantum dots 
to 6-HB structures which allow a clear detection of the presence of the ligands by tSEM 
and AGE (Figure 3-12 and Figure 3-13).160,276 
Inorganic nanoparticles 
To test this, waveguide precursors as in Gür et al.160 were polyplexed with increasing 
amounts of the (long) PEG12kLys18. From the tSEM images it was observed that the struc-
tures get distorted and from N/P = 1 onwards, a detachment of AuNPs from the structure 
was observed (Figure 3-11). This could be explained by a dense coverage of both the 
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AuNPs and the 6-HBs with the block polymers. The combined exclusion radii of the PEG 
segments of the PEG-PLys on the 6-HB and the AuNPs were too large (measured: 
20 nm, compare Figure 3-4) for the chosen oligonucleotide linker length. This possibly 
created a repulsive force that could not be overcome by the hybridization strength. 
 
Figure 3-11. Compatibility of waveguide precursors as in Gür et al. with micellization 
using (long) PEG12kLys18 polymers at varying N/P ratios. A) Artistic representation of the 
reference complex. B-L) tSEM image of the reference structure with an increasing 
amount of long block copolymer. Scale bars = 100 nm. 
Therefore, the experiment was repeated with the shorter PEG-PLys (5 kDa PEG with 10 
lysine units vs. 12 kDa PEG with 18 lysine units) and intact structures were found (Figure 
3-12 and Figure 3-11). The site occupancy changed from 97% to 94.3% after micelliza-
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tion (N=300 binding sites). This indicates that the short polymer is compatible with func-
tional particles. As mentioned earlier, the replacement of the long polymer with the 
shorter PEG-PLys does not compromise the protection against nucleases and low salt 
conditions (Figure 3-10). 
 
Figure 3-12. Compatibility of waveguide precursors as in Gür et al. with micellization 
using (short) PEG5kLys10 block copolymers at N/P = 4. A) Artistic representation of the 
reference complex. tSEM images for B) unprotected and C) protected waveguide pre-
cursors functionalized with 4 AuNPs. Scale bars = 100 nm.  
Biomolecule functionality 
To test if protein-ligand interactions would be compatible with the approach, streptavidin-
functionalized quantum dots (QD) were added to biotin-modified oligonucleotides on the 
6-HBs (Figure 3-13). These were polyplexed using both the short and long block copol-
ymers showing only intact structures which were shielded against DNase I digestion 
(Figure 3-13 B). 
The AGE results show that both the short and the long polymer are protecting the struc-
tures against DNase I. The unprotected structures were completely digested as shown 
in the previous studies. The electrophoretic mobility of the QD functionalized 6-HBs are 
indistinguishable from the control after polyplexing, DNase I treatment, inactivation of 
DNase I and final decomplexation. Bands indicated by the red rectangles were excised, 
extracted and imaged by tSEM (Figure 3-13 C). The red arrows point to the quantum 
dots that were functionalized on to the 6-HBs. It is crucial to not that the 6-HB-QD DOPMs 
subjected to DNase I treatment were decomplexed before AGE. 
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Figure 3-13. Compatibility of micellization with streptavidin-modified QDs. 6-HBs were 
functionalized with streptavidin-modified quantum dots over biotinylated strands dis-
played on the 6-HBs. (A) Artistic representation of the reference complex. (B) AGE re-
sults of both the short and the long polymer protected 6-HB-QD structures against 
DNase I. The red boxes denote the product bands that were excised for tSEM imaging. 
(C) tSEM images of 6-HBs functionalized with 2 QDs at terminal positions. DNase I 
treated polyplexed QD functionalized 6-HBs were decomplexed before tSEM imaging. 
The red arrows point to the quantum dots that were functionalized on to the 6-HBs. Scale 
bars = 100 nm. 
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3.2.7 Accessibility of handles on DOPMs 
Finally, we tested if the presence of the PEG shell hindered the accessibility of functional 
overhanging oligonucleotides (“handles”) on DOPMs. To carry out this study, the acces-
sibility of Cy3 modified oligonucleotides on polyplexed 6-HBs was tested in solution by 
hybridizing the complementary oligonucleotides with Cy5 modification. The accessibility 
was measured by the fluorescence resonance energy transfer (FRET) between Cy3 (do-
nor) and Cy5 (acceptor) pairs (Figure 3-14 A). The FRET between the dyes was recorded 
using a laser scanner that excited the Cy3 dye (532 nm) and measured the Cy5 fluores-
cence using the emission low pass red (LPR) filter (665 nm). Non-polyplexed versions 
of the Cy3-6-HBs conjugates and just the Cy5 modified oligonucleotides were used as 
controls for this study. The concentration of Cy5 modified oligonucleotides was increased 
logarithmically to a maximum of 8-times excess over the number of Cy3-modified oligo-
nucleotides on the 6-HBs. The measured fluorescence intensities from various solutions 
were normalized and plotted e. the concentration of Cy5 modified oligonucleotide (Figure 
3-14 B and Figure A 4 B).  
From the fluorescence intensities of the respective solutions under different emission 
channels (Figure 3-14 B and Figure A 4), it can be observed that the polyplexed variants 
exhibit results comparable to the non-polyplexed variants with only a 15% loss in the 
FRET fluorescence intensity. We hypothesize that this loss is due to the solvent effect 
on the fluorescence emission, which arises from the crowding effect of the PEG shell 
surrounding the FRET pair. The PEG-crowded environment changes the polarity of so-
lution in the vicinity of the dye (see also Chapter 4), which may cause a slight decrease 
in the quantum yield of the dye. We conclude that the addressability of single-stranded 
overhangs (handles) on the DNA origami is unaffected by the polyplex micellization strat-
egy. 
3.3 Conclusion  
 
64 
 
 
Figure 3-14. Testing the accessibility of the overhanging sequences on DNA origami 
after polyplex micellization. A) Cy3 - Cy5 FRET pairs were used as per the artistic rep-
resentation. B) The fluorescent intensities of the various wells in (Figure A 4) was nor-
malized and plotted versus the increasing concentrations of Cy5 modified oligonucleo-
tides. 
3.3 Conclusion 
In this part of my dissertation, we showed that PEG-PLys block copolymers form a robust 
shell around various DNA origami structures including flat; compact; or long tubular, hol-
low wireframe structures; as well as DNA origami structures functionalized with AuNPs 
or streptavidin-modified QDs. The shape of these DOPM was dictated by the DNA ori-
gami template. Our method is a fast, cost-effective, and user-friendly reaction, taking 
place at any temperature from 4-37°C. The micellization protected the DNA structures 
from nuclease digestion by DNase I and FBS, as well as from denaturation in low salt 
conditions, whereas un-protected DNA origami were degraded and may therefore enable 
applications in which un-protected DNA origami structures would be degraded. 
The micellization is not limited to certain designs such as triangulated structures,230,231 
but also protected other standard DNA origami designs including flat 2-D and compact 
multilayer 3 D structures. The protection effect was stronger than that provided by the 
triangulation approach alone (Figure 3-12 D) and does not require any expensive or la-
borious and design-specific modifications such as previous stabilization meth-
ods.228,229,233 The DOPM strategy is compatible even with bulky functionalizations such 
as AuNPs or streptavidin-modified QDs. The method may therefore also be suitable for 
functionalized origami structures containing smaller proteins or other delicate ligands,235 
and facilitates the display of ligands compared with the lipid encapsulation method.233 
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The length of the double-stranded linker between the origami and the respective ligand 
(Figure 3-12) and the length of the PEG linker could easily be adjusted to tune the ac-
cessibility of the respective ligands to meet requirements of specific applications. Such 
ligands could include molecules such as peptides or antibodies targeting cell surface 
markers for uptake studies thus opening up potential applications including biological 
imaging, cell labelling, and anti-cancer therapies. Moreover, DNA origami could be uti-
lized as a tool to elucidate effect of size or aspect ratio on the interactions with cells or 
the stability in the blood flow. For all this, the stabilization of DNA origami in biologically 
relevant environmental conditions we show here, is a necessary precondition. 
3.4 Outlook and state of the art 
As discussed in the beginning of the chapter, the potential DNA origami-based therapeu-
tic must remain stable during the journey to the cell, recognize, bind and penetrate the 
cell type of interest. The block copolymer strategy can be an important step towards this 
goal. A publication that appeared shortly after ours demonstrated that a similar approach 
protects DNA structures from low-salt denaturation and nuclease digestion, in turn im-
proving the retention times in blood of mice. Moreover, structures were delivered to the 
target cell via the blood stream.277  
Bastings et al. reported that to improve the cellular uptake of DNA nanostructures, it is 
essential to use compact shapes instead of elongated, high-aspect ratio particles.278 By 
simply altering the DNA origami shape and size the cellular uptake can be affected. An 
alternative approach to that is the direct delivery of DNA structures to the cytoplasm via 
electroporation, which employs a strong electric field to increase the permeability of the 
cell membrane. Chopra et al. reported stable electroporation of DNA origami structures 
folded in spermidine.234 Interestingly, another effective strategy was demonstrated using 
DNA with cell-penetrating peptide ‘TAT’ that can overcome the cell membrane and in-
crease cellular entry.279  
Certain cell delivery mechanisms rely on targeting specific cell-types. Towards that, an 
obvious approach is the employment of ligands that can specifically recognize and bind 
to cell-surface receptors on the cell type of interest. This can be achieved by using DNA 
aptamers. A number of aptamers coupled DNA origami were demonstrated and success-
fully tested for functionality (discusses earlier in section 1.3.7). An alternative approach 
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was reported where folate was included in a DNA tetrahedron to target the folate receptor 
which is overexpressed on a number of cancer cell types.280,281 
Upon cell delivery, usually a foreign particle is taken into the endosome and it is essential 
that the therapeutic can escape to reach the final destination in the cytosol or nucleus. A 
possible solution is to avoid endosomes altogether by the use of the ‘cell squeezing 
technique’.282 
Liang et al. used DNA tetrahedrons to understand the uptake pathway in the cells by 
single particle tracking methods.283 They reported a receptor mediated uptake where the 
DNA tetrahedron fuses with membrane and is taken up by endocytosis. They were also 
able to determine the percentage of the tetrahedron that moved large distances with the 
help of kinesin and dynein. The final destination was shown to be lysosome, and by 
further modification with peptides, they were able to demonstrate a lysosomal escape 
with the nucleus being the end destination. 
In conclusion, DNA nanotechnology promises a tremendous potential for biomedical ap-
plications but there are several challenges that still need to be overcome to ensure an 
effective therapeutic functionality of DNA origami structures. To have the DNA origami 
structures clinically approved as a potential therapeutic it needs to pass preclinical trials 
that include efficacy, toxicity and pharmacokinetic test. Till date, only a few studies have 
reported successful DNA structures in vivo, however, within these approaches there 
have been reported inconsistencies in results that employ the usage of fluorescence-
based assays.284 Moreover, there have been contrasting reports on the immunogenicity 
of DNA structures and more study needs devoted to ensure that the DNA nanostructures 
are immune-silent. In addition, with the ever-expanding toolset, it is possible to further 
diversify the cargo-carrying capabilities of DNA structures, as only a selected number of 
therapeutic molecules have been tested so far. For further improvement, there is a dire 
need to unify all the potential design strategies and discard the ones that serve as dead-
ends. Then, by presenting a modular approach it should be possible for a clinical re-
searcher to change/or add components as per the required therapeutic. Once estab-
lished, DNA structures could be used as highly specific drug delivery system that would 
have the potential to understand and direct intricate cellular processes along desired 
routes. 
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3.5 Methods 
3.5.1 DNA origami folding 
To fold the 6-HBs, ROs and the dodecahedral truss, 10 nM of p8064 scaffold (produced 
by Dr. David Smiths’ Lab, IZI Leipzig), respective staple strands set (Integrated DNA 
Technologies, IDT or Eurofins) at 100 nM (each), 5 mM Tris (Applichem) adjusted with 
~1 mM EDTA (Applichem) to pH 8 and 12 mM MgCl2 (Applichem) were mixed. The mix-
ture was annealed in a thermal cycler (Bio-Rad C1000 Touch) from 80 to 65 °C at a rate 
of -1 °C/min and from 65 °C to room temperature at a rate of -1 °C per 20 min. Excess 
staple strands were then removed by ultrafiltration columns (Amicon Ultra, AMD Milli-
pore). 
To fold 24-HBs, 10 nM of p7560 scaffold (produced by Dr. David Smiths’ Lab, IZI Leip-
zig), staples strands (kindly donated by Dr. David Smiths; one oligonucleotide in the set 
was labelled with atto 647 dye) at 100 nM (each), 5 mM Tris, 1 mM EDTA and 14 mM 
MgCl2 were mixed. The mixture was annealed from 80 to 60 °C at a rate of -1 °C per min 
and from 60 to 55 °C at a rate of -1 °C per 20 min and from 55 °C to 45 °C at a rate 
of -0.5 °C per 30 min and from 45 °C to room temperature at a rate of -1 °C per 10 min. 
Excess staples strands were removed by PEG precipitation method. 
Purification with ultrafiltration columns 
Passivation of the ultrafiltration filters (100 kDa MWCO, Amicon Ultra, AMD Millipore) 
membrane was carried out by incubating them 16 h in 400 µl of 5 mM Tris, 1 mM EDTA 
and 12 mM MgCl2 solution (1X folding buffer (FB)) at room temperature. The filters were 
washed with ultrapure water before the DNA origami folding reaction was transferred into 
it. The folded DNA origami solution was washed six times with 400 μL of 1X FB at 14,000 
rcf for 2 min at room temperature. After the final wash the filter was reversed, placed in 
a fresh tube, and centrifuged at 1,000 rcf for 2 min. The purified DNA origami solution 
was then collected for further characterization and reactions. 
Purification with PEG precipitation 
The unpurified DNA origami folding reaction was mixed at a 1:1 (v/v) ratio with PEG 
precipitation buffer consisting of 15% PEG 8000 (VWR), 505 mM NaCl, 5 mM Tris and 
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1 mM EDTA. The solution was mixed by tube inversion and centrifuged at 16,000 rcf for 
25 min at room temperature. After the centrifugation, the supernatant was carefully re-
moved using a pipette. The pellet was re-suspended in the 5 mM Tris, 1 mM EDTA and 
14 mM MgCl2 and incubated for 30 min at room temperature. 
3.5.2 Preparation of ssDNA functionalized AuNPs 
AuNPs with a diameter of ~17 nm were synthesized and functionalized by the protocol 
described in Gür et al.160 For the synthesis of AuNPs, 50 mL of 0.25 mM tetrachloroauric 
acid (HAuCl4) (Sigma-Aldrich) solution was boiled in an Erlenmeyer flask cleaned with 
aqua regia (mixture of nitric acid and hydrochloric, mixed in a molar ratio of 1:3). Under 
vigorous stirring, 1.5 mL of freshly prepared 34 mM (1% w/v) sodium citrate (Applichem) 
solution was added very quickly. After the color of the solution turned to red, the heater 
was turned off and the solution was refluxed for another 30 min. The colloidal AuNPs 
solution was filtered through a syringe filter (Whatman) with a pore size of 0.2 μm. 
For concentration of the AuNPs and exchanging the citrate shell with phosphine ligand, 
20 mg of bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassium salt (BSPP, 
Sigma-Aldrich) were added to 50 mL of the colloidal AuNPs solution and were shaken 
for 16 h. An aqueous 5 M NaCl solution was added dropwise until a color change from 
red to dark blue was observed. The solution was then centrifuged for 30 min at 1,600 rcf; 
the supernatant was removed; pellet was re-suspended in 1 mL of an aqueous 2.5 mM 
BSPP solution 1 mL of methanol. The sample was pelleted once more by centrifugation 
(1,600 rcf, 30 min); the supernatant was carefully removed by pipette, and the AuNPs 
were again re-suspended in 1 mL of a 2.5 mM BSPP solution. The AuNPs concentration 
was determined photometrically.  
AuNPs were conjugated to thiol-modified oligonucleotides (IDT) either (5′-ThioMC6-T19) 
for the experiments with AuNPs polyplexing and waveguide precursors polyplexed with 
the longer polymer or (5′-ThioMC6-TTTTTTTCTTTGTTTCTTT) for the polyplexing ex-
periment involving AuNPs-modified 6-HBs and short polymer. First, the thiol-modified 
oligonucleotides were incubated with 20 mM TCEP (tris(2-carboxyethyl)phosphine hy-
drochloride, Sigma-Aldrich) for 45 min. Then, AuNPs and the thiol-modified oligonucleo-
tides were mixed at a ratio of 1:300 (AuNPs/DNA) in 0.5X TBE (Tris base, boric acid, 
EDTA, pH 8.0) buffer. To increase the oligonucleotide loading density on the AuNPs, an 
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aqueous 5 M NaCl solution was added in four steps for a final concentration of 500 mM 
NaCl as described previously.160 After each addition of NaCl, the solution was sonicated 
for 10 s and incubated for 20 min. After the last NaCl addition, the mixture of AuNPs and 
oligonucleotides was shaken for a day at 25 rpm at room temperature in a rotator. The 
excess of oligonucleotides was removed by ultrafiltration (100 kDa MWCO, Amicon Ultra, 
AMD Millipore) and washed seven times with 400 μL of 0.5X TBE buffer at 10,000 rcf for 
5 min just before hybridization to 6-HBs or polyplex micellization. 
Assembly of AuNPs functionalized 6-HBs 
The purified 6-HBs solution was quickly mixed with functionalized AuNPs (10 AuNPs per 
binding site) for 2 nM final 6-HBs concentration in 1X FB and incubated for 90 min at 
room temperature. 
The waveguide precursors used for polyplexing experiments involving long polymers 
were folded using 6-HBs containing eight binding sites for AuNPs functionalization, the 
staple strands for this is listed in Gür et al.160 For the experiments involving short poly-
mers, the 6 HBs were only carrying 4 binding site (positions 2, 4, 6, and 8) with an ex-
tension of 5′-AAAGAAACAAAGAAA sequences instead of 5′-A15 as used in the other 
waveguide precursors containing 8 binding sites. 
3.5.3 Agarose gel electrophoresis 
For the AGE analysis, 1% agarose gels (Roche) were casted with 0.5X TBE buffer con-
taining 12 mM MgCl2 and stained with 1X Sybr safe DNA gel stain (Life technologies). 
0.5X TBE buffer with 12 mM MgCl2 was used as a running buffer. 15 µL of sample so-
lution were mixed with 3 µL of 6X gel loading dye (50% glycerol, 5 mM Tris, 1 mM EDTA, 
12 mM MgCl2, 0.25% bromophenol blue and 0.25% of xylene cyanol). Electrophoresis 
was performed at 70 V for 2 h at room temperature. As a reference, 3 µL of 1 kb plus 
DNA ladder (Thermo Scientific) were added. The gel was imaged with a Typhoon FLA 
9500 gel scanner (GE Healthcare) using the excitation wavelength of 473 nm suitable 
for SYBR safe stained gels. 
For purification of the AuNPs functionalized 6-HBs and for experiments involving quan-
tum dot functionalized 6-HBs, 0.75% agarose gels were casted and the electrophoresis 
was performed at 70 V for 2 h at 4 °C. The running buffer was cooled to 4 °C before 
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usage. The samples were extracted from the gel with DNA gel extraction columns (Bio-
Rad, Freeze ’N Squeeze) by centrifuging the excised bands at 5,000 rcf for 10 min. 
3.5.4 Block copolymer preparation 
The long PEG-PLys block copolymers (PEG12KLys18), is composed of a PEG segment 
with Mn 12 kDa and a PLys segment with degree of polymerization (DP) 18. The synthe-
size was carried out via ring-opening polymerization as previously reported.274 The DP 
of the PLys segments were determined by comparing the peak intensity of the methylene 
protons from the PEG chain (CH2CH2O) and the methylene protons from the PLys side 
chain [(CH2)3CH2NH3] in the 1H-NMR spectra (JEOL EX300 spectrometer, JEOL Ltd., 
Tokyo, Japan). 
The short PEG-PLys (PEG5KLys10) was purchased from Alamanda Polymers. It is com-
posed of a PEG segment with Mn 5 kDa and a PLys segment with DP 10. 
3.5.5 DNA origami polyplex micelle preparation 
Standard preparation:  
For the preparation of DOPMs, the block copolymer solution was added at a 1:2 (v/v) 
ratio to DNA origami solution and the mixture was immediately vortexed.  
Steps for preparing block copolymer solution at a particular N/P ratio: 
Step 1: Calculating the total number of phosphate groups of DNA origami. 
Base pairs in 6-helix bundles 7,182 
Bases in the excess scaffold 882 
Bases in 24 handles 360 
Total number of bases/phosph.  15,606 
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Step 2: Calculating the molar concentration of DNA origami solution. 
After purification, the concentration of DNA origamis was determined photometrically. 
The value for the mass concentration (in µg/mL) provided by the spectrophotometer was 
used to calculate the molar concentration of 6-HBs. 
example concentration [µg/mL] 4.75 
average mass of one base pair [g/mol] 660 
Base pairs in 6-helix bundles 7182 
Molecular Mass 6-HB [g/mol] ~4,740,000  
𝑐 [
𝑚𝑜𝑙
𝐿
] =  
𝑐 [
𝑔
𝐿]
𝑀[
𝑔
𝑚𝑜𝑙]
 
𝑐(𝑜𝑟𝑖𝑔𝑎𝑚𝑖) =  
𝑚𝑜𝑙
4,740,000 𝑔
·
4.75 · 10−6𝑔
10−3𝐿
= 1 𝑛𝑀 
𝒄(𝒐𝒓𝒊𝒈𝒂𝒎𝒊) =  𝟏 𝒏𝑴 
Step 3: Calculating the amount phosphates in solution. 
Volume of DNA origami solution (µL) 40 
Total number of phosphate groups 15606 
Concentration of DNA origami solution (nM) 1 
𝑛(𝑃ℎ𝑜𝑠𝑝ℎ𝑎𝑡𝑒𝑠) = 𝑉 · (𝑃ℎ𝑜𝑠𝑝ℎ𝑎𝑡𝑒𝑠/𝑜𝑟𝑖𝑔𝑎𝑚𝑖) · 𝑐(𝑜𝑟𝑖𝑔𝑎𝑚𝑖) 
=  (40 µ𝑙) · (15606) · (1 𝑛𝑀) = 0.624 𝑛𝑚𝑜𝑙 
𝒏(𝑷𝒉𝒐𝒔𝒑𝒉𝒂𝒕𝒆𝒔) = 𝟎. 𝟔𝟐𝟒 𝒏𝒎𝒐𝒍 
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Step 4: Calculations for PEG-PLys. 
As per the description for N/P: 
𝑁/𝑃 =  
𝑛(𝑎𝑚𝑖𝑛𝑒 𝑜𝑓 𝑃𝐿𝑦𝑠)
𝑛(𝑃ℎ𝑜𝑠𝑝ℎ𝑎𝑡𝑒𝑠)⁄  
The block copolymer stock solution was diluted with 5 mM TE buffer solution to a working 
concentration of 0.25 mg/ml. 
PEG segment molecular weight (g/mol) 12000 
Degree of polymerization (DP) of PLys segment 18 
Molecular weight of each lysine unit* (g/mol) 164.63 
Molecular weight of PEG-PLys 14963 
*counter ion is included in molecular weight calculation  
n (Phosphates) [nmol] 0.624 
M (PEG-PLys) 14963 
DP of PLys segment 18 
amines per lysine 1 
Working concentration of PEG-PLys (mg/ml) 0.25 
Volume of stock solution needed to prepare the block copolymer solution at a particular 
N/P: (the calculation is demonstrated for N/P = 1/4): 
𝑉 [µ𝑙] =
𝑁
𝑃⁄ · 𝑛(𝑃ℎ𝑜) · 𝑀(𝑃𝐸𝐺-𝑃𝐿𝑦𝑠) · 10
−3
𝑐(𝑃𝐸𝐺-𝑃𝐿𝑦𝑠)𝑤𝑜𝑟𝑘𝑖𝑛𝑔 · 𝐷𝑃 𝑜𝑓 𝑃𝐿𝑦𝑠 · 𝑎𝑚𝑖𝑛𝑒𝑠 𝑝𝑒𝑟 𝑙𝑦𝑠𝑖𝑛𝑒 )
 
𝑉𝑜𝑙 [µ𝑙] =
(0.25 · 0.624 𝑛𝑚𝑜𝑙 · 14963
𝑔
𝑚𝑜𝑙 ·  10
−3)
(0.25
𝑚𝑔
𝑚𝑙 · 18 · 1)
 
𝑽 = 𝟎. 𝟓𝟐 µ𝒍 
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To this volume of the PEG-PLys working solution, 19.48 µL of the folding buffer solution 
were added to bring up the total block copolymer solution volume to 20 µL. In a similar 
pattern, the volume of PEG-PLys needed for all the other N/P were calculated.  
Pipetting scheme for PEG-PLys solution at different N/P is calculated for DP = 18: 
N/P 0.25 0.5 1 2 4 8 
Stock Solution Volume (μL) 0.52 1 2.1 4.15 8.3 16.6 
Folding Buffer solution (µL) 19.48 19 17.9 15.85 11.7 3.4 
3.5.6 Decomplexation of DOPM using dextran sulfate 
To decomplex the DOPMs, they were mixed with polyanions. Amongst the various poly-
anions available for this purpose, dextran sulfate (Sigma Aldrich, M = 20,000 g/mol) was 
considered suitable as it has a high density of negative charges.268,274 
The concentration of dextran sulfate which is used to decomplex the DOPMs is described 
by the A/P ratio (similar to N/P ratio) = the molar ratio between the sulfates (A) of DS and 
the phosphates (P) of the DNA backbone. For all the decomplexation reactions carried 
out in this paper, A/P was 100. High A/P was maintained to ensure complete removal of 
the PEG-PLys shell from the core DNA origami structures. After the addition of DS to the 
DOPMs solution, the mixture was vortexed immediately. The reaction took place within 
seconds after the addition and the solution was analyzed using AGE and tSEM. 
Purification of decomplexed DOPM solution using ultrafiltration columns 
For purifying the mixture after decomplexation and to remove the PEG-PLys-DS complex 
from DNA origami, 100 kDa Amicon ultracentrifugal filters were used passivated with 
folding buffer. The decomplexed DOPMs solution was transferred to the filter columns 
and diluted to 400 µL using folding buffer. The filters were centrifuged at room tempera-
ture at 14,000 rcf for 2 min. The solution retained in the filter was diluted to 400 μL by 
adding dextran sulfate solution at A/P = 100 and centrifuged again under the same con-
ditions. A total of three washes were performed. After the final wash, the filters were 
reversed, placed in a fresh tube, and centrifuged at 1,000 rcf for 2 min. The purified 
decomplexed DNA origami solution was then collected and further characterized with 
tSEM, AFM and AGE. 
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For the initial test experiments, 10 kDa MWCO filter columns were also used and the 
same protocol as the 100 kDa MWCO filter columns was followed but only one washing 
step was performed using the folding buffer. To analyze the outcome of the initial purifi-
cation processes, the samples were loaded on agarose gels stained with gel green. 
Since gel green interacted with DS and produced produce a smear, this dye was used 
to detect remaining DS in the purified solution. 
3.5.7 Stability tests 
Low salt conditions using RPMI: 
To test the stability at low salt conditions, the control DNA origami and DOPMs were 
added to the standard RPMI media (without FBS) at a 1:10 (v/v) ratio. The standard 
RPMI buffer media contains 132.9 mM NaCl, 5.3 mM KCl, 0.4 mM MgCl2, 0.4 mM CaCl2. 
The samples were incubated for 16 h at 37 °C and analyzed by AGE and tSEM. The 
incubated DOPM samples were decomplexed before AGE. 
Low salt conditions by buffer exchange:  
To test the stability of control DNA origami and DOPM under salt conditions even lower 
than RPMI, the standard 12 mM Mg2+ buffer solution of the samples was exchanged to 
30 mM Na+ buffer using ultrafiltration columns. For this purpose, the samples were trans-
ferred to 100 kDa filter columns (passivated with folding buffer) and diluted to 400 µL 
with 5 mM Tris, 1 mM EDTA and 30 mM NaCl. The filters were centrifuged at room 
temperature at 14,000 rcf for 2 min. The retained solution was diluted again to 400 µL 
using the same buffer. A total of two washes were performed. After the final wash, the 
filters were reversed, placed in a fresh tube, and at 1,000 g for 2 min. The buffer ex-
changed solution was then collected and further characterized with tSEM, AGE and 
AFM. The incubated DOPM samples were decomplexed before characterization. 
DNase I stability test: 
To test the stability of DNA origami and DOPM against nuclease digestion, the samples 
were incubated for 16 h at 37 °C in a buffer containing DNase I at a 1:5 (v/v) ratio. The 
final reaction mixture consisted of 1X DNase I buffer, 1X folding buffer and 1 µL of 
DNase I enzyme (16 U/mL for protected/unprotected 6-HBs, ROs and dodecahedral 
trusses; 2000 U/mL for protected/ unprotected 24-HBs).  
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After the incubation period the enzyme was removed by phenol chloroform extraction. 
For this phenol (in amyl alcohol, VWR) was added 1:1 (v/v) to the sample mixture and 
vortexed. The solution was centrifuged shortly to separate the phenol and the aqueous 
phase. Next, the top (aqueous) phase was carefully removed and transferred to a fresh 
tube while the bottom phase was discarded. To purify the solution from the remaining 
phenol, chloroform (Applichem) was added in a 1:1 (v/v) to the sample solution and the 
sample extraction process was repeated. The chloroform wash step was performed 2 
times and the solution was used for AGE, tSEM and AFM analysis.  
FBS stability test: 
To test the stability of the protected and unprotected DNA origami structures against 
nuclease digestion under cell culture buffer conditions, the samples were incubated for 
16 h at 37 °C in a buffer containing RPMI supplemented with 10% FBS and adjusted to 
6 mM Mg2+. The samples were added in a 1:5 (v/v) ratio to the above mentioned buffer. 
After the incubation, the unprotected samples were loaded directly to the AGE while the 
protected samples were loaded after decomplexation (except for the 24-HBs, which was 
decomplexed after AGE). For tSEM and AFM analysis the bands were extracted using 
DNA gel extraction spin columns (Bio-Rad, Freeze ’N Squeeze) to recover the structures. 
3.5.8 tSEM characterization  
Carbon-coated TEM grids (400 mesh copper, carbon on formvar, Science Services Mu-
nich) were plasma-treated for 15 s. 5 µL of the sample solution were applied on the TEM 
grid and incubated for 5 min. The excess solution was removed from the grid with a filter 
paper. Next, 5 µL of a 2% uranyl formate solution was applied for 90 s to stain the DNA 
origami structures, and the solution was removed with a filter paper. The samples were 
scanned on Gemini SEM500 (Zeiss) and Helios 660 SEM/STEM system (FEI) operated 
at 10 kV. 
For experiments involving osmium tetroxide staining, the TEM grid was stained for 1 min 
with a 4% osmium tetroxide solution. While for experiments involving uranyl acetate 
staining, the TEM grid was staining for 2 min with a 2% uranyl acetate solution. Rest of 
the protocol was same as mentioned before. 
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Preparation of 2% uranyl formate solution 
100 mg of uranyl formate (Science Services Munich) were added to 5 ml of boiled ul-
trapure water. The mixture was stirred for a minimum of 5 min and filtered using a 
0.22 µm syringe filter. The filtered solution was stored at -20 °C in 100 µL aliquots. Prior 
to staining, 2.5 µL of 1 M NaOH solution were added to 100 µL aliquot of 2 % uranyl 
formate and mixed at room temperature for 5 min. 
3.5.9  AFM imaging 
70 μL of a 0.01% poly-l-ornithine solution (Sigma-Aldrich) were placed on a piece of 
freshly cleaved mica. After 1 min, the mica surface was washed with water. 3 μL of the 
respective sample were placed inside a circle (diameter ca. 3 mm) drawn with a perma-
nent marker. After incubation for 1 min, 70 μL of 1X FB were added to the sample and 
30 μL of the same buffer were added onto the AFM tip (BioLever-mini, Olympus). Scan-
ning was performed using AC liquid mode using a Cypher ES AFM (Asylum Research). 
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Chapter 4 Improving organic solubility and 
stability of DNA origami using 
polyplex micellization 
The work presented in this chapter has several contributors. Saranya Muthusamy helped 
with the proof-of-concept experiments with the polyplexed ssDNA-AuNPs; Kristin Joffroy 
performed the optimization reactions with DNA origami polyplexed micelles; Olha Afte-
neiva provided the AuNPs conjugated DNA origami structures; Katarina Iric performed 
the organic reaction experiments to prove the accessibility of functionalities on DNA ori-
gami in organic solvents; Michael Matthies and Bastian Joffroy provided useful sugges-
tions and numerous discussions. All the contributors were former members in the group 
of Dr. Thorsten-Lars Schmidt at the Center of Advancing Electronics Dresden, TU Dres-
den. This work will be submitted for publication soon after submission of the dissertation. 
4.1 Introduction 
DNA nanotechnology is an emerging field that enables self-assembly of discrete objects, 
which can be used as templates for subnanometer-precise placement of functional ele-
ments with the help of specific Watson-Crick base pairing principles (see section 1.3 for 
more details). Within the field, the scaffolded DNA origami technique has become a pop-
ular route to construct usable devices with dimensions ranging from the nanometer to 
the micrometer scale (1.3.5). Potential applications include the usage of switchable de-
vices in electronics and plasmonics or biology and nanomedicine (1.3.6), molecular de-
tection devices for drug delivery and in vivo therapeutics (1.3.6), etc.  
Nevertheless, in the native state, DNA is a highly charged macromolecule, that requires 
water molecules and cations to neutralize the charge repulsion among the phosphate 
groups and support the stacking of the bases. These requirements limit DNA molecule 
to aqueous solution based systems and inhibits any water sensitive reactions or the us-
age of water insoluble reagents.285,286 By placing DNA in extreme environment should 
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expand its properties and verstality.287 However, any attempt to move DNA away from 
the physiological environment into organic solvents leads to a dramatic change in the 
behavior and the conformation or dissociation into single strands.288 For instance, the 
addition of ethanol forces a B- to A-form transition of DNA.289 While, other organic sol-
vents like methanol, dimethyl sulfoxide, formamide, or pyridine causes complete dena-
turation to single-stranded DNA.290–292 
The solubility of any molecule or a higher-order structure in a specific solvent, particularly 
depends on the way the outer surface interacts with the surrounding environment. By 
modifying the surface, it is possible to tune these interactions and expand the favorable 
environments. Operating on this notion, several studies were reported where the intrinsic 
insolubility of DNA in pure organic solvents was overcome.293–296 These studies involve 
methylation of the phosphate residues in the backbone to make phosphonates or placing 
a benzyl group at the 2’ position of the deoxyribose rings.297,287 These methods are tedi-
ous and often lead to the deformation of the structure due to sterically hindered groups. 
Alternatively, quaternary alkyl ammonium salts298–300 or cationic amphiphiles such as li-
pids, polymers or surfactants,301–303 were also used to make complexes that are soluble 
in organic solvents by electrostatically binding to the phosphates in the backbone. In 
addition, proteins and oligonucleotides (DNAzymes) were covalently modified with PEG 
and were shown to maintain their activity upon organic solubility in various solvents in-
cluding methanol, acetonitrile, 1,4-dioxane and 1,2-dichloroethane.304–308 Despite the 
progress, to our knowledge, no study has been reported that can stabilize higher-order 
DNA assemblies in organic solvents. 
In this chapter, we explore the option of using a polymeric shell to tune the solubility of 
DNA-based structures and make it soluble in organic solvents. By doing so, we poten-
tially open the paradigm of possibilities of using the subnanometer-precise placements 
of reagents and hydrophobic functional organic molecules in the organic solution as well. 
To achieve this, we use the polyplex-strategy that was previously established in our 
group with the help of (PEG)-b-poly(L-Lysine) block copolymers (PEG-PLys), wherein, 
the PEG segment of the block copolymer forms a protective shell around the structures 
with the help of the positively charged lysine segment that binds electrostatically to the 
phosphate backbone. 
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We demonstrate the extent of solubility of the PEG-based DNA origami polyplex micelles 
(DOPMs) in various organic solvents (Chloroform, dichloromethane, acetone, isopropa-
nol, etc.). Upon optimizing the method, we have further tested the compatibility of the 
strategy with various functionalities organized in DNA origami, including fluorescent dyes 
(Cy3 and Cy5), inorganic materials (AuNPs) and biological molecules (biotin and strep-
tavidin). In addition, we have also checked if these elements were still functional after 
the switch from the organic solvent to the aqueous phase. Finally, we also tested the 
possibility to functionalize DNA origami in the organic solvent with water sensitive rea-
gents (fluorescamine) with the help of modified oligonucleotides. The results were ana-
lyzed with the help of agarose gel electrophoresis (AGE), transmission mode in scanning 
electron microscopy (tSEM) and fluorescence imaging using a laser (gel) scanner. 
4.2 Results and discussions 
4.2.1 Strategy for organic solubility of DNA origami 
Using the block copolymer PEG-PLys, we hypothesized that similar to our previous ap-
proach (3.2.1),[A] the positive lysine residues would electrostatically attach to the negative 
phosphate residues of DNA and form DNA origami polyplex micelles (DOPMs). The sol-
vent solubility of the complex would be dominated by the polymer shell around the DNA 
and should solubilize it in organic solvents. An overview of the strategy is presented in 
Figure 3-1. 
 
Figure 4-1. Overview of organic solubility of DNA origami using polyplex micellization. In 
the native state, DNA origami is only soluble in aqueous solutions (depicted in blue). A) 
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By adding PEG-PLys block copolymers, DOPMs are formed through electrostatic inter-
actions. These DOPMs are soluble in organic solvents (e.g. Chloroform, depicted in or-
ange) due to the preferential solubility of the PEG shell. B) The polymer shell can be 
removed by the polyanionic dextran sulfate (red, similar to Figure 3-1 E), hence reversing 
the solubility. 
4.2.2 Proof of concept using AuNPs functionalized with ssDNA 
To test the organic solubility strategy using polyplex micellization, we first used gold na-
noparticles (AuNPs) functionalized with single-stranded DNA (ssDNA) as a test system. 
The behavior of the surface of ssDNA-AuNPs in solution is comparable to that of DNA 
structures, as both present a negatively charged surface to the environment, with the 
added benefit of the characteristic reddish-pink color of AuNPs solution that facilitates 
quick analysis. The surface of these AuNPs are densely packed with 20-mer long ssDNA 
oligonucleotides (Figure 4-2 A), with the average packing density estimated to be ~130 
oligonucleotides per particle, calculated for AuNPs with 17 nm diameter and the surface 
area of 7 nm2 occupied by per oligonucleotide as per Hurst et al.270 
The initial tests were done using phenol/chloroform/isoamyl alcohol (25:24:1 v/v) solu-
tion, which is commonly used for the liquid-liquid extraction technique for separating DNA 
from proteins and lipids. With the addition of the reddish-pink ssDNA-AuNPs solution to 
the organic solvent, it was observed that two separate phases were formed with the col-
ored (aqueous) phase on the top while the immiscible organic phase remained on the 
bottom (Figure 4-2 B, tube marked with ‘C’). The ssDNA-modified AuNPs were then pol-
yplexed with either the “long” (12 kDa long PEG units and 18 lysines) or the “short” (5 
kDa long PEG units and 10 lysines) PEG-PLys at N/P = 10, as per the optimized proto-
cols established in Chapter 3. After the addition of both the variants of polyplexed ssDNA-
AuNPs to the organic solvent in separate tubes, the pink color occupied the organic 
phase (bottom), indicating the organic solubility of polyplexed ssDNA-AuNPs (Figure 4-2 
B, tubes marked with “SP” and “LP”). Next, a two-step process was tested, where the 
block copolymers were added directly to the aqueous (colored) phase (in a two-phase 
system with the organic solvent) and mixed thoroughly. It was observed that (Figure 4-2 
B, tube marked with LP*), the polyplex micellization with the ssDNA-AuNPs is quick, 
making the particles soluble in the organic phase right away.  
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The versatility of the method was further tested using various organic solvents that were 
divided into two categories, water miscible and water immiscible (Figure A 5, summary 
in Figure 4-2 C). For water miscible solvents it was observed that the ssDNA-AuNPs 
precipitate easily at lower (<2,000) relative centrifugal forces, indicating a reduced solu-
bility. In contrast, for the polyplexed variants, majority of the particles stay in the solution 
indicating a preferential solubility (Figure A 5). However, it was observed that for water 
miscible organic solvents even small amounts of water can assist the solubility of non-
modified DNA structures. Therefore, it was essential to maintain a higher purity of the 
organic solvent for a better comparison with the native conditions of DNA structures. For 
further details refer to section 4.2.3. 
The results with ssDNA-AuNPs only gives a baseline prediction of the organic solvents 
that can be used for testing polyplexed DNA origami, as these tests only cover the solu-
bility aspect but do not account for anything on the stability or structural integrity aspect. 
However, it can be confirmed that the solubility of ssDNA-AuNPs is indeed dependent 
on the polymer shell that protects it. By varying the composition of the shell, it is possible 
to tune the solubility of the core structure. 
 
Figure 4-2. Testing the organic solubility strategy using polyplex micellization with the 
help of ssDNA functionalized AuNPs. A) Artistic representation of polyplexing of ssDNA-
AuNPs. The AuNPs are densely covered with 20-mer oligonucleotides that bind electro-
statically to the lysine units on PEG-PLys to form polyplex micelles. B) The initial tests 
were done using the phenol/chloroform/isoamyl alcohol (25:24:1 v/v) solution, which is a 
4.2 Results and discussions  
 
82 
 
water immiscible organic solvent that forms a two-phase system with water (aqueous 
phase) on top and organic phase at the bottom. C = control with non-modified ssDNA-
AuNPs; ssDNA-AuNPs were polyplexed with SP = short PEG-PLys polymer; or LP = 
long PEG-PLys polymer; LP* = two-step process for organic solubility using the long 
polymer. C) Summary of the solubility results with various organic solvents. Collection of 
the images of the results can be referred to in Figure A 5. 
Understanding solubility parameters  
The organic solubility of ssDNA-AuNPs with the help of the PEG shell can further be 
explained by Hansen’s solubility parameters, which explains solubility as a function of 
the cohesive forces that exist between the molecules.309 These forces comprise hydro-
gen bonding energy (H), dispersive energy (D) and polarization energy (P), and by using 
these three parameters, molecules and high-order assemblies can be plotted on a “sol-
ubility space” with coordinates as [D, P, H]. The closer the molecule are in this space, 
the more likely are they miscible. For instance, water [18.1, 17.1, 16.9] and DNA [19, 20, 
11] are known to be miscible but same is not true for either of the molecules with chloro-
form [17.8, 3.1, 5.7]. The immiscibility of the chloroform molecules with water can be 
explained by the mismatch of polar cohesive energy and electron exchange probability 
parameters, leading to the formation of a two-phase system as observed in the initial 
studies. Interestingly, PEG [17, 3, 9] has parameters that match closely with that of chlo-
roform. These solubility parameters also further explain the immiscibility of polyplexed 
ssDNA-AuNPs in cyclohexane [16.8, 0, 0.2], 1-Pentanol [15.9, 5.9, 13.9] and 1-Butanol 
[16, 5.7, 15.8] (Figure A 5 and summary in Figure 4-2 C). 
4.2.3 Extending the strategy to DNA origami 
Chloroform 
After establishing a basic understanding of the organic solubility using the polyplex mi-
cellization method on ssDNA functionalized AuNPs, the strategy was then tested on DNA 
origami. For this, 6-HBs were polyplexed using the long PEG-PLys polymer at N/P = 8 
and chloroform was used as the test solvent. The solubility, stability and structural integ-
4.2 Results and discussions 
 
83 
 
rity was analyzed using AGE and tSEM. 6-HBs without polyplexing were used as con-
trols. It is essential to point out that the polyplexed conjugates were re-dissolved in the 
standard aqueous buffer to facilitate the analyses. 
From AGE results, it was observed that the control structures, similar to the observation 
with ssDNA-AuNPs, exist only in the aqueous phase (Figure 4-3 A). While for the poly-
plexed 6-HBs, the structures were distributed across both the phases, with ~65% of the 
structures residing in the aqueous phase (Figure 4-3, pointed with the red arrow). Similar 
to our previous study, the polyplexed 6-HBs product bands exhibit the characteristic mi-
gration towards the cathode.[A] From this, we concluded that the organic solubility is hin-
dered by the formation of a ‘foamy’ looking (emulsion) interphase that extends to the 
aqueous phase (Figure 4-3 B). This interphase formation was not observed for control 
structures, indicating that it is due to the presence of the long PEG-PLys polymers (Fig-
ure A 6). 
We hypothesize that the excess of the block copolymers lead to the formation of coales-
cent W/O or W/O/W emulsion due to the amphiphilic nature of PEG.310 The emulsion can 
be broken by adding salt (NaCl or MgCl2) and indeed a reduction in the coalescent-inter-
phase was observed after the addition of 300 mM NaCl to the two-phase system, along 
with 30 min centrifugation at 17,000 rcf (Figure 4-3 D, more details in Figure A 6). The 
AGE results support these observations, as nearly all the polyplexed 6-HBs reside in the 
organic phase, while the results for the non-polyplexed structures were unaffected (Fig-
ure 4-3 C). tSEM images of the polyplexed 6-HB after organic solubility were comparable 
to the non-polyplexed structures (Figure 4-3 E). 
We conclude that the overall structural integrity is unaffected by the strategy and the 
structures are stable even in the absence of salt or water molecules in the surrounding 
organic environment. We hypothesize that some water molecules along with the ions do 
get ‘trapped’ inside the polymeric shell but no experiments were performed to support 
this. 
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Figure 4-3. Testing the organic solubility strategy using polyplex micellization on DNA 
origami. A) AGE confirms that the control structures were only in the aqueous phase. 
The polyplexed 6-HBs were distributed across both the phases, with ~65% of the struc-
tures in the aqueous phase (pointed with the red arrow). B) The solubility is hindered by 
the formation of an emulsion at the interphase that extends to the aqueous phase, D) 
which can be reduced by the addition of 300 mM NaCl. C) After the salt addition step, 
nearly all the polyplexed 6-HBs reside in the organic phase, while the results for the non-
polyplexed structures are unaffected. E) tSEM images comparing the polyplexed 6-HBs 
after organic solubility with the non-polyplexed structures. Scale bars = 400 nm. 
Other organic solvents 
Next, the organic solubility strategy using polyplex micellization for DNA origami was 
extended to other water immiscible (dichloromethane) and water miscible (acetone and 
1-propanol) organic solvents. 6-HBs were used for all the experiments along with 
300 mM NaCl to break the formation of the coalescent emulsion-interphase. AGE and 
tSEM results show that DOPMs are soluble in dichloromethane as in chloroform (Figure 
4-4).  
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In case of the water miscible organic solvents, a strategy similar to that of our test exper-
iments with ssDNA-AuNPs was applied. The solution consisting of the test structures, 
standard aqueous buffer (5 mM Tris EDTA buffer at pH 7.4, 12 mM MgCl2), 300 mM 
NaCl and organic solvent (50% acetone or 50% 1-propanol) were subjected to 30 min 
centrifugation at 17,00 rcf. We predicted that, similar to ssDNA-AuNPs, the 6-HBs with-
out polyplexing would form aggregates that were insoluble in the organic solvents. Un-
expectedly, AGE and tSEM showed that 6-HBs were completely soluble in 50% ace-
tone/water (product bands pointed by red arrows in Figure 4-4 A). In 50% 1-propanol, 
however, only a small amount (~ 3%) of the non-polyplexed 6-HBs remain soluble while 
the rest formed aggregates and a pellet during centrifugation. The selective solubility of 
the non-polyplexed DNA origami in this case is strongly dependent of the percentage 
composition of water in the overall solution. 
This effect of the solvent composition for water-miscible organic solvents was further 
tested and from the AGE results (Figure A 7), it was observed that for acetone nearly a 
pure solvent (>95%) is necessary to render DNA origami insoluble. While for isopropa-
nol, the organic solvent composition should be more than 75% to precipitate majority of 
the structures. 
 
Figure 4-4. Extending the organic solubility strategy for DNA origami to other organic 
solvents (dichloromethane, 50% acetone and 50% 1-propanol). The results were ana-
lyzed using, A) AGE; and B) tSEM. Scale bars = 200 nm. The red arrows point to the 
solubility of non-polyplexed 6-HBs in the water miscible organic solvents (acetone and 
1-propanol). 
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4.2.4 Optimizations 
Dependency of the organic solubility on N/P ratio 
Subsequently, the extent of organic solubility of DOPMs was studied as function of the 
N/P ratio. To carry out this study, similar to our previous approach (3.2.2), the stoichiom-
etry was optimized by mixing increasing amounts of PEG-PLys with a constant amount 
of 6-HBs functionalized with Cy5 dyes. The N/P ratio was increased from 0 to 9/1. Chlo-
roform was used as the test solvent and the final equilibrated two-phase system was 
divided into three parts, namely, aqueous phase, interphase and organic phase (Figure 
4-5 A). The Cy5-modified oligonucleotides help facilitate the analysis by measuring the 
fluorescence intensity in each phase using the Cy5 optical channel on a laser scanner. 
The measured fluorescent intensities of individual phases at respective N/P ratios were 
normalized and plotted on a histogram (Figure 4-5 B). To further support our findings the 
results were also characteristics by AGE (Figure A 8). It is essential to point out that the 
polyplexed conjugates were re-dissolved in the standard aqueous buffer to facilitate the 
analyses. 
The histograms show that the percentage of DOPMs in organic phase increases with the 
increase in the N/P ratio, with the maximum at N/P = 3/1 (~75%, blue bars in Figure 4-5 
A). While for the aqueous phase this trend was reversed with nearly no DOPMs after 
N/P = 3/1. From this, we can hypothesis that it is necessary to maintain nearly a three 
times higher molar ratio of amines over phosphates (N/P), to have a higher population 
of DOPMs with surface saturated with PEG-PLys, that can neutralize the polyplex and 
facilitate the organic solubility. Similar surface-saturation observations were also made 
for the DLS studies performed for polyplexed ssDNA-AuNPs (3.2.2) where the hydrody-
namic radius reached a constant value after N/P =3/1, indicating a saturated ssDNA-
AuNP surface. Another interesting observation made from this study was that at N/P = 
9/1, the amount of DOPMs increases at the interphase when compared with N/P = 3/1. 
This behavior can be compared with the observations in section 4.2.3, where the DOPMs 
population in the organic phase decreases due to the formation of coalescent emulsions. 
Hence, we recommended N/P ratios between [3/1, 9/1] for a higher organic solubility of 
DOPMs and a reduced interphase coalescent emulsion formation.  
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Figure 4-5. Optimization of the organic solubility strategy using polyplex micellization. 
For this, 6-HB functionalized with Cy5 dyes were used and analyzed by measuring the 
fluorescence intensity of the solution and in AGE (Figure A 8). A) The two-phase system 
using chloroform as the organic solvent was divided into three part, namely, aqueous 
phase (blue), interphase and organic phase (orange). B) The fluorescence intensity of 
individual solutions was plotted as a function of the N/P ratio. The solubility of DOPMs in 
organic solvents (chloroform in this case) is directly dependent on the N/P ratio. From 
the graphs it can be observed that the content of DOPMs in the organic phase (blue 
bars) increases with the increase in the N/P ratio, with the maximum at 3/1 (~75%).  
Extent of solubility of DOPMs in different organic solvents 
Next, using the optimized N/P ratio, we measured the extent of solubility of DOPMs in 
different organic solvents. For this, 6-HBs were functionalized with Cy5 to facilitate the 
analyses. To attain a pure test system without salts or any other impurities, the DOPMs 
were first solubilized in chloroform using the two-phase system mentioned earlier, after 
which the chloroform phase was transferred to a fresh tube and evaporated (Figure 4-6 
A, i to iii). The dried DOPMs were then dissolved in the standard aqueous buffer or dif-
ferent organic solvents and the equilibrated solutions were again transferred to a fresh 
tube and evaporated (Figure 4-6 A, iv to vi). Next, the dried DOPMs were re-dissolved in 
the standard aqueous buffer to facilitate the analysis by measuring the fluorescence of 
the solution. The measured fluorescent intensities were normalized and plotted on a his-
togram (Figure 4-6 B). The added fluorescent intensities of the solutions in tube (vii) and 
tube (iv) defined the total DNA origami content (100%). It is essential to mention that all 
the fluorescence measurements were performed by evaporating the organic solvent and 
re-dissolving the pallet in standard aqueous buffer. 
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Figure 4-6. The extent of solubility of DOPMs in different solvents. A) To achieve this, 
DOPMs with Cy5 modification were first solubilized in chloroform using the two-phase 
system (i), after which the chloroform phase was transferred to a fresh tube (ii) and evap-
orated (iii). The dried, salt-free DOPMs were then dissolved in respective test solvents 
(iv) and the equilibrated solutions were again transferred to a fresh tube (v) and evapo-
rated (vi). The dried DOPMs were re-dissolved in the standard aqueous buffer (vii). 
B) Measured fluorescent intensities were plotted for the test solvents. The extent of sol-
ubility of DOPMs in different organic solvents varies from solvent to solvent (chloroform 
~95%, dichloromethane ~80%, isopropanol ~40% and acetone ~75%). 
The histogram in Figure 4-6 shows that the organic solubility of DOPMs varies from sol-
vent to solvents (chloroform ~95%, dichloromethane ~80%, isopropanol ~40% and ace-
tone ~75%; green bars in Figure 4-6 B). This discrepancy in differential solubility is well 
supported by Hansen’s solubility parameters as discussed in the section 4.2.2. Interest-
ingly, in accordance with those parameters, the PEG-shell does indeed exhibit a higher 
solubility in chloroform compared with the standard aqueous buffer (blue bar in Figure 
4-6 B). 
4.2.5 Compatibility with functional ligands 
For several potential applications, DNA origami can be used as a template to organize 
functional inorganic nanoparticles or biological molecules (for more details see 1.3.6). 
To test if the organic solubility strategy is compatible with these functionalizations, we 
introduced different functional ligands to DNA origami including fluorescent dyes (Cy3 or 
Cy5), inorganic materials (AuNPs), and biological molecules (streptavidin). The following 
sub-sections discuss the outcome of these compatibility tests in detail. 
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Dye-DNA origami conjugates 
Initially, the compatibility of the functional ligands with the organic solubility strategy was 
tested using Cy3 or Cy5 conjugated 6-HBs (Figure 4-7 A). For this, several organic sol-
vents (chloroform, dichloromethane, isopropanol and acetone) were used. The non-pol-
yplexed dye-DNA origami conjugates were used as controls. The results were analyzed 
by imaging the fluorescence of the aqueous solution in PCR plates using a laser scanner 
(Figure 4-7 B). In addition, AGE and tSEM analyses were also performed (Figure A 9 
and Figure 4-7 C-D). It is essential to mention that all the fluorescence measurements 
were performed by evaporating the organic solvent and re-dissolving the pallet in stand-
ard aqueous buffer. 
The fluorescence analysis shows that without polyplexing, similar to the previous obser-
vations (4.2.3), the dye-DNA origami conjugates are only soluble in the aqueous buffer 
(wells marked with ‘-’ in Figure 4-7 B). On the other hand, polyplexing facilitates the or-
ganic solubility of dye-DNA origami conjugates and the fluorescent wells indicate that the 
conjugates are stable and the activity of the dye is maintained (wells marked with ‘+’ in 
Figure 4-7 B). From this, it can be concluded that the DNA hybridizations (hydrogen 
bonds and base pair stacking) that hold the dyes in place on the DNA origami are also 
protected by the block copolymer when the structure is dissolved in the organic solvents. 
The results from AGE (Figure A 9) and tSEM (Figure 4-7 C-D) further support the con-
clusion. 
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Figure 4-7. Compatibility of the organic solubility strategy with DNA origami functional-
ized with either Cy3 or Cy5 dyes. A) Each binding site on the 6-HBs was hybridized with 
three Cy3/Cy5 dye modified oligonucleotides, with a total of five binding sites, spread out 
at equal distances of 82 nm. B) To achieve this, the DOPMs with Cy5 modification were 
first solubilized in respective organic solvents, after which the organic phase was trans-
ferred to a fresh tube (i) and evaporated (ii) and re-dissolved in the standard aqueous 
buffer for analysis (iii). C) The fluorescence of the dye-DNA origami conjugates was 
measures using 96-well plates and the Cy3/Cy5 optical channels on a laser scanner. 
The green colors correspond to Cy3 fluorescence while the red colors correspond to Cy5 
florescence (C = 6-HB controls; ‘+’ or ‘-’ = samples with or without polyplexes; aq = aque-
ous phase or org = organic phase for immiscible organic solvents; P = pallet or sup = 
supernatant for miscible organic solvents). The tSEM images represent dye-DNA origami 
conjugates, D) without polyplexing, recovered from the aqueous phase (immiscible) or 
the pallets (miscible) after organic solubility test and E) with polyplexing, solubilized in 
the organic phase (immiscible) or the supernatant (miscible). Scale bars = 200 nm. AGE 
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results can be referred to in Figure A 9. NOTE: Prior to the various analysis processes, 
the polyplexed dye-DNA origami conjugates from respective organic solvents were re-
dissolved in the standard aqueous buffer to facilitate the analyses. 
AuNP-DNA origami conjugates 
Next, AuNPs functionalized with ssDNA were conjugated to DNA origami with five bind-
ing sites (Figure 4-8 A). These AuNP-DNA origami conjugates were polyplexed with 
short PEG-PLys block copolymers according to the previous study (3.2.6). The tSEM 
images revealed a site occupancy of 96.5% post-polyplexing (N = 175 binding sites, 
Figure 4-8 B and Figure A 10). As a next step, these polyplexed conjugates were dis-
solved in chloroform, and the compatibility of these conjugates with the organic solubility 
strategy was analyzed by tSEM imaging. From the images, the occupancy was calcu-
lated to be 96% (N = 150 binding sites, Figure 4-8 C and Figure A 11). This indicates 
that the block copolymer not only solubilizes the AuNP-DNA origami conjugates but 
helps also maintain the organization of the AuNPs on DNA origami in organic solvents. 
 
Figure 4-8. Compatibility of the organic solubility strategy with DNA origami functional-
ized with AuNPs. A) The 6-HBs were functionalized with five AuNPs at alternative bind-
ing sites (1010101010, 1 = presence; and 0 = absence of AuNPs), that were placed 
82 nm away from each other. The tSEM images represent, B) polyplexed AuNP-DNA 
origami conjugates; and C) polyplexed AuNP-DNA conjugates after the solubilization in 
chloroform. Scale bars = 100 nm. The polyplexed conjugates prior to tSEM imaging were 
re-dissolved in the standard aqueous buffer to facilitate the grid preparation process. The 
red arrow points towards AuNP-dimers that are the potential side-effects from polyplex-
ing and account for 3-5% of the bound AuNPs (collection of tSEM images in Figure A 10 
and Figure A 11). 
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Biotin-DNA origami conjugates 
To test the compatibility of the organic solubility strategy with biological ligands, we used 
biotin functionalized DNA origami. For this, biotinylated oligonucleotides were hybridized 
at terminal binding sites on 6-HBs (Figure 4-9 A). At first, the polyplexed biotin-DNA ori-
gami conjugates were tested for organic solubility in chloroform. After which, the activity 
of biotin was confirmed by adding quantum dots functionalized with streptavidin (Figure 
4-9 B and Figure A 12). The excess of quantum dots were purified using AGE (Figure A 
18). The presence of quantum dots at terminal positions clearly indicates the presence 
and active-state of the biotin and streptavidin after organic solubility. 
 
Figure 4-9. Compatibility of the organic solubility strategy with DNA origami functional-
ized with biotin. A) The 6-HBs were hybridized with six biotinylated oligonucleotides, 
three at each terminal positions. Each of these positions can bind to streptavidin func-
tionalized quantum dots. B) The AGE purified QD-biotin-DNA origami conjugates were 
then analyzed using tSEM. The red arrows point out the quantum dots at expected po-
sitions. Scale bars = 100 nm, and 50 nm for enlarged figures. Collection of tSEM images 
can be referred to in Figure A 12. 
Streptavidin-DNA origami conjugates 
Next, we used streptavidin functionalized DNA origami structures. For this, similar to the 
previous setup, the streptavidin molecules were conjugated to the biotinylated binding 
sites on the 6-HBs. The polyplexed streptavidin-DNA origami conjugates were first tested 
for organic solubility in chloroform. After which, the stability was analyzed using AGE 
(Figure A 13). The streptavidin-DNA origami conjugates were then extracted from AGE 
and further analyzed using tSEM (Figure 4-10 B-D and Figure A 15 to Figure A 17). The 
tSEM images show that the conjugates after organic solubility are comparable to the 
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controls. In conclusion, the strategy helps maintain the organization of a non-covalently 
bound biological ligand on the DNA origami in organic solution. 
 
Figure 4-10. Compatibility of the organic solubility strategy with DNA origami functional-
ized with streptavidin. A) Each binding site on the 6-HBs was hybridized with three bio-
tinylated oligonucleotides, with a total of five binding sites, spread out at an equal dis-
tance of 84 nm. These positions were then functionalized with streptavidin, with a binding 
probability of 1-3 streptavidin units per site (Figure A 14). The tSEM images represents 
streptavidin-DNA origami conjugates, B) without any modification; C) polyplexed control; 
and D) polyplexed and solubilized in chloroform. Scale bars = 100 nm, and 50 nm for 
enlarged figures. It is essential to mention that prior to the addition on AGE, the poly-
plexed samples were decomplexed using dextran sulfate to help facilitate the AGE ex-
traction process and get comparable product bands. The red arrows point out the strep-
tavidin units at expected positions. Collection of tSEM images can be referred in Figure 
A 15, Figure A 16 and Figure A 17. 
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4.2.6 Functionalization of DNA origami in organic solvent 
After establishing the strategy for pre-functionalized DNA origami, next, we tested if it 
was possible to functionalize the DNA origami while it was still in the organic solvent. 
From the previous studies (3.2.7), it is established that in aqueous solution, the oligonu-
cleotides are still accessible post polyplex micellization. However, it is still unclear if these 
oligonucleotides are still accessible even in organic solution.  
To test this, we used the chemical reaction between primary amines and fluorescamine 
in chloroform. Fluorescamine is a non-fluorescent compound that reacts rapidly (10-
100 milliseconds) with primary amines containing molecules to generate a pyrrolidinone 
derivative which is fluorescent having emission wavelengths at 470 ± 20 nm.311 This re-
agent has been used to quantify proteins containing solvent exposed basic amino acids 
such as lysine and arginine.312,313 Another advantage of this compound is that it under-
goes rapid hydrolysis (1-10 seconds) in water to give non-fluorescent products.314  
To carry out this study, 6-HBs were hybridized with complementary amino-modified oli-
gonucleotides at four binding sites, with each binding site having three overhanging se-
quences (Figure 4-11 A). The polyplexed 6-HBs were solubilized in chloroform using the 
previously mentioned two-phase system and to that fluorescamine (dissolved in chloro-
form) was added and reacted. After the reaction, chloroform was evaporated and stand-
ard aqueous buffer was added to hydrolysis the excess fluorescamine molecules. 
It is essential to mention that the amines on the block copolymers also serve as potential 
reaction sites for fluorescamine. To remove all the excess block copolymers from the 
final reaction mixture as well as from the 6-HBs, dextran sulfate was used for decom-
plexation and with the help of AGE, the product band with 6-HBs and fluorescamine was 
extracted and used for fluorescence measurement using a fluorospectrometer (Figure 
4-11 B). 6-HBs without polyplexing were used as controls. The fluorescence emission 
shows the presence the fluorescent fluorescamine (~470 nm) on DNA origami, confirm-
ing the accessibility of the handles on DNA origami. With this we can conclude that this 
method can be used to make DNA origami a useful candidate for templated organic 
synthesis. 
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Figure 4-11. Fluorescamine functionalization of DNA origami in organic solvent. A) Each 
binding site on the 6-HBs was hybridized with three amino-modified oligonucleotides, 
with a total of four binding sites. These 6-HBs were then polyplexed and solubilized in 
chloroform where it was reacted with fluorescamine. B) The outcome of the reaction was 
analyzed with the help of fluorospectrometer using the excitation wavelength of 390 nm. 
The red curve represents the AGE extracted decomplexed 6-HBs that were reacted with 
fluorescamine in chloroform while the black curve represents the non-polyplexed 6-HBs 
structures without any reaction. The dotted line represents the expected emission maxi-
mum at 470 nm. 
4.3 Conclusion and outlook 
In this work, we showed that polyplex micellization using PEG-PLys block copolymers 
presents a robust, modular and reversible method to solubilize DNA origami structures 
and AuNPs functionalized with oligonucleotides soluble in a large variety of organic sol-
vents including chloroform, dichloromethane, isopropanol, acetone, etc. Our method is a 
fast, cost-effective, and user-friendly reaction taking place at any temperature from 4-
37°C.[A] The micellization also protected the DNA structures from any potential denatur-
ation in the absence of water and salts in the organic solvents. 
We further established the DOPM strategy to be compatible even with various functional 
ligands organized on DNA origami, such as fluorescent dyes (Cy3 and Cy5), inorganic 
materials (AuNPs and quantum dots), or biological molecules (biotin and streptavidin). 
The method not only helped maintain the organization but also the activity of the ligands 
after organic solubility. Moreover, with this method it is now also possible to perform 
organic solution based reactions on DNA origami using hydrophobic reagent including 
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fluorescamine. This should make DNA origami an exciting candidate for templated or-
ganic synthesis that has already been shown to be promising to make new small mole-
cules, synthetic polymers and new chemical reactions.285  
The solubility of DNA nanostructures using the DOPM strategy potentially can be tuned 
as per the demand of the application by simply changing the PEG segment of the block 
copolymer making the method versatile. We anticipate that this strategy should further 
ensure the likelihood of using DNA structures for therapeutic and diagnostic applications 
such as gene therapy including DNA vaccines and DNA-based sensing. 
  
4.4 Methods 
 
97 
 
4.4 Methods 
The methods listed in this section are unique to this chapter, while the ones that were 
common with the previous chapters were not mentioned again (3.5.1, 3.5.3, 3.5.4, 3.5.5, 
3.5.6 and 3.5.8). 
4.4.1 Conjugation of functional ligands to DNA origami 
Preparation of ssDNA functionalized AuNPs 
AuNPs with a diameter of ~17 nm were synthesized and functionalized by the protocol 
described in 3.5.2.  
Preparation of AuNPs-DNA origami conjugates 
The purified 6-HBs solution was quickly mixed with functionalized AuNPs (10 AuNPs per 
binding site) for 2 nM final 6-HBs concentration in 1X FB and incubated for 90 min at 
room temperature. The waveguide precursors used for polyplexing experiments involv-
ing short polymers were folded using 6-HBs containing five binding sites (positions 1, 3, 
5, 7, and 9) for AuNPs functionalization with an extension of 5′-AAAGAAACAAAGAAA 
sequences. 
Preparation of dye (Cy3/Cy5)-DNA origami conjugates 
The PEG precipitation purified 6-HBs containing five binding sites (1, 3, 5, 7 and 9), with 
three overhanging sequence each, were mixed with complementary oligonucleotides 
modified with the fluorescent dye (Cy3 or Cy5) at 5’ position (IDT) at a 30-fold excess 
per binding site. The above mixture was incubated for 60 min at room temperature and 
purified using PEG precipitation method.  
Preparation of biotin-DNA origami conjugates 
PEG precipitation purified 6-HBs containing two binding sites (1 and 10), with three over-
hanging sequence each, were mixed with complementary oligonucleotides modified with 
the biotin at 5’ position (IDT) at 30 times excess per binding site. The above mixture was 
incubated at 60 min room temperature for and purified using PEG precipitation method. 
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Addition of streptavidin/quantum dots functionalized with streptavidin to biotin-
DNA origami conjugates 
The PEG precipitation purified 6-HBs functionalized with biotin at terminal positions, were 
mixed with streptavidin (New England Biolabs) or quantum dots functionalized with strep-
tavidin (Thermo fisher) at 10 times excess per binding site. The above mixture was incu-
bated overnight at room temperature. The excess of the functional ligand was removed 
by AGE purification. 
For the experiment with quantum dots, the polyplexed biotin 6-HB conjugates were first 
tested for organic solubility in chloroform, after which they were re-dissolved in standard 
aqueous buffer and decomplexed. Only after that the streptavidin functionalized quantum 
dots were added to test the activity of biotin.  
4.4.2 Organic solubility 
Water immiscible organic solvents 
DOPMs or polyplexed ssDNA-AuNPs in standard aqueous buffer were added to water 
immiscible organic solvents (chloroform or dichloromethane) at 1:1 (v/v) ratio and mixed 
thoroughly. The above mixture was incubated at room temperature for 10 min and cen-
trifuged at 17,000 rcf for 30 min to separate the phases. After the centrifugation, the 
organic phase was transferred to a fresh tube. The solutions for all the tubes were then 
evaporated using speed vacuum concentrator. The pallet in each tube was re-dissolved 
in the standard aqueous buffer for further analysis. 
Water miscible organic solvents 
DOPMs or polyplexed ssDNA-AuNPs in standard aqueous buffer were added to water 
miscible organic solvents (isopropanol, acetone etc.) at 5:95 (v/v) ratio and mixed thor-
oughly. The above mixture was incubated at room temperature for 10 min and centri-
fuged at 17,000 rcf for 30 min. After the centrifugation, the entire solution was transferred 
to a fresh tube and evaporated using speed vacuum concentrator. The pallet in each 
tube was re-dissolved in the standard aqueous buffer for further analysis. 
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Dependence of organic solubility on N/P ratio 
To test this 6-HBs functionalized with Cy5 were polyplexed with N/P ratios varying be-
tween 0 to 9 using the calculations similar to the one done previously (3.5.5). The DOPMs 
were then solubilized in the organic phase as per the above mentioned protocol. The 
equilibrated two-phase solution was divided into three parts as described in Figure 4-5. 
The solution from each part was evaporated using the speed vacuum concentrator at 
room temperature and the pallet was re-dissolved in the standard aqueous buffer for 
further analysis. 
Extent of organic solubility test 
To ensure complete removal of salts and obtain pure organic phase separation the above 
protocol was modified as per Bligh and Dyer extraction and purification method.315 Chlo-
roform, methanol and DOPMs in standard aqueous buffer were added in a 2:2:1.8 (v/v/v) 
ratio. The mixture was equilibrated at room temperature for 10 min prior to rigorous mix-
ing to obtain a milky mono-phase. This was subjected to 10 min of centrifugation at 
17,000 rcf to separate it into 2 distinct phases with DOPMs residing in the chloroform 
phase while the other phase consists of methanol and the aqueous buffer. The chloro-
form phase with the DOPMs was carefully transferred to a fresh tube and the evaporated 
with the help of speed vacuum concentrator at room temperature. The pallet was then 
dissolved in different organic solvents (95% acetone, dichloromethane, isopropanol, 
chloroform, or standard aqueous buffer as control), and incubated for 60 min at room 
temperature. The equilibrated solution was then transferred to a fresh tube. The organic 
solvent was then evaporated and the pellet was re-dissolved in the standard aqueous 
buffer for analysis. 
4.4.3 Reactions in organic solution on DOPMs 
Fluorescamine reaction with amino-modified oligonucleotides 
The PEG precipitation purified 6-HBs containing 4 binding sites, with three overhanging 
sequence each, were mixed with complementary oligonucleotides modified with amino 
group at 5’ position (IDT) at 30 times excess per binding site. The above mixture was 
incubated for 60 min at room temperature and purified using PEG precipitation method. 
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These 6-HBs were then polyplexed using the long PEG-PLys at N/P = 3 and solubilized 
in chloroform using the above mentioned two-phase protocol.  
The accessibility of amino oligonucleotides was confirmed with the help of fluorescamine. 
For that, 11 mM of fluorescamine stock solution was prepared by added 3 mg of fluo-
rescamine in 1 mL of chloroform. The solution is stable at room temperature if kept mois-
ture free. 
The fluorescamine stock solution was added at a 25 times excess over the total number 
of amines in the solution (including the amines on the block copolymers) to the DOPMs 
in chloroform, and incubated for 30 min at room temperature. After the reaction the or-
ganic solvent was evaporated and the DOPMs were re-dissolved in standard aqueous 
buffer. The solution was incubated for 30 min to fully hydrolysis excess fluorescamine. 
After the incubation, dextran sulfate solution was added at A/P = 100 to decomplex the 
6-HBs and separate all the block copolymers. The above solution was further purified by 
AGE. 
4.4.4 Fluorescence imaging using gel scanner 
The fluorescently labelled 6-HBs were placed in 96-well plates and analyzed by imaging 
the fluorescence of the solution using the laser gel scanner (Typhoon FLA 9500 gel 
scanner, GE Healthcare) using the excitation wavelength of 473 nm or 532 nm suitable 
for respective dyes (Cy3 or CY5). The fluorescence intensity of each well was quantified 
using ImageJ (http://rsb.info.nih.gov/ij/). Resulting values were normalized and plotted 
using Microsoft excel. 
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Chapter 5 Structural transformation of 
wireframe DNA origami via DNA 
polymerase assisted gap-filling 
The work presented in this chapter is published and the sections were adapted with per-
mission from ref. [B]. Copyright (2018) American Chemical Society. Michael Matthies 
contributed equally to this work and he is also the shared first author. His contribution 
included the writing of the text, designing of the structures, initial test experiments (not 
mentioned in this chapter, but crucial for the conception of the project), AFM imaging and 
artistic representations. Bastian Joffroy helped with the PAGE analysis and quantifica-
tion. Both the contributors are former Ph.D. students in the group of Dr. Thorsten-Lars 
Schmidt at the Center of Advancing Electronics Dresden, TU Dresden. 
5.1 Introduction 
DNA nanotechnology utilizes the bottom-up, self-assembly approach wherein DNA is 
assembled into well-defined complex higher-order structures with the help of the speci-
ficity of Watson-Crick and Hoogsteen base-pair interactions (see details in section 1.3). 
The DNA origami technique is a particularly robust and popular method to design and 
build DNA based nanostructures (1.3.4). DNA origami structures can be compact and 
designed with mostly parallel helices. Examples include most flat origami structures and 
3-dimensional structures.133,316–318 Alternatively, grid-iron319 or wireframe structures230–
232,320,321 can be designed strictly from triangulated double-stranded helices231 or where 
edges consist of no more than two helices.230,232,321 The wireframe building principle is 
more material-efficient, allowing the structure to cover a larger area or encompass a 
larger volume, and increases the steric accessibility of the individual DNA helices. More-
over, the structures are stable in a wide range of salt conditions due to the reduced elec-
trostatic repulsion between the DNA helices. Overall, these examples demonstrate that 
DNA is a versatile material for constructing shapes. The addressability of DNA origami 
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structures further allows for a complex nanomaterial assembly,147 with applications rang-
ing from nanophotonics and nanoelectronics to biophysics, nanomedicine, and molecu-
lar biology.148,160,276 
Apart from building static structures, DNA can also be used to design dynamic molecular 
motors, walkers, robots and tweezers, reconfigurable DNA devices like a DNA origami 
actuator that can perform autonomous internal motions.322,323 The working principle of 
these examples is often a strand-displacement mechanism. Alternative approaches to 
build dynamic structures using DNA include temperature or salt control, restriction en-
zymes and the pH, ion or light responsive DNA motives.148 Such molecular motors con-
vert chemically energy to induce structural transformations (for more detail see section 
1.3.7).  
A major drawback of prototyping and improving complex DNA nanoscale structures is 
the cost of DNA oligonucleotides.324 To this end, the usage of staple strand sequences 
can be minimized by custom scaffolds.325 The drawback is the loss of unique addressa-
bility. Alternatively, a polymerase-assisted gap filling process on the M13 scaffold along 
with Rec A protein was shown to increase the persistence length of double-stranded 
DNA.326 However, it was concluded that this approach displayed defects when the DNA 
origami was pre-folded and the M13 scaffold was gap filled as a second step. In the work 
presented here, DNA polymerases were used to fill designed single-stranded gap re-
gions in DNA origami triangulated truss structures (Figure 5-1) and to transform the 
chemical energy obtained by the DNA polymerases into forces capable of mechanically 
transforming the structures. 
5.2 Results and discussion 
5.2.1 Design of the structures 
To develop a method for a DNA polymerase assisted gap-filling, four wireframe DNA 
origami designs were chosen: flat small (FS), tube small (TS), flat large (FL) and tube 
large (TL). “Small” designs have a typical gap size of 16 or 21 nucleotides (nt) and an 
edge length of 58 or 63 base pairs (bp) after gap filling, whereas “large designs” typically 
have gaps of 81 or 86 nt and an edge length of 123 or 128 bp after extension. Similar to 
the previous work by Matthies et al,231 the flat designs (FS and FL) were modified by 
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exchanging the edge staple strands (orange oligonucleotides in Figure 5-2) to form the 
tube designs (TS and TL), which consist of adjacent decahedral units. The resulting tube 
structures correspond to the 4(0, 1, 1) notation by Erickson.327 The isosceles triangles 
were chosen with two equal legs of odd helical half turns of DNA (58 bp and 123 bp for 
the small and large designs respectively) while the base of the triangle consisted of even 
helical half turns of DNA (63 bp and 128 bp for the small and large designs respectively). 
 
Figure 5-1. DNA polymerase assisted gap filling of wireframe DNA origami structures. 
(A) DNA origami structures are folded such that some or all edges contain unpaired sin-
gle-strand “gap regions” in the scaffold strand (grey). (B) These flexible gap regions are 
filled with a polymerase such as T4 DNA polymerase using the staple strands as primers 
resulting in stiff, double-stranded edges (C). Artistic representations were produced from 
PDB models of DNA (created using 3DNA)328 and the T4 DNA polymerase (PDB: 
1NOY).329 
The benefit of this composition of the structures is a planar and relaxed design230 com-
pared with the design with equilateral triangles with odd helical half turns of DNA by 
Matthies et al.231 The neighboring vertices of the triangles are connected by single-
stranded spacers of two nucleotides, for both the scaffold and staple strands. The staple 
oligonucleotides throughout the design have two domains of 21 bp each that connect the 
edges of the neighboring triangles, with the exception of the edge oligonucleotides (or-
ange oligonucleotides in the Figure 5-2) that have only one domain of 21 bp. The gap 
regions are positioned in the middle of each edge of the triangle, for the small designs 
(FS and TS) these gap regions are 16 and 21 nt long while for the large designs (FL and 
TL) they are 79 and 84 nt long. Thus, 33% of the scaffold remains single-stranded or 
66% in the large design. 
5.2 Results and discussion  
 
104 
 
 
Figure 5-2. Schematic representations of the DNA origami wireframe structures with gap 
regions. The structures were designed with the help of k-router.231 Both the small (A) and 
the large designs (B) are made up of isosceles triangles, where each edge of the triangle 
corresponds to a single DNA double helix. The gap regions are located in the central 
position on the edges of each triangle. In the control structures, gap regions are filled by 
additional staple-strands represented by red arrows that are annealed during the folding 
reaction. Schematic representation of one edge of the triangle can be seen in (B and D). 
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The blue arrows represent the scaffold, while green arrows represent the annealed sta-
ple-strands. The scaffold regions highlighted in yellow mark the gap regions acting as 
the entropic springs curving the structure (A, details in section 5.2.9). 
5.2.2 Folding of gap-structures 
The four different wireframe DNA origami structures were self-assembled by slowly an-
nealing the staple strand sets with their respective scaffold strands (p7560 for small de-
signs and p8064 for large designs). The gap-structures and control structures, where the 
gap regions were filled with additional staples, formed a single product band that mi-
grated slower than the corresponding scaffold strand band as observed in the agarose 
gel electrophoresis (AGE) analysis (Figure 5-3). The gap regions in the designs did not 
lead to an aggregation and the product yield for all the gap structures was calculated to 
be nearly 90%. This demonstrated the robustness of the wireframe design and supported 
the possibility of using fewer staples to assemble a structure. The shape of the gap-
structures is, however, not well defined (TEM images, Figure A 19 to Figure A 22) as 
expected due to the high flexibility of single-stranded DNA. 
 
Figure 5-3. AGE analysis of the T4 DNA polymerase assisted gap-filling of the wireframe 
DNA structures (A and B). Lanes marked with the red label “Gap” indicate structures 
with gap regions, blue label “Ext” = enzymatically filled structures; “p7560” and “p8064” 
= respective DNA scaffold used for the structure assembly; “C” = control structures with 
staple-filled gaps; “L” = 10 kb plus DNA ladder (Thermo Fisher Scientific). C) The product 
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yield was calculated from the ratio of the intensity of the product band and the entire 
material in a lane excluding the excess staple strands using ImageJ.330 From the graph 
it can be concluded that the final product yield is not affected by the absence of a large 
number staple-strands (33% for the small design and 66% for the large design) during 
the folding step and is in fact better when compared with the control structures where all 
the staple-strands were provided.  
 
Figure 5-4. Wireframe DNA structures before and after gap filling. Four structures, A) 
Flat small, B) Tube small, C) Flat large and D) Tube large were used here. Artistic models 
are displayed to scale such that the relative sizes can be compared. The structures con-
taining the gap regions were folded (1). Then T4 DNA polymerase and dNTPs were 
added to fill the gap regions (2) with the optimized protocol. Enzymatically filled struc-
tures are compared with the control structures (3), where the structures were folded with 
additional staples complementary to the gap regions. Scale bars of tSEM micrographs: 
100 nm. (Wide-field images: Figure A 19 to Figure A 22). 
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5.2.3 Single-stranded DNA binding proteins  
In nature, single-stranded DNA (ssDNA) is produced during strand breaks, replication, 
recombination or DNA repair. Single-stranded regions are typically stabilized either by 
the replication of the counter strand by DNA polymerases or are covered with single-
stranded binding (SSB) proteins. Initially, we tested the stabilization of single-stranded 
gaps with two SSB proteins (Figure 5-5). The motivation to add SSB proteins was to 
selectively fill the gap regions similar to Schiffels et al.326 This would have improved the 
contrast of these regions and would have also provided a method to improve the rigidity 
of these structures.331 Moreover, RecA and T4 gene 32 protein both exhibit a strong 
affinity towards ssDNA and are known to stabilize the ssDNA domains and effectively 
denature potential secondary structures. Therefore, the SSB proteins were added alone 
and also in combination with DNA polymerases with the hope to extend these regions 
with higher efficiencies. 
 
Figure 5-5. Efficiency comparison of different single-stranded binding (SSB) proteins (A) 
for the gap-filling of wireframe DNA structures. The different extension reactions were 
performed on flat small structures for 1 h in the respective buffers recommended by the 
supplier and at temperatures as mentioned in the table. The outcome of the extension 
reaction was analyzed on AGE (B). C) PAGE analysis was performed with AGE purified 
samples (highlighted with red boxes in B). D) For the analysis by tSEM the extension 
reactions were performed freshly and not purified by AGE. Scale bars: 100 nm.  
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However, the addition of RecA to the test structures resulted in the formation of aggre-
gates that can be observed as a smeared band above the leading product band (Figure 
5-5 B). The migration of the leading product band is similar to the gap-structures, sug-
gesting that most of the starting product was unaltered. Using RecA in conjunction with 
T4 DNA polymerase resulted in slower migration of the product band when compared 
with the control gap structures. However, neither the denaturing polyacrylamide gel elec-
trophoresis (PAGE) analysis, nor the tSEM micrographs of the AGE extracted product 
band could confirm the formation of the desired product (Figure 5-5 B-D). Similarly, the 
addition of T4 gene 32 protein to the gap structures and the usage of the protein in con-
jugation with T4 DNA polymerase produced no defined conclusive structures. 
RecA was reported to have a strong tendency to form a triple-helix and we believe that 
this phenomenon was responsible for the formation of higher order aggregates that could 
have also led to the formation of the undesired shapes in tSEM images.332 This further 
explains the formation of inconclusive products obtained from the conjunction of RecA 
with T4 DNA polymerase. The triple-helix formation tendency of RecA could be used to 
improve the stiffness and the persistence length of dsDNA and this route was recently 
explored by Schiffels et al.326 While, for the combination of T4 gene 32 protein and T4 
DNA polymerase, the DNA polymerase was previously reported to be more processive 
in the presence of the protein. This could potentially be the reason for the formation of a 
slower migrating product band. A possible route to improve the results with T4 gene 32 
protein, would be to add the T4 DNA polymerase in a second step. This would first give 
time to the SSB protein to bind to the ssDNA and denature any possible secondary struc-
tures. And as a second step, the T4 DNA polymerase would then be able to fill the gap 
regions. But Schiffels et al. conclude, that folded DNA origami is not suitable for the 
binding to the SSB proteins considering and in our case it would be necessary to main-
tain the shape and size of the resulting DNA origami. In conclusion, the approach with 
SSB proteins did not produce the desired structural transformation and was no longer 
explored in the work presented here. 
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5.2.4 Gap filling with different polymerases 
Next, a purely DNA polymerase assisted gap filling without SSB proteins was explored 
with different polymerases including T4 DNA polymerase, DNA polymerase I, Phi29 pol-
ymerase, T7 DNA polymerase, Vent DNA polymerase, Taq DNA polymerase, Phusion 
high-fidelity DNA polymerase, large Klenow fragment and Q5 high-fidelity DNA polymer-
ase. For this, the test structure (FS) was incubated with these DNA polymerases in sep-
arate vials in the respective buffers provided by the suppliers for 1 h. From all these 
polymerases, only T4 DNA polymerase is commonly used for gap-filling reactions in bi-
ology,333 for example in cloning applications.334 To test T4 DNA polymerase extensively, 
three different incubation temperatures (12, 25 and 37 °C) were tested. On AGE, the 
product bands of all the three reactions were observed to migrate slower than the control 
gap structure (Figure 5-6 B), indicating an extension by the DNA polymerases. 
 
Figure 5-6. Efficiency comparison of different DNA polymerases (A) for the gap-filling of 
wireframe DNA structures. The different extension reactions were performed on flat small 
structures for 1 h in the respective buffers recommended by the supplier and at temper-
atures as mentioned in the table. The outcomes of the extension reactions were analyzed 
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on AGE (B). C-D) PAGE and tSEM analysis were performed with AGE purified samples 
(highlighted with red boxes in B). Scale bars: 100 nm. 
For all reactions, we further analyzed the extended strands by 15% denaturing PAGE to 
investigate the extension of the individual staple strands (Figure 5-6). For the control gap 
FS structure before extension, only distinct 21-mer and 44-mer bands can be observed. 
After extension with the T4 DNA polymerase, 60-mer and 65-mer bands were observed 
as expected. An additional continuous smear below the 60-mer band was also observed 
indicating the formation of shorter undesired side products or incomplete extension. We 
hypothesized that these products were formed as a result of an increased 3’ -> 5’ exo-
nuclease activity of the DNA polymerase with long incubation times (see below). The 
product bands for DNA polymerase I, phi29 polymerase and large Klenow fragment mi-
grate slower compared with the T4 DNA polymerase product. For DNA polymerase I, 
this can be explained by the strong 5’-3’ exonuclease activity of the polymerase, which 
presumably digests downstream staple strands leading to the formation of double-
stranded (ds) scaffold strands. The Phi29 polymerase and the large Klenow fragment 
are known for their strong strand-displacement activity resulting in a circular ds M13 and 
a long ssDNA concatemer and no defined staple bands were observed in the PAGE gels.  
Vent DNA polymerase, Taq DNA polymerase, Phusion high-fidelity DNA polymerase and 
Q5 high-fidelity DNA polymerase are widely used DNA polymerases for PCR reactions 
and are typically used at high temperatures. Despite of their thermophilic character, gap-
filling resulted in a band pattern similar to that of T4 at moderate temperatures (37 °C), 
both for in AGE and PAGE gels. Furthermore, tSEM micrographs show the formation of 
defined FS structures (Figure 5-6 and Figure 5-7) that were comparable to the control 
structures where the gap regions were filled by complementary staple strands (Figure A 
19). The AGE (Figure 5-7 A) indicates that for all the three DNA polymerases there were 
consistent shifts in the band migration and this is corresponding to the gap filled struc-
tures. For further analysis, the samples were extracted from the AGE and loaded on a 
15% denaturing urea PAGE gel (Figure 5-7 B) which shows bands corresponding to the 
extended DNA staple strands. However, T4 DNA polymerase produced smeary bands 
that are less intense in comparison to the bands produced with the help of Phusion and 
Q5 DNA polymerases. The smear in the T4 lane was later found to be caused by the 3’-
>5’ exonuclease activity of T4 and, which could be avoided if the extension time was 
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reduced to 5 min by quenching of the reactions with 2-ME, T4 polymerase (see figures 
Figure 5-10, Figure 5-11 and Figure 5-12 for more details). In conclusion, T4 DNA poly-
merase, Phusion and Q5 can all potentially be used for the polymerase assisted gap-
filling of wireframe DNA origami structures. 
 
Figure 5-7. Efficiency comparison of different DNA polymerases (T4, Phusion and Q5) 
for the gap-filling of wireframe DNA structures. The different extension reactions were 
performed on flat small structures for 1 h in the buffers recommended by the suppliers 
for the respective enzyme and at 37 °C. The outcomes of the extension reactions were 
analyzed on AGE (A). B-C) PAGE and tSEM analysis were performed with AGE purified 
samples (highlighted with red boxes in B). tSEM micrographs of the samples filled with 
Q5 can be observed in (C). Scale bar left: 200 nm and right: 100 nm. 
5.2.5 Gap filling with Phusion high-fidelity DNA polymerase 
From all the tested DNA polymerases, Phusion seemed to perform the best for the FS 
structures in the first experiments. However, for the other designs (TS, FL and TL), the 
expected oligonucleotide bands were missing. Instead, a smeary background was ob-
served (Figure 5-8 A). The product bands with an expected shift were observed in AGE 
(Figure 5-8 A), but PAGE revealed that staple extension did not occur correctly and that 
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the extended structures did not resemble the desired shape in tSEM micrographs except 
for the flat small structures (Figure 5-8 B-C). These results imply that extension with 
Phusion DNA polymerase is possible for the small (flat and tube) structures but it is not 
able to extend all the gap structures with equal efficiency at the tested conditions. How-
ever, the ideal working temperature of the polymerase is 74 °C (according to the sup-
plier), therefore, we hypothesize that the reduced activity at lower temperatures prevents 
extension.  
 
Figure 5-8. Phusion DNA polymerase assisted gap-filling of all four wireframe DNA struc-
tures. The extension reactions were performed for 1 h in the buffer recommended by the 
supplier at 37 °C. The AGE results (A) indicate that the electrophoretic mobility of all four 
structures changes after the extension reaction (lanes marked with “ext” in blue) in com-
parison to the respective gap structures (lanes marked with “Gap” in red). For further 
analysis, the samples were extracted from the AGE (highlighted with red boxes) and 
loaded on a 15% denaturing urea PAGE gel (B). (C) tSEM micrographs of the extended 
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samples only FS structures resemble the expected shape, while other structures seem 
not intact. Scale bars: 100 nm. 
Optimization of the extension reaction using Phusion DNA polymerase 
The optimizations were performed on FS and FL structures for 1 h in the buffers provided 
by the supplier for at different temperatures (12, 25, 37 and 45 °C). The AGE results 
(Figure 5-9 A) indicate that for extension at temperatures 12 and 25 °C, the product band 
migration for both FS and FL is comparable to the respective gap structures. As hypoth-
esized earlier, the reduced activity of the polymerase at lower temperatures prevents 
extension, as the ideal working temperature is 74 °C (according to the supplier). Increas-
ing the incubation time to 15 h at 25 °C, the polymerase was able to fill the gap region 
and this can be seen in the retardation of the product band compared with the one where 
the sample was just incubated for 1 h (Figure 5-9 B). 
At higher extension temperatures (37 °C and 45 °C), the product bands migrate slower 
compared with the control gap structures as a result of the extension reaction after one-
hour incubation. But for FL structure the extension at 45 °C seems to have a further 
retardation in the band migration. We hypothesize that this effect could be a result of 
increased fraying of staple-domains in the structure at higher temperatures leading to a 
(partial) strand displacement reaction which could further lead to the aggregation of the 
structures resulting in lower band migration. 
The PAGE results (Figure 5-9 C-D) indicate that the extension reactions with Phusion as 
the DNA polymerase works with expected efficiency for flat small structures at 37 °C and 
45 °C, whereas for lower temperatures (12 and 25 °C) the oligonucleotides are not com-
pletely extended. Whereas, for FL structures, the expected oligonucleotide bands were 
missing. Instead, a smeary background was observed. This was observed across all 
temperatures. Like in the AGE analysis, the 15 h incubation of the samples that were 
extended at 25 °C showed expected oligonucleotide bands compared with the sample 
that was extended for 1 h (Figure 5-9 D) as expected from the reduced activity of the 
polymerase at lower temperatures. tSEM images also show intact structures for the FS 
structure that was extended at 25 °C for 15 h, while all the other samples have deformed 
shapes (Figure 5-9 E). With these experiments and optimizations, it can be concluded 
that Phusion DNA polymerase is not able to extend all the gap structures with equal 
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efficiency and this approach did not produce the desired structural transformation and 
was no longer explored in the work presented here. 
 
 
Figure 5-9. Optimization of the extension reaction using Phusion DNA polymerase. (A-
B) AGE results for the extension reaction at respective temperatures. For further analy-
sis, the samples were extracted from the AGE (highlighted with red boxes) and loaded 
on a 15% denaturing urea PAGE gel (C-D). (E) tSEM micrographs of the extended sam-
ples for FS and FL structures at different reaction temperatures. Scale bars: 100 nm. 
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5.2.6 Optimization of the extension reaction using T4 DNA polymerase 
Inactivation of polymerase 
Due to the inconsistent results with Phusion polymerase and since T4 DNA polymerase 
is widely used for gap-filling in molecular biology, we further optimized conditions for T4 
DNA polymerase. We hypothesized its strong 3’ -> 5’ exonuclease activity may have led 
to the undesired products in the smear on PAGE as discussed above (Figure 5-7 B). By 
adding 2-mercaptoethanol, the enzyme and probably also the exonuclease activity could 
be denatured in less than 1 min. This fast quenching provides the necessary control over 
the reaction time (Figure 5-10). From the AGE results it can be observed that the 2-
Mercaptoethanol inactivated the enzyme and the product bands have a slower migration 
compared with the product bands that were not inactivated (Figure 5-10 A). On further 
analysis with the PAGE gels (Figure 5-10 B), the inactivated product lanes produce dis-
tinct oligonucleotide bands when compared with the non-inactivated product lane that 
have a smeary background. This behavior was observed across all the structures. The 
mechanism is not clear, but after the inactivation step, much fewer undesired products 
were observed and the structures looked more intact in TEM images (Figure 5-10 C). 
Additionally, the products were comparable to the ones obtained after the gap-filling re-
action with Phusion DNA polymerase, with the advantage that the method was now con-
sistent across all the designs. We therefore strongly recommend inactivation of the pol-
ymerase after the extension reaction. 
Optimizing dNTP concentration and polymerase concentration 
For further optimization, different concentrations of the dNTPs and the T4 DNA polymer-
ase were tested. These optimizations were performed on FS structures for 5 min at 25 
°C. The extension reaction was inactivated with the help of 2-Mercaptoethanol after 5 
min of incubation. From the AGE results (Figure 5-11 A) it can be concluded that while 
keeping the polymerase concentration constant at 3 units in 20 µL reaction and lower 
dNTP concentration (0 to 5 µM/dNTP) the polymerase has a higher exonuclease activity 
that leads to the digestion of the excess staples along with some amounts of the main 
product. This effect is reduced for dNTP concentrations >50 µM/dNTP, with 500 
µM/dNTP being the optimum concentration. 
5.2 Results and discussion  
 
116 
 
To test the optimal polymerase concentration, five different concentrations were tested 
(3, 1, 0.3, 0.1 and 0.03 units in a 20 µL reaction). The AGE results (Figure 5-11 A) indi-
cate that a lower concentration of the polymerase reduces the extension efficiency. The 
minimum concentration is around 1-3 units, with 1 unit being a borderline case. All the 
conclusions are backed by the PAGE analysis (Figure 5-11 B). In summary, the optimum 
dNTP concentration is 500 µM/nt while the optimum T4 DNA polymerase concentration 
is 3 units in 20 µl reaction. To inactivate the polymerase, 1 min of incubation with 2-
Mercaptoethanol is sufficient. 
 
Figure 5-10. Inactivation of T4 DNA polymerase with 2-mercaptoethanol. The extension 
reactions were performed for 45 min in the supplier’s buffer at 25 °C. After extension, 
reactions were quenched with 10% 2-Mercaptoethanol (final) for 10 min at 25 °C. A) AGE 
results for the extension reaction. The lane with 2-Mercaptoethanol inactivation step are 
marked with “ext*” in blue. For further analysis, the samples were extracted from the 
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AGE and loaded on a 15% denaturing urea PAGE gel (B). (C) tSEM micrographs com-
paring the effect of quenching of the polymerase. Scale bars: 100 nm. 
 
Figure 5-11. Optimizing dNTP and polymerase concentration using T4 DNA polymerase 
with 2-Mercaptoethanol. The optimizations were performed on the FS structure in buffer 
recommended by the supplier at 25 °C. A) The AGE results for the extension reaction at 
varying dNTP and T4 DNA polymerase concentrations. For further analysis, the samples 
were extracted from the AGE and loaded on a 15% denaturing urea PAGE gel (B). The 
optimal condition for the extension reaction is denoted with the grey box in both the AGE 
and PAGE results. 
Optimizing time and temperature 
Next, we tested gap-filling reactions at different temperatures. For that, both the FS and 
FL structures were extended at five different time points (1, 3, 10, 30 and 100 min) and 
3 different temperatures (12, 25 and 37 °C). From the AGE results (Figure 5-12 A for FS 
and B for FL), it can be observed that for temperatures 12 and 25 °C the product band 
migration for both FS and FL across all time points are comparable and correspond to 
the filled structures. While for the extension reactions for both the structures at 37 °C, 
the excess staple bands in the bottom of the lanes were observed to be fainter compared 
with the corresponding bands at 12 and 25 °C. Also, at the 100 min time point the product 
band along with the extra staple band is inexistent. Both these observations for the re-
actions at 37 °C support the hypothesis that the polymerase is more processive at higher 
temperatures and has a higher 3’->5’ exonuclease activity that leads to the digestion of 
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the products while some of the remaining forms aggregates (bands in the pockets of the 
wells). The PAGE gels (Figure 5-12 C for FS and D for FL) show less background smear 
at higher temperatures. Nevertheless, for the FL samples, extra unaccounted oligonu-
cleotide bands can still be observed, potentially caused by slippage at secondary struc-
tures (see section 0 for more details). The conclusions are backed tSEM images as well 
(Figure 5-13). In conclusion, the optimum conditions for T4 DNA polymerase assisted 
gap-filling of the wireframe structures is: 25 °C extension for 1-10 min followed by 2-
Mercaptoethanol inactivation at 25 °C for 1-3 min (AGE and PAGE analysis for this can 
be referred to in Figure 5-12 E and F). 
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Figure 5-12. Optimizing incubation time and temperature for extension using T4 DNA 
polymerase with 2-mercaptoethanol. The optimizations were performed on FS and FL 
structures for different time points (1, 3, 10, 30 and 100 min) in the supplier’s buffers at 
different temperatures (12, 25 and 37 °C). A-B) The AGE results for the extension reac-
tion at varying time and temperature for FS and FL respectively. For further analysis, the 
samples were extracted from the AGE and loaded on a 15% denaturing urea PAGE gel 
(C-D). The optimal incubation time at 25 °C was further confirmed and the AGE and 
PAGE analysis for both FS and FL structure can be referred to in (E and F). Correspond-
ing tSEM images can be found in Figure 5-13. 
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Figure 5-13. TEM micrographs corresponding to the time and temperature optimizations 
of the extension reactions with T4 DNA polymerase. A) Flat (small); B) Flat (large) 
C) Tube (large). Scale bars = 100 nm. 
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5.2.7 Secondary structures 
As per the observations in the previous section for the FL structure, fewer low-molecular 
weight side products were obtained at 37 °C after 3-10 min incubation compared with 
lower temperatures. Insufficient processivity does not seem to be responsible for tem-
perature-dependent differences, as even after 3 minutes at 12 °C, the majority of staples 
were extended to the full-length product and even a 33-fold longer incubation time did 
not reduce the remaining shorter side products (Figure 5-12) significantly. So, even at 
lower temperatures, the enzyme should in principle be fast enough to extend the gaps. 
We therefore hypothesize that the additional lower molecular weight bands might be 
caused by hairpins, which could act as a roadblock to the polymerase. Alternatively, 
hairpins may also lead to replication slippage,335 which is an effect inversely related to 
the DNA polymerase strand-displacement mechanism and would also results in shorter 
extension products. Much fewer short side products were observed at 37 °C, which 
would be consistent with the model of hairpins. The higher temperatures would lead to 
an increased temporary melting (fraying), which could enable the polymerase to suc-
cessfully read through the hairpin. We observed a similar effect for Phi 29 polymerase 
which has a high strand displacement capacity and which had a significantly higher am-
plification rate if temporary melting (fraying) probabilities were increased due to geomet-
rical constraints.336 
Gibbs free energy calculations 
To further understand the low gap-filling efficiency of large (flat and tube) structures. The 
Gibbs free energy of the gap-regions for the two gap designs (small and large) was cal-
culated using the mfold algorithm.84 The results from the simulation were classified into 
four categories depending on the computed Gibbs free energy value and the observation 
from the PAGE analysis. A lower (more negative) Gibbs free energy directly corre-
sponded to stronger hairpin regions. The results were plotted on a heat map graphic 
using k-router231 for respective structures (Figure 5-14).  
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Figure 5-14. Heat map plot for Gibbs energy values calculated for all the gap regions in 
different structures performed at four different temperatures (12, 25, 37 and 40 °C). 
A) Small gaps corresponding to FS and TS; B) Large gaps corresponding to FL and TL; 
C) Partially filled large gaps with complementary oligonucleotides for FL and TL The 
results from the simulation were distributed into four categories depending on the en-
ergy (kcal/mol) required to melt the gap regions at respective temperatures.  
At lower temperatures, nearly all the gap regions have a high probability of hairpin for-
mation, while at higher temperatures, the probability of hairpin formation is reduced. 
However, in the large structures, there are still 13 gap regions with a strong high hairpin 
formation probability at 40 °C. We hypothesize that hairpins with a Gibbs free energy of 
less than -7 kcal/mol are likely to undergo a replication slippage when extended with the 
help of T4. 
To locate potential hairpins, we performed a Gibbs free energy simulation using mfold 
on all the gap regions at four different temperatures (12, 25, 37 and 40 °C) for the two 
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gap designs (small and large). A lower (more negative) Gibbs free energy directly corre-
sponded to stronger hairpin regions (Figure 5-14). Increasing the extension temperature 
to 37 °C eliminated most side products. Alternatively, additional staples complementary 
to strong hairpins or artificially designed scaffold strands337 with reduced secondary 
structures may improve extension results for regions with strong secondary structures 
further. 
In conclusion, the optimal conditions for the T4 DNA polymerase assisted gap-filling 
method are 25 °C for 5 minutes for the FS and TS structures and 40 °C for 5 min for the 
FL and TL structures, followed by an inactivation step with 2-mercaptoethanol (Figure 
5-3, Figure 5-4 and Figure 5-15). 
 
Figure 5-15. Denaturing PAGE analysis of the DNA polymerase assisted gap filling of 
the wireframe DNA structures. The lanes marked with a red ‘-’ contain the structures with 
the gap regions, while the lanes marked with a blue ‘+’ contain the enzymatically ex-
tended structures. The expected staple strand bands are marked with a dotted line in 
each lane. The lengths before (red) and after gap filling (blue) and the number of strands 
for each expected final length is summarized in the insert tables. The occurrence number 
of each staple extension is denoted in brackets in black. Structures before and after 
enzymatic extension were purified by AGE. 
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5.2.8 Folding kinetics of gap origami  
We tested four different protocols (tables in Figure 5-16 A) to find the minimum time 
needed to fold the gap structures. We tested cooling ramps over 16 h, 1 h, and 10 min, 
and a 6 min isothermal reaction similar to the one described by Sobczak et al.,338 after 
which the gap structures were extended at the optimized conditions (25 °C for 3 min, 
followed by 2-Mercaptoethanol inactivation at 25 °C for 1 min). AGE, PAGE and AFM 
results indicated that all the annealing protocols work with comparable efficiency (Figure 
5-16) and we conclude that despite the utilization of an incomplete staple set the gap 
structures can be folded in just 6 min and then gap-filled with T4 DNA polymerase in 3 
min, resulting in a total reaction time of just 9 min. 
 
Figure 5-16. Fast folding of gap flat small structures followed by fast T4 DNA polymerase 
assisted gap-filling. A) The flat small structures were folded with gap regions 4 different 
folding protocols were tested to assess the minimum time needed to anneal and hybrid-
ize the domains of the wireframe structures. B) The AGE results suggest that all folding 
protocols work with equal efficiency and the expected oligonucleotide bands were pre-
sent in all cases in the PAGE gels (C). D) Further analysis by AFM does not show sig-
nificant differences. Scale bars: 500 nm. 
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5.2.9 Bending of tubes 
Finally, TS structures were folded with gap regions only at one side of the tube (Figure 
5-17 A-left) which act as entropic springs and induce a global curvature.339 After filling 
the gap regions with a polymerase, they were rigidified, thus releasing the bending 
stresses resulting in a straight tube (Figure 5-17 A-right). To quantify the curvature of the 
tubes, angles were measured from the tSEM micrographs (Figure A 23 and Figure A 24), 
plotted in a histogram (Figure 5-17 C) and fitted with a Gaussian curve. The curved tubes 
had an angle of 130° ± 15°, whereas straightened tubes were almost perfectly linear 
180° ± 6°. These results demonstrate a well-defined structural transformation in DNA 
origami structures by gap filling polymerases. Varying the number and the position of the 
gap regions may allow a precise control of the resulting transformation. 
 
Figure 5-17. Structural transformation of the wireframe tubes using the DNA polymerase-
assisted gap-filling method. Tube small structures were folded with gap regions high-
lighted by red arrows (A). These gap regions act as entropic springs that force the entire 
structure to curve. After filling the gap regions with T4 DNA polymerase, tubes were 
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straightened (A-right). (B) tSEM micrographs of the corresponding curved and straight-
ened tubes (scale bars: 100 nm). (C) Histograms of the angular distributions plotted 
against the occurrence number in respective samples (N=260 for each state). The histo-
grams were fitted with a Gaussian curve with a standard deviation of 130° ± 15° for the 
curved tubes and 180° ± 6° for the straightened tubes. (D) Denaturing PAGE analysis of 
the DNA polymerase assisted gap filling of curved tube small structure. The lane marked 
with a red ‘-’ contains the curved gap structures, while the lane marked with a blue ‘+’ 
contain the enzymatically extended/straightened structures. The expected staple strand 
bands are marked with a dotted line in each lane. E) The lengths before (red) and after 
gap filling (blue) and the number of strands for each expected final length is summarized 
in the insert tables. The occurrence number of each staple extension is denoted in brack-
ets in black. Structures before and after enzymatic extension were purified by AGE. The 
staple strands that do not undergo any extension include the strands that are comple-
mentary to the gap regions as well as the strands that act as “primers” for the extension 
reaction. 
5.3 Conclusion 
In this work, we have demonstrated the structural transformations of DNA origami struc-
tures induced by strand extension reactions with DNA polymerases. For this purpose, 
we tested a wide range of DNA polymerases and found that T4 DNA polymerase is the 
most suitable. The presence of single-stranded gap regions in the design requires fewer 
staple-strands (33% less in small design and 66% less in large design) and allows very 
fast annealing times in only 6 min compared with 16 h used for most DNA origami struc-
tures. Gap regions in the structures act as entropic springs that lead to a collapse of the 
entire structure if gap regions are introduced on all edges. When gap regions are only 
introduced on one side of the tubular DNA origami, the resulting structures were selec-
tively curved. The DNA polymerase assisted gap-filling transformed collapsed structures 
into full-size filled structures or straightens curved structure tubes. In one of our typical 
reactions, we used 1 µl of dNTPs (~0.06 €) and 1 µl of T4 Polymerase (~1 €) to modify 
0.4 pmol of DNA origami. We envision that this approach will enable reducing costs for 
the prototyping of different wireframe origami designs or be used to construct force gen-
erating mechanical units which can be switched within 3 min. This switching can, for 
example, be used to switch plasmonic devices or to build dynamic devices for single-
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molecule force spectroscopy. The costs of the polymerase could be reduced by 1-2 or-
ders of magnitude when produced in house, which would make this technique attractive 
for larger scale reactions as well. 
5.4 Outlook 
DNA origami provides a wide range of possibilities of placement of functional elements 
at specific pre-defined locations with subnanometer precision. Traditionally this is 
achieved by using commercially available modified oligonucleotides that can be hybrid-
ized either to a complementary overhanging DNA single-stranded oligonucleotide or di-
rectly to the scaffold. Using the DNA polymerase assisted gap filling strategy, it is possi-
ble to insert functional elements on DNA origami by using modified nucleotides (for ex-
ample fluorescently labelled dNTPs) as building-blocks for the DNA polymerase. This 
method could potentially provide a cheap in-house, versatile, and competitive approach 
with which the functional elements can be inserted in any arbitrary position on wireframe 
DNA origami trusses and with further optimizations also on other compact DNA struc-
tures as well.  
Along the same lines, it should also be possible to introduce single RNA units at selected 
locations, which can then serve as sites for the introduction of nicks using RNase H 
polymerase. Using this, it should be possible to control the curvature of wireframe DNA 
origami tube truss structures reversibly using DNA polymerases, with the nicks serving 
as the stopping points for the enzyme. Another possible approach to control the curva-
ture is by using the already established strand-displacement method. With this, is should 
be possible to switch between several possible curvatures of the tube. This would po-
tentially open up applications that are directed towards controlling the movement of func-
tional elements that are bound to DNA origami over hundreds of nanometers. 
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5.5 Methods 
5.5.1 DNA origami folding 
For folding wireframe DNA origami structures (with or without gap regions) the following 
mixture composition was used: 20 nM of p8064 (for large design) or p7560 (for small 
design) scaffold (Tilibit), staple strands set (Eurofins) (sequences in 5.5.9) at 200 nM 
(each), 1X of NEB 2.1 buffer (New England Biolabs Inc.) that consists of 50 mM NaCl, 
10 mM Tris-HCl, 10 mM MgCl2 and 100 µg/mL BSA adjusted to pH 7.9 were mixed. The 
mixture was annealed in a thermal cycler (Bio-Rad C1000 Touch) from 80 to 65 °C at a 
rate of -1 °C/min and from 65 °C to room temperature at a rate of -1 °C per 20 min. 
Excess staple strands were then removed by agarose gel electrophoresis. For fast fold-
ing the following variations were made to the annealing protocol. 
1-hour protocol: 1 min at 80 °C, 80 to 65 °C at a rate of -1 °C/20 s and from 65 °C to 
room temperature at a rate of -1 °C per min. 
10 min protocol: 1 min at 80 °C followed by cooling down to 20 °C at the rate of 5 
°C/min. 
6 min protocol (isothermal): 1 min at 80 °C and 55 °C for 5 min.  
Following the annealing reaction, the samples were stored at -20 °C in 1.5 mL DNA 
LoBind vials (Eppendorf). 
5.5.2 Gap filling of the wireframe DNA origami structures 
For the extension of the gap regions the following routes were explored. 
SSB protein assisted gap filling method (RecA and T4 gene 32) 
10 µL of 20 nM unpurified gap structures (FS) were added to a 200 µL PCR tube. To 
that, the respective SSB protein buffer provided by the supplier was added to a final 1X 
concentration. Ultrapure water was added to bring the volume of the mixture to 19 µL. 
To this mixture 1 µL of the SSB protein (RecA or T4 gene 32, New England Biolabs) 
were added and mixed carefully (Final volume: 20 µL). The mixture was incubated for 
1 h at 25 °C (for Rec A) or 37 °C (for T4 gene 32). The reacted sample was then used 
for further analysis and purification by AGE.  
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Combination of the SSB protein and T4 DNA polymerase (RecA+T4 DNA pol; T4 
gene 32+T4 DNA pol) 
10 µL of 20 nM unpurified gap structures (FS) were added to a 200 µL PCR tube. To 
that, the respective SSB protein buffer provided by the supplier to a final 1X concentra-
tion. Ultrapure water was added to bring the volume of the mixture to 18 µL. To this 
mixture 1 µL of each component was added and mixed carefully. Final volume: 20 µL. 
The mixture was incubated for 1 h at 25 °C (for Rec A) or 37 °C (for T4 gene 32). The 
reacted sample was then used for further analysis and purification by AGE. 
Initial test with different DNA polymerase assisted gap filling methods (T4, T7, DNA 
pol1, Vent, Taq, Phusion, Q5, Klenow and phi29) 
10 µL of 20 nM unpurified gap structures (FS) were added to a 200 µL PCR tube. To 
that, the respective enzyme buffer provided by the supplier was added to a final 1X con-
centration. Ultrapure water was added to bring the volume of the mixture to 19 µL. To 
this mixture 1 µL of the DNA polymerase were added and mixed carefully. Final volume: 
20 µL. The mixture was incubated for 1 h at 12 °C (for T4) or 25 °C (for T4, DNA pol1) 
or 30 °C (for phi29) or 37 °C (for T4, T7, Vent, Taq, Phusion, Q5 and Klenow). The 
reacted sample was then used for further analysis and purification by AGE. 
NOTE: All the different activities of the DNA polymerases that are summarized in the 
main text were derived from the website of the supplier (New England Biolabs Inc.).  
Final optimized T4 DNA polymerase assisted gap filling method with 2-Mercap-
toethanol inactivation 
10 µL of 20 nM unpurified gap structures (FS, TS, FL and TL) were added to a 200 µL 
PCR tube. To that, the respective enzyme buffer was added to bring the final concentra-
tion of the buffer to 1X. Ultrapure water was added to bring the volume of the mixture to 
17 µL. To this mixture 1 µL of the T4 DNA polymerase were added and mixed carefully. 
The mixture was incubated for 5 min at 25 °C (for FS and TS) or 40 °C (for FL and TL). 
To stop the reaction, 2 µL of 2-Mercaptoethanol was added and incubated for 1 min at 
25 °C. The reacted sample was then used for further analysis and purification by AGE. 
NOTE: For all the optimization reactions, the same reaction mixture composition was 
prepared as described in the initial test section. 
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5.5.3 Agarose gel electrophoresis 
For the AGE analysis, 1% agarose gels (DNA pure grade, VWR) was casted with 0.5X 
TBE buffer supplemented with 12 mM MgCl2 and 1X Gelgreen nucleic acid gel stain 
(Biotium). 0.5X TBE buffer with 12 mM MgCl2 was used as a running buffer. 15 µL of 
sample solution were mixed with 3 µL of 6X gel loading dye (50% glycerol, 5 mM Tris, 
1 mM EDTA (pH 8.0), 12 mM MgCl2, 0.25% bromophenol blue and 0.25% of xylene 
cyanol). Electrophoresis was performed at 70 V for 2 h at room temperature. As a refer-
ence, 10 µl of 1 kb plus DNA ladder (Thermo Scientific) were added. The gel was imaged 
with a Typhoon FLA 9500 gel scanner (GE Healthcare) using the excitation wavelength 
of 473 nm suitable for SYBR safe stained gels.  
For the purification of the wireframe DNA origami structures (with or without gap regions), 
the desired band was cut out with a razor blade and the excess agarose was carefully 
removed. The slice was then chopped, transferred into a DNA gel extraction column (Bio-
Rad, Freeze ’N Squeeze) and centrifuged at 4,800 rcf, at room temperature for 5 min. 
After centrifugation, the inner filter tube was rotated by 180° and centrifuged again under 
same conditions to completely filter out the sample from the agarose debris. The purified 
sample was transferred into a DNA LoBind tube and stored at 4 °C. 
5.5.4 PAGE gel analysis 
Casting 15% denaturing PAGE gel  
18.2 g of Urea (99.5% for analysis, ACROS Organics) was dissolved in 20 mL of ul-
trapure water. To the mixture following components were added: 5 mL of 10X Tris-EDTA-
Borate (TBE) buffer, 18.75 mL of Acrylamide : Bisacrylamide (29:1); 40% solution (Alfa 
Aesar), 400 µL of freshly dissolved Ammonium persulfate, 10% wt. (Applichem), 30 µL 
of N,N,N′,N′-Tetramethylethylenediamine (TEMED, Sigma Aldrich). This solution was 
mixed by inverting the tube. Then the solution was carefully poured into empty PAGE 
cassettes (1.5 mm thickness, mini, Thermo Fisher Scientific). The prepared volume was 
sufficient for 4 cassettes. Combs were carefully placed into the cassettes without spilling 
the solution. The cassettes were incubated for 30 min. For storage the cassettes were 
placed in a bag with 0.5X TBE buffer and placed at 4 °C until further usage. 
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Sample loading preparation 
5 µL of the AGE extracted sample were mixed with 5 µL of 2X denaturing loading solution 
(50% formamide, 10 mM NaOH, traces of bromophenol blue and xylene cyanol). For the 
ladder, 1 µL of 10 bp ladder (Thermo Scientific) were mixed with 0.5 µL 10X folding 
buffer, 5 µL of 2X denaturing loading dye and 3.5 µL of ultrapure water. The empty lanes 
were filled with a blank solution composed of 0.5 µL 10X folding buffer, 5 µL of 2X loading 
dye and 4.5 µL of ultrapure water.  
Protocol for running the gel 
0.5X TBE buffer warmed to ~65 °C was used as the running buffer. The lanes were 
washed with 0.5X TBE buffer using a syringe. The gel was pre-run at 220 V for 30 min 
inside a thermos-box filled with hot water (~65 °C). The lanes were washed with 0.5X 
TBE buffer using a syringe. The prepared samples were loaded into the lanes (10 µL 
each). The gel was run under the same condition as in the pre-run. After the run, the gel 
was post-stained with 1X SYBR gold (Life technologies). The gel staining solution was 
contained mixing 45 mL ultrapure water, 5 mL absolute ethanol. To this mixture 5 µL of 
the SYBR gold dye (solution in DMSO) was added. The gel was imaged with a Typhoon 
FLA 9500 gel scanner (GE Healthcare) using the excitation wavelength of 473 nm suit-
able for SYBR gold stained gels.  
5.5.5 tSEM characterization 
Carbon-coated TEM grids (400 mesh copper, carbon on Formvar, Science Services Mu-
nich) were plasma-treated for 15 s. 5 µL of the sample solution were applied on the TEM 
grid and incubated for 3 min. The excess solution was removed from the grid with a filter 
paper. Next, 5 µL of a 2% uranyl formate solution were applied for 90 s to stain the DNA 
origami structures, and the solution was removed with a filter paper. Additionally, 2 wash-
ing steps were performed with ultrapure water for 10 s each and the water removed with 
a filter paper. The samples were scanned on Gemini SEM500 (Zeiss) operated at 30 kV. 
5.5.6 AFM imaging 
70 μL of a 0.01% poly-L-ornithine solution (Sigma-Aldrich) were applied to a piece of 
freshly cleaved mica. After 1 min, the mica surface was washed with water. 3 μL of the 
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respective sample were placed inside a circle (diameter ca. 3 mm) drawn with a perma-
nent marker. After incubation for 1 min, 70 μL of 1X FB were added to the sample and 
30 μL of the same buffer were added onto the AFM tip (BioLever-mini, Olympus). Scan-
ning was performed using AC liquid mode using a Cypher ES AFM (Asylum Research). 
5.5.7 AGE based folding-yield estimation  
The quantification of the bands on AGE was done using ImageJ 
(http://rsb.info.nih.gov/ij/) according to the previously used technique.134 
5.5.8 Gibbs free energy simulation using mfold 
mfold is a tool that helps in the prediction of secondary structures of RNA and DNA by 
using thermodynamics.84 In the current study, this algorithm was used to compute the 
Gibbs free energy for the gap regions in the two gap designs (small and large). For this 
purpose, conditions similar to the experiments were chosen (10 mM MgCl2, 50 mM NaCl) 
and four different temperatures (12, 25, 37 and 45 °C) were simulated. The output values 
were plotted on the respective structure design in the form of a heat map graphic with 
the help of k-router231 using a color-coded scheme where the results were classified into 
four categories depending on the computed Gibbs free energy value and the observation 
from the PAGE analysis (Figure 5-14). 
5.5.9 Staple list for folding the DNA origami triangulated structures  
All the oligonucleotide sequences of the respective structures are summarized in the file 
“sequences.yaml” in the supplementary file of [B]. This file type can be opened using any 
text editor. The sequences are sorted into two groups: Small and large design. The se-
quences are further divided into sub-categories as per the following table: 
  
5.5 Methods 
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SMALL Name Description 
 CORE Common for all small designs 
 UFFS Unique for flat small design 
 UFTS Unique for tube large design 
 SGF To fill all the small gap regions 
 SGFC For curved tubes 
LARGE Name Description 
 CORE Common for all large designs 
 UFFL Unique for flat large design 
 UFTL Unique for tube small design 
 LGF To fill all the large gap regions 
 LH To partially fill the hairpin containing gap-region 
 
The structures that are discussed in the main text are assembled by mixing the sequence 
from the above mentioned sub-categories in an equimolar ratio as per the following 
scheme: 
1) All the gap-filled control structures: 
o Flat small = CORE + UFFS + SGF 
o Flat large = CORE + UFFL + LGF 
o Tube small = CORE + UFTS + SGF 
o Tube large = CORE + UFTL + LGF 
2) All the gap structures:  
o Flat small = CORE + UFFS 
o Flat large = CORE + UFFL 
o Tube small = CORE + UFTS 
o Tube large = CORE + UFTL 
3) Gap large structures with partially filled gap-regions: 
o Flat large = CORE + UFFS + LH 
o Tube large = CORE + UFTL + LH 
4) Curved tube small structures: 
o Tube small curved = CORE + UFTS + SGFC 
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Appendix 
A.1 Additional figures from chapter 3 
 
Figure A 1. tSEM images of polyplexed 6-HB structures at N/P = 4 using long PEG-PLys. 
The DOPMs demonstrated a peculiar “lateral stacking” behavior on the TEM grids when 
compared to non-polyplexed variants (Figure 3-2 B) in the presence of uranyl acetate 
staining (A-B). However, this behavior was not consistent as no such stacking of the 
DOPMs was observed for uranyl formate staining (C-D). To aid the lateral the lateral 
stacking of the DOPMs, the TEM grid were modified with poly-L-ornithine (E-F). Scale 
bars: A = 200 nm, and B to F = 500 nm. 
A.1 Additional figures from chapter 3 
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Figure A 2. Polyplexing and decomplexation (D) of the RO structure (A) and the D-truss 
structure from Matthies et al.231 (C) In both cases the decomplexed structures are indis-
tinguishable in the gel from the reference structures. Corresponding tSEM, AFM images 
are found in Figure 3-9. B and D) Artistic representations of RO and D-Truss respec-
tively. 
 
Figure A 3. tSEM images of polyplexed 6-HB structures stained with 4% osmium tetrox-
ide. Scale: A, B = 200 nm; C = 100 nm. 
A.1 Additional figures from chapter 3  
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Figure A 4. Testing the accessibility of the overhanging sequences on DNA origami after 
polyplex micellization. A) The fluorescence images of the respective solutions under dif-
ferent emission channels. The concentration of Cy5 modified oligonucleotides was in-
creased logarithmically to a maximum of 8-times excess over the Cy3-modified se-
quences on the 6-HBs. B) The fluorescent intensities of the various wells in (B) was 
normalized and plotted versus the increasing concentrations of Cy5 modified oligonucle-
otides. For more information, please refer to section 3.2.7. 
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A.2 Additional figures from chapter 4 
 
Figure A 5. Testing the organic solubility strategy using polyplex micellization with the 
help of ssDNA-functionalized AuNPs. The method was tested for both, A) water immis-
cible, and B) water miscible organic solvents. For details, please check section 4.2.2 and 
Figure 4-2. 
  
A.2 Additional figures from chapter 4  
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Figure A 6. The extent of organic solubility using the polyplex micellization method is 
hindered by the formation of a ‘foamy’ coalescent emulsion interphase that extends to 
the aqueous phase (Top tubes, Figure 4-3). We hypothesize that this ‘foamy’ interphase 
is due to the amphiphilic nature of PEG and by adding salt (NaCl or MgCl2) is it possible 
to reduce the foam by breaking the emulsion (Bottom tubes). However, it was observed 
that the reduction in the emulsion is less significant for higher N/P ratios (>8). We rec-
ommend using N/P ratios lower than 8 for better results. Both MgCl2 and NaCl can be 
used interchangeably as both demonstrated an equal impact on the reduction of the 
emulsion. 
 
Figure A 7. Optimization of the organic to aqueous solvent composition for water miscible 
organic solutions (Acetone and Isopropanol). This was done to ensure complete precip-
itation of native DNA origami structures for a better control system. For this, 6-HBs were 
used with three compositional variations (50:50, 75:25 and 95:5) of the organic solvent 
(acetone or isopropanol). L = ladder; S = p7560 scaffold control; C = non-polyplexed 6-
HBs; P = pallet, referring to the precipitated 6-HBs that were re-dissolved in the standard 
aqueous buffer; sup = supernatant, mixture of the organic phase and aqueous phase 
that were separated from the precipitated structures. 
A.2 Additional figures from chapter 4 
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Figure A 8. Optimization of the organic solubility strategy using polyplex micellization of 
DNA origami. A) Fluorescent image corresponding to Figure 4-6. The fluorescent wells 
correspond to the DOPMs that were, not dissolved (top row) or dissolved (bottom row) 
in the respective organic solvents. For more details, please refer Figure 4-6. B-C) Fluo-
rescent image and AGE image corresponding to Figure 4-5. The DOPMs were prepared 
at increasing N/P ratios. For more details, please refer Figure 4-5.  
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Figure A 9. AGE analysis of the test to confirm the compatibility of the organic solubility 
strategy with DNA origami functionalized with either, A) Cy3, or B) Cy5 dyes. C = 6-HB 
controls; ‘+’ or ‘-’ = samples with or without polyplexes in respective solvents; aq = aque-
ous buffer, org = organic solvent, L = ladder and S = p7560 scaffold control. For details, 
please refer to the section 4.2.5 - Dye-DNA origami conjugates and Figure 4-7. 
A.2 Additional figures from chapter 4 
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Figure A 10. tSEM images representative of polyplexed AuNP-DNA origami conjugates. 
Scale bar: 100 nm. (More details in section 4.2.5 – AuNP-DNA origami conjugates). 
A.2 Additional figures from chapter 4  
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Figure A 11. tSEM images representative of polyplexed AuNP-DNA origami conjugates 
after solubilization in chloroform. Scale bar: 100 nm. (More details in section 4.2.5 – 
AuNP-DNA origami conjugates). 
A.2 Additional figures from chapter 4 
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Figure A 12. tSEM analysis of the test to confirm the compatibility of the organic solubility 
strategy with DNA origami functionalized with biotin. The activity of biotin was confirmed 
by adding quantum dots functionalized with streptavidin. The excess of quantum dots 
were purified using AGE (Figure A 18). The purified QD-biotin-DNA origami conjugates 
A.2 Additional figures from chapter 4  
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were then analyzed using tSEM. The red arrows point out the quantum dots at expected 
positions. Scale bars = 100 nm. For details, please refer to the section 4.2.5 - Biotin-DNA 
origami conjugates and Figure 4-9. 
 
Figure A 13. AGE analysis of the test to confirm the compatibility of the organic solubility 
strategy with DNA origami functionalized with streptavidin. For this, 6-HBs with 5 binding 
sites used and chloroform was used as the test solvent. 6-HB 5H = DNA origami with 5 
binding sites, C = 6-HB controls; C-D = control with decomplexed 6-HBs; aq = aqueous 
buffer, org = organic solvent and L = ladder. For details, please refer to the section 4.2.5 
- Streptavidin-DNA origami conjugates and Figure 4-10. 
 
Figure A 14. Multiple binding probability of streptavidin to 6-HBs. Each binding site on 
the 6-HBs is hybridized with three biotinylated oligonucleotides, that can bind to either 
one, two or three streptavidin units. tSEM images represent different bound streptavidin 
units (each unit pointed out by red arrows). Scale bars = 100 nm, and 50 nm for enlarged 
figures. More details in section 4.2.5 – Streptavidin-DNA origami conjugates. 
A.2 Additional figures from chapter 4 
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Figure A 15. tSEM images representing AGE purified streptavidin-DNA origami conju-
gates without any modification. Scale bars = 100 nm. It is essential to mention that prior 
to the addition on AGE, the polyplexed samples were decomplexed using dextran sulfate 
to help facilitate the AGE extraction process and get comparable product bands. More 
details in section 4.2.5 – Streptavidin-DNA origami conjugates. 
A.2 Additional figures from chapter 4  
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Figure A 16. tSEM images representing control polyplexed streptavidin-DNA origami 
conjugates. Scale bars = 100 nm. It is essential to mention that prior to the addition on 
AGE, the polyplexed samples were decomplexed using dextran sulfate to help facilitate 
the AGE extraction process and get comparable product bands. More details in section 
4.2.5 – Streptavidin-DNA origami conjugates. 
A.2 Additional figures from chapter 4 
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Figure A 17. tSEM images representing polyplexed streptavidin-DNA origami conjugates 
solubilized in chloroform. Scale bars = 100 nm. It is essential to mention that prior to the 
addition on AGE, the polyplexed samples were decomplexed using dextran sulfate to 
help facilitate the AGE extraction process and get comparable product bands. More de-
tails in section 4.2.5 – Streptavidin-DNA origami conjugates. 
A.2 Additional figures from chapter 4  
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Figure A 18. AGE analysis of the test to confirm the compatibility of the organic solubility 
strategy with DNA origami functionalized with HaloTag/AuNPs/Biotin. For this, 6-HBs 
with 2 or 5 binding sites were used (2 binding sites in case of HaloTag/biotin conjugation 
or 5 binding sites in case of AuNP conjugation) and chloroform was used as the test 
solvent. 6-HB 5H = DNA origami with 5 binding sites, C = 6-HB controls; C-D = control 
with decomplexed 6-HBs; aq = aqueous buffer, org = organic solvent, L = ladder and S 
= p7560 scaffold control. The red boxes depict the product bands that were extracted for 
further analysis by tSEM. For details, please refer to section 4.2.5 and Figure 4-9 and 
Figure 4-8. 
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A.3 Additional figures from chapter 5 
 
Figure A 19. Wide-field tSEM micrographs for the flat small structures. (A) Folded struc-
tures with gap regions; (B) Structures filled by T4 DNA polymerase at 25 °C for 3 min, 
followed by an inactivation step using 2-Mercaptoethanol at 25 °C for 1 min; (C) Control 
structure, without gap regions were folded with additional complementary staples. Scale 
bars: 200 nm. 
A.3 Additional figures from chapter 5  
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Figure A 20. Wide-field tSEM micrographs for the tube small structures. (A) Folded struc-
tures with gap regions; (B) Structures filled by T4 DNA polymerase at 25 °C for 3 min, 
followed by an inactivation step using 2-Mercaptoethanol at 25 °C for 1 min; (C) Control 
structure, without gap regions were folded with additional complementary staples. Scale 
bars: 200 nm. 
A.3 Additional figures from chapter 5 
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Figure A 21. Wide-field tSEM micrographs for the flat large structures. (A) Folded struc-
tures with gap regions; (B) Structures filled by T4 DNA polymerase at 40 °C for 3 min, 
followed by an inactivation step using 2-Mercaptoethanol at 25 °C for 1 min; (C) Control 
structures without gap regions were folded with additional complementary staples. Scale 
bars: 100 nm. 
A.3 Additional figures from chapter 5  
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Figure A 22. Wide-field tSEM micrographs for the tube large structures. (A) Folded struc-
tures with gap regions; (B) Structures filled by T4 DNA polymerase at 40 °C for 3 min, 
followed by an inactivation step using 2-Mercaptoethanol at 25 °C for 1 min; (C) Control 
structures without gap regions were folded with additional complementary staples. Scale 
bars: 200 nm. 
A.3 Additional figures from chapter 5 
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Figure A 23. Wide-field tSEM image for the curved “gap” tube small structures (Figure 
5-17). The angles were between the end points and the center of 260 structures were 
determined using ImageJ. The measured angles were then plotted on a histogram and 
fitted with a Gaussian function (Figure 5-17 C). Scale bars: 200 nm. 
A.3 Additional figures from chapter 5  
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Figure A 24. Wide-field tSEM image for the curvature study of extended tube small struc-
tures (Figure 5-17). Angles were measured and plotted as above (Figure 5-17 C). The 
gap regions in the curved tubes were extended with the help of T4 DNA polymerase at 
25 °C for 3 min, followed by inactivation with 2-Mercaptoethanol. Scale bars: 200 nm. 
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